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Chondroitin	   sulfate	   proteoglycans	   (CSPGs)	   and	   their	   specific	   sulfation	   pattern	   by	  
chondroitinsulfotransferases	   (Chsts)	   appear	   to	   play	   a	   crucial	   role	   for	   the	  behaviour	   of	   neural	  
stem	  cells	  (NSCs)	  in	  the	  embryonic	  neural	  stem	  cell	  niche	  during	  mouse	  forebrain	  development.	  
It	  has	  been	  shown	  that	  the	  inhibition	  of	  the	  sulfation	  by	  sodium	  chlorate	  or	  the	  degradation	  of	  
the	   CSPG	   glycosaminoglycans	   (GAGs)	   by	   chondroitinase	   ABC	   leads	   to	   less	   proliferation	   and	  
altered	  cell	  fate	  decisions	  of	  the	  NSCs	  (Sirko	  et	  al.,	  2007,	  Akita	  et	  al.,	  2008,	  Sirko	  et	  al.,	  2010).	  
In	  the	  present	  study,	  the	  impact	  of	  the	  overexpression	  of	  one	  specific	  Chst	  on	  the	  behaviour	  of	  
NSCs	  was	  examined.	  Therefore,	  Ust	  was	  overexpressed	   in	   in	   vitro	   and	   in	   vivo	   experiments	   in	  
order	  to	  elucidate	  the	  role	  of	  disulfated	  CS-­‐units	  on	  NSCs'	  self-­‐renewal,	  proliferation	  as	  well	  as	  
differentiation.	  
The	  functionality	  of	  the	  Ust	  fusion	  proteins	  (Ust,	  Ust	  mut)	  and	  their	  correct	  location	  to	  the	  Golgi	  
apparatus,	  where	  the	  sulfation	  of	  the	  GAGs	  takes	  place,	  could	  be	  confirmed	  by	  CS-­‐GAG	  epitope	  
detection	   with	   the	   monoclonal	   antibody	   473HD	   and	   with	   the	   Golgi	   apparatus	   marker	  
transgolgin-­‐97.	  
Initially,	  the	  effect	  of	  Ust	  overexpression	  on	  the	  differentiation	  and	  proliferation	  behaviour	  of	  
neurosphere-­‐derived	   NSCs	   was	   examined	   by	   the	   respective	   in	   vitro	   assays.	   Here,	   I	   could	  
observe	   an	   increase	   in	   neurogenesis.	   The	   enhanced	   neuronal	   differentiation	   occurred	   at	   the	  
expense	  of	  oligodendrocyte	  precursor	  cell	   (OPC)	  generation,	  while	  NSC	  proliferation	  and	  self-­‐
renewal	   were	   not	   effected.	   Although,	   there	   was	   a	   very	   small	   but	   significant	   increase	   in	   the	  
number	  of	  neurospheres	  after	  Ust	  overexpression	  without	  growth	  factor	  supplementation.	  
To	  verify,	  whether	  Ust	  overexpression	  stimulates	  neurogenesis	  similarly	  in	  vivo,	  I	  performed	  in	  
utero	   electroporation	   experiments.	   The	   immunohistochemical	   analysis	   of	   in	   utero	  
electroporated	   E14.5	   mouse	   cortices	   two	   days	   post-­‐transfection	   revealed	   that	   Ust	  
overexpression	  caused	  a	  thinner	  cortical	  plate,	  which	  is	  a	  consequence	  of	  reduced	  numbers	  of	  
NeuN+-­‐neurons	  in	  this	  area.	  In	  contrast,	  the	  amount	  of	  Pax6+	  radial	  glia	  cells	  in	  the	  ventricular	  
zone	  was	  slightly	  increased.	  The	  analysis	  of	  NSC	  proliferation	   in	  vivo	  by	  EdU	  incorporation	  did	  
not	  reveal	  a	  significant	  difference	  and	  was	  consistent	  with	  the	  obtained	  in	  vitro	  results.	  
Moreover,	   I	  designed	  a	   strategy	   for	  an	  Ust	  conditional	  knockout	  mouse	   line	   to	  enable	   future	  
examinations	  of	  the	  sulfation	  pattern	  impact	  on	  CNS	  development.	  
In	  conclusion,	  I	  could	  show	  an	  efficient	  and	  functional	  Ust	  overexpression,	  which	  exhibited	  an	  
effect	  on	  NSC	  behaviour	  in	  vitro	  and	  in	  vivo.	  The	  effect	  is	  due	  to	  the	  modified	  sulfation	  pattern,	  
which	   could	   be	   confirmed	   by	   using	   the	   negative	   control	   Ust	   mut.	   Consistent	   with	   previous	  
observations,	  the	  sulfation	  of	  the	  CSPGs	  plays	  a	  role	  in	  the	  commitment	  of	  NSCs	  within	  the	  NSC	  
niche	   and	   could	   function	   as	   a	   possible	   communication	   platform	   between	   NSCs	   and	   their	  
extracellular	  surrounding	  in	  the	  NSC	  niche.	  
ZUSAMMENFASSUNG	   VII	  
IV.	  ZUSAMMENFASSUNG	  
Chondroitinsulfatproteoglykane	   (CSPGs)	   und	   deren	   spezifisches	   Sulfatierungsmuster	   durch	  
Chondroitinsulfotransferasen	   (Chsts)	   scheinen	   eine	   besondere	   Rolle	   für	   das	   Verhalten	   von	  
neuralen	   Stammzellen	   (NSCs)	   in	   der	   embryonalen	   Stammzellnische	   während	   der	  
Vorderhirnentwicklung	   der	   Maus	   zu	   spielen.	   Durch	   Inhibierung	   der	   Sulfatierung	   duch	  
Natriumchlorat	   oder	   Abverdau	   der	   CSPG	   Glykosaminoglykane	   (GAGs)	   durch	   Chondroitinase	  
ABC	   konnte	   gezeigt	   werden,	   dass	   dies	   zu	   einer	   reduzierten	   Proliferation	   und	   veränderten	  
Zellschicksalentscheidungen	  führte	  (Sirko	  et	  al.,	  2007,	  Akita	  et	  al.,	  2008,	  Sirko	  et	  al.,	  2010).	  
In	  der	  vorliegenden	  Arbeit	  wurde	  der	  Einfluss	  einer	   spezifischen	  Chst	  Überexpression	  auf	  das	  
Verhalten	   von	   NSCs	   untersucht.	   Dafür	   wurde	   Ust	   in	   in	   vitro	   und	   in	   vivo	   Experimenten	  
überexprimiert	  um	  die	  Rolle	  von	  disulfatierten	  CS-­‐Einheiten	  bezüglich	  Selbsterhalt,	  Proliferation	  
und	  Differenzierung	  von	  NSCs	  zu	  überprüfen.	  
Die	  Funktionalität	  der	  Ust	  Fusionsproteine	  (Ust,	  Ust	  mut)	  und	  deren	  korrekte	  Lokalisierung	  im	  
Golgi	  Apparat,	  wo	  die	  Sulfatierung	  stattfindet,	  konnten	  immunologisch	  mit	  dem	  CS-­‐GAG	  Epitop	  
erkennenden	   473HD	   Antikörper	   und	   dem	   Golgi	   Apparat	   Marker	   transgolgin-­‐97	   bestätigt	  
werden.	  
Zunächst	   wurde	   der	   Einfluss	   durch	   Ust	   Überexpression	   auf	   das	   Differenzierungs-­‐	   und	  
Proliferationsverhalten	   aus	   Neurosphären	   generierter	   NSCs	   in	   den	   jeweiligen	   in	   vitro	   Assays	  
untersucht.	   Dabei	   konnte	   ein	   Anstieg	   der	   Neurogenese	   beobachtet	   werden.	   Die	   verstärkte	  
neuronale	   Differenzierung	   trat	   gegenläufig	   zur	   Generation	   von	   Oligodendrozyten	  
Vorläuferzellen	   (OPCs)	   auf,	   wobei	   die	   Proliferation	   und	   der	   Selbsterhalt	   der	   NSCs	   nicht	  
beeinflusst	  wurde.	  Allerdings	  konnte	  ein	  sehr	  kleiner	  jedoch	  signifikanter	  Anstieg	  in	  der	  Anzahl	  
der	  Neurosphären	  nach	  Ust	  Überexpression	  ohne	  Zusatz	  von	  Wachtsumsfaktoren	  beobachtet	  
werden.	  
Zur	  Verifizierung,	  ob	  Ust	  Überexpression	  die	  Neurogenese	  in	  vivo	  ähnlich	  stimuliert,	  habe	  ich	  in	  
utero	   Elektroporationen	   durchgeführt.	   Die	   immunhistochemische	   Analyse	   der	   E14.5	   in	   utero	  
elektroporierter	   Maus-­‐Cortices	   zeigten	   zwei	   Tage	   nach	   der	   Transfektion,	   das	   die	   Ust	  
Überexpression	  eine	  dünnere	  kortikale	  Platte	  hervorruft,	  welche	  durch	  eine	  geringere	  Anzahl	  
an	   NeuN+-­‐Neuronen	   verursacht	   wurde.	   Im	   Kontrast	   dazu	   war	   die	   Anzahl	   Pax6+	   radialer	  
Gliazellen	   in	   der	   ventrikulären	   Zone	   leicht	   erhöht.	   Die	   Proliferationsanalyse	   der	   NSCs	   in	   vivo	  
durch	   EdU	   Inkorporation	   ließ	   keine	   signifikanten	   Unterschiede	   in	   der	   Anzahl	   der	  
proliferierenden	  NSCs	  erkennen	  und	  stimmte	  mit	  den	  in	  vitro	  Ergebnissen	  überein.	  
Außerdem	  habe	  ich	  eine	  Strategie	  zur	  Generierung	  einer	  konditionalen	  Ust	  Knockout-­‐Mauslinie	  
entworfen,	   um	   die	   zukünftige	   Analyse	   des	   Einflusses	   des	   Sulfatierungsmusters	   auf	   die	  
Entwicklung	  des	  ZNS	  zu	  ermöglichen.	  
Zusammenfassend	  konnte	  die	  effiziente	  und	   funktionelle	  Ust	  Überexpression	  gezeigt	  werden,	  
deren	  Effekte	  in	  vitro	  offensichtlicher	  waren	  als	  in	  vivo.	  Der	  Effekt	  beruht	  auf	  der	  modifizierten	  
Sulfatierung,	  was	  durch	  den	  Einsatz	  von	  Ust	  mut	  zu	  sehen	  war.	  Übereinstimmend	  mit	  früheren	  
Ergebnissen,	  konnte	  der	  Einfluss	  der	  Sulfatierung	  von	  CSPGs	  auf	  das	  Verhalten	  von	  NSCs	  in	  der	  
NSC	  Nische	  festgestellt	  werden	  und	  es	  könnte	  als	  mögliche	  Kommunikationsplatform	  zwischen	  
NSCs	  und	  ihrer	  extrazellulären	  Umgebung	  in	  der	  Nische	  fungieren.	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1	  INTRODUCTION	  
1.1	  NEURAL	  DEVELOPMENT	  
1.1.1	  NEUROGENESIS	  DURING	  THE	  DEVELOPMENT	  OF	  THE	  VERTEBRATE	  CENTRAL	  NERVOUS	  SYSTEM	  
During	  the	  vertebrate	  central	  nervous	  system	  (CNS)	  development	  a	  lot	  of	  intrinsic	  and	  extrinsic	  
cues	  play	  a	  role	  for	  the	  generation	  of	  the	  different	  cell	   types	  and	  for	  the	  establishment	  of	   its	  
complex	   architecture.	   The	   vertebrate	   CNS	   develops	   from	   one	   single	   layer	   of	   neuroepithelial	  
stem	  cells	  (NECs),	  which	  are	  lining	  the	  ventricle	  after	  neurulation	  and	  forming	  the	  neural	  tube.	  
The	   NECs	   are	   undergoing	   symmetric,	   proliferative	   divisions	   and	   thereby	   causing	   the	   lateral	  
expansion	   of	   the	   developing	   brain	   (Gotz	   and	   Huttner,	   2005).	   In	   symmetric	   divisions	   two	  
identical	   daughter	   cells	   are	   generated,	   in	   this	   case	   two	   identical	   NECs.	   The	   NECs	   exhibit	   an	  
apical-­‐basal	  polarity	  (Huttner	  and	  Brand,	  1997).	  They	  possess	  two	  processes,	  one	  apical	  process	  
facing	   the	   ventricle	   and	   one	   basal	   process	   spanning	   to	   the	   pial	   basal	   membrane	   of	   the	  
neuroepithelium	  (Figure	  1).	  Their	  nucleus	  is	  migrating	  along	  the	  apical-­‐basal	  axis	  during	  the	  cell	  
cycle	   (interkinetic	   nuclear	   migration	  =	  INM)	   and	   resides	   at	   the	   apical	   side	   during	   mitosis	  
(Taverna	  and	  Huttner,	  2010).	  The	  fact	  of	  INM	  of	  the	  NECs	  creates	  a	  stratified	  appearance	  and	  
therefore	  the	  single	  layered	  neuroepithelium	  is	  classified	  as	  pseudostratified.	  
The	  phase	  of	  symmetric	  proliferative	  divisions	  is	  followed	  by	  a	  phase	  of	  asymmetric	  neurogenic	  
divisions	   (Rakic,	   1995),	  meaning	  a	  neural	   stem	  cell	   generates	  one	   identical	  daughter	   cell	   and	  
one	  more	  differentiated	  cell.	  The	  latter	  can	  refer	  to	  a	  pool	  of	  intermediate	  progenitor	  (IP)	  cells,	  
that	  usually	  undergoes	  symmetric	  neurogenic	  divisions,	  or	  to	  directly	  generated	  neurons	  (Gotz	  
and	  Huttner,	  2005).	  This	  process	  of	  generating	  the	  different	  neuronal	  cell	   types	  of	   the	  CNS	   is	  
named	  neurogenesis	  and	  the	  first	  waves	  of	  neurogenesis	  start	  in	  mice	  at	  about	  embryonic	  day	  
(E)	  9-­‐10	   (Rowitch	  and	  Kriegstein,	  2010).	   Figure	  1	  gives	  an	  overview	  of	  neurogenesis	  depicting	  
the	  involved	  types	  of	  stem	  and	  progenitor	  cells	  and	  their	  progeny	  as	  well	  as	  the	  resulting	  layers	  
and	  zones	  of	   the	  developing	  cortex.	  With	   the	  onset	  of	  neurogenesis	   the	  NECs	   transform	   into	  
radial	   glia	   cells	   (RGCs)	   and	   reduce	   their	   epithelial	   properties	   and	   hallmarks	   of	   astroglial	   cells	  
appear	   (Gotz	   and	  Huttner,	   2005).	   RGCs	   still	  maintain	   the	   highly	   polarized	   structure,	   conduct	  
INM	   and	   retain	   their	   proliferative	   capacities.	   They	   are	   responsible	   for	   the	   generation	   of	   all	  
neurons	  and	  at	  later	  developmental	  stages	  of	  macroglial	  cells,	  astrocytes	  and	  oligodendrocytes	  
(Paridaen	   and	   Huttner,	   2014).	   That	   is	   why	   they	   are	   also	   often	   referred	   as	   neural	   stem	   cells	  
(NSCs),	  which	   is	   further	  described	   in	   the	   following	  chapter	   (1.1.2	  Neural	  Stem	  Cells	  and	   their	  
Niche).	  
The	   transition	  of	   the	  NECs	   to	  RGCs	  and	   the	   change	   from	   symmetric	  proliferative	  divisions	   to	  
asymmetric	  neurogenic	  divisions	   is	   accompanied	  by	  prolongation	  of	   the	   cell	   cycle	   length	  and	  
starts	  with	  the	  onset	  of	  neurogenesis	  (Takahashi	  et	  al.,	  1995,	  Calegari	  et	  al.,	  2005,	  Paridaen	  and	  
Huttner,	   2014).	   Concomitantly,	   the	   location	   of	   mitosis,	   cell	   polarity	   properties,	   proliferative	  
capacity	   and	   the	   mode	   of	   cell	   division	   influence	   the	   progeny's	   cell	   fate	   determination	   and	  
development	   (Taverna	   et	   al.,	   2014).	   In	   the	  mammalian	   neocortex,	   additional	   progenitor	   cell	  
types	  are	  present	  as	  indicated	  in	  the	  box	  of	  Figure	  1,	  e.g.	  basal	  radial	  glia	  cells	  (bRGs)	  (Pilz	  et	  al.,	  
2013,	  Taverna	  et	  al.,	  2014).	  bRGs	  only	  have	  a	  basal	  process	  and	  seem	  to	  be	  important	  during	  
the	  evolutionary	  expansion	  of	  the	  mammalian	  cortex	  (LaMonica	  et	  al.,	  2013).	  The	  cells	  directly	  
lining	   the	   ventricle	   establish	   the	   ventricular	   zone	   (VZ),	   whereas	   the	   newly	   generated	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progenitors	   create	   the	   adjacent	   subventricular	   zone	   (SVZ)	   by	   migrating	   out	   of	   the	   VZ	   and	  
detach	  from	  the	  apical	  membrane	  (Noctor	  et	  al.,	  2004).	  The	  newly	  born	  neurons	  migrate	  along	  
the	  RGC	  processes	  towards	  the	  pial	  surface	  to	  the	  cortical	  plate	  (CP)	  and	  generate	  the	  six	  layers	  
of	  the	  neocortex	   in	  an	  "inside-­‐out"	  pattern,	  with	   its	  deep	   layer	  neurons	  born	  earlier	  than	  the	  
upper	  layer	  neurons	  (Rakic,	  1972,	  Marin	  and	  Rubenstein,	  2003).	  At	  around	  E	  18.5	  a	  switch	  from	  
neurogenesis	   to	   gliogenesis	   occurs,	   during	   which	   most	   RGCs	   retract	   their	   apical/radial	  
processes	  and	  adopt	  a	  more	  astrocytic	  morphology	  (Martynoga	  et	  al.,	  2012).	  This	  switch	  from	  
neuro-­‐	   to	   gliogenesis	   is	   caused	   by	   the	   production	   of	   neurons	   itself:	   via	   upregulation	   of	   the	  
important	   factors	  and	  crosstalk	  of	  the	  different	  signalling	  pathways,	   the	  timing	  signals	  to	  end	  
neurogenesis	   and	   start	   producing	   glial	   cells	   are	   provided	   (Martynoga	   et	   al.,	   2012).	   Although,	  
the	   process	   of	   neurogenesis	   is	  maintained	   until	   adulthood,	   the	   RGCs	   are	   restricted	   to	   a	   few	  
niches	  as	  adult	  neural	  stem	  cells	  (NSCs)	  and	  are	  drastically	  reduced	  in	  number	  (Kriegstein	  and	  
Alvarez-­‐Buylla,	  2009,	  Dimou	  and	  Gotz,	  2014).	  
	  
Figure	  1	  Schematic	  overview	  of	  neurogenesis	  in	  the	  embryonic	  vertebrate	  CNS	  
The	  different	   stem/progenitor	  cell	   types	  and	   their	  progeny	  are	  shown	   in	   the	   indicated	  colour	  and	   the	  
corresponding	   division	  mode/lineage	   outcome	   is	   listed	   beneath/above.	   In	   the	   box	   are	   progenitor	   cell	  
types	  depicted,	  that	  are	  usually	  attendant	  in	  mammalian	  species.	  Note,	  that	  not	  every	  possible	  progeny	  
is	  included	  here.	  Modified	  from	  Paridaen	  and	  Huttner	  2014.	  
1.1.2	  NEURAL	  STEM	  CELLS	  AND	  THEIR	  NICHE	  
Stem	  cells	  are	  defined	  as	  cells	  that	  are	  capable	  of	  self-­‐renewal	  (for	  an	  (un-­‐)limited	  number	  of	  
cell	  divisions)	  and	  are	  multipotent	  (able	  to	  give	  rise	  to	  numerous	  differentiated	  cell	  types	  of	  a	  
tissue).	  In	  the	  CNS,	  these	  stem	  cells	  are	  called	  neural	  stem	  cells	  (NSCs),	  which	  include	  NECs	  and	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RGCs	  as	  well	  as	  the	  progenitor	  cells,	  which	  are	  more	  limited	  in	  their	  proliferation	  capacity	  and	  
can	  be	  further	  distinguished	  by	  their	   location	  of	  mitosis,	  their	  extent	  of	  cell	  polarity	  and	  their	  
proliferative	  capacity	  (Taverna	  et	  al.,	  2014).	  They	  give	  rise	  to	  neurons	  and	  macroglial	  cell	  types	  
(astrocytes,	  oligodendrocytes,	  NG2	  glia,	  ependymal	  cells)	  (Taverna	  et	  al.,	  2014).	  Figure	  2	  shows	  




Figure	  2	  Schematic	  overview	  of	  neural	  stem	  cells	  
The	  overview	  shows	   the	  capacity	  of	  NSCs	   for	   self-­‐renewal	  and	   their	  potential	  progeny	   lineages.	  Note:	  
oligodendrocytes	  and	  astrocytes	  are	  exemplarily	  depicted	  for	  the	  macroglial	  lineage.	  
	  
NSCs	   are	   abundant	   in	   the	   embryonic	   developing	   brain	   and	   also	   reside	   in	   the	   adult	   brain	   of	  
vertebrates,	  although	  in	  a	  greatly	  reduced	  number	  and	  in	  a	  more	  regionally	  restricted	  manner	  
(Kriegstein	   and	   Alvarez-­‐Buylla,	   2009,	   Barry	   et	   al.,	   2014,	   Ninkovic	   and	   Gotz,	   2014).	   The	  
microenvironment,	  that	  surrounds	  NSCs	  and	  maintains	  their	  stem	  cell	  character	  as	  well	  as	  their	  
proliferation	  capacity,	  is	  called	  a	  stem	  cell	  niche	  (Doetsch,	  2003,	  Kriegstein	  and	  Alvarez-­‐Buylla,	  
2009,	   Ihrie	   and	   Alvarez-­‐Buylla,	   2011).	   The	   stem	   cell	   niche	   usually	   comprises	   niche	   cells,	  
adhesion	  molecules	  and	  a	  specialised	  extracellular	  matrix	  (ECM)	  with	  its	  corresponding	  factors	  
(Scadden,	  2006,	  Discher	  et	  al.,	  2009).	  The	  distinct	  microenvironment	  composition	  of	  a	  stem	  cell	  
niche	  will	  be	  further	  described	  in	  the	  following	  chapter	  of	  the	  ECM.	  Figure	  3	  gives	  an	  overview	  
of	  neurogenesis	  with	  its	  involved	  types	  of	  neural	  stem	  and	  progenitor	  cells	  and	  their	  progeny	  as	  




Figure	  3	   Schematic	   overview	   of	   neurogenesis	   with	   its	   influencing	   environmental	   cues	   during	   the	   embryonic	  
vertebrate	  CNS	  development	  
The	  different	  cell	   types	  present	  during	  neurogenesis	  are	   indicated	   in	  distinct	  colours.	  The	  scheme	  also	  
depicts	   influencing	   cues	   derived	   from	   the	   surrounding	  microenvironment,	   constituted	   by	   the	   present	  
cell	  types	  and	  signals	  within	  the	  extracellular	  matrix.	  Modified	  from	  Paridaen	  and	  Huttner	  2014.	  
During	  developmental	  neurogenesis	  several	  environmental	  cues	  play	  a	  role	  in	  the	  commitment	  
of	   the	  NSCs.	   The	  meninges	   for	  example	   secrete	   retinoic	  acid	   (RA)	   from	   the	  basal	   side,	  which	  
promotes	   asymmetric	   neurogenic	   divisions	   at	   the	   onset	   of	   neurogenesis	   (Siegenthaler	   et	   al.,	  
2009).	   Extracellular	   matrix	   (ECM)	   components	   (e.g.	   basal	   lamina	   of	   blood	   vessels)	   and	  
morphogen	   gradients,	   such	   as	   Wnts,	   Shh,	   FGFs	   and	   BMPs,	   induce	   by	   their	   patterning	   the	  
expression	  of	  homeodomain	  and	  bHLH	  transcription	  factors	  and	  thereby	  cause	  the	  generation	  
of	   specific	   cell	   types	   (Martynoga	   et	   al.,	   2012).	   For	   instance,	   the	   FGF	   signalling	   pathway	   is	  
implicated	  in	  several	  ways:	  among	  slowing	  down	  the	  RGC	  to	  BP	  progression	  (Kang	  et	  al.,	  2009),	  
FGF	  10	  has	  been	  shown	  to	  increase	  RGC	  hallmarks	  after	  overexpression	  and	  a	  mutant	  version	  of	  
FGF	  10	  led	  to	  the	  extension	  of	  NE	  expansion	  and	  a	  delayed	  neurogenesis	  (Sahara	  and	  O'Leary,	  
2009),	   whereas	   a	   constitutively	   active	   form	   of	   the	   FGF	  2	   receptor	   (FGFR	  2)	   caused	   an	   early	  
transition	  from	  NECs	  to	  RGCs	  (Yoon	  et	  al.,	  2004).	  Additionally,	  FGF	  2	  maintains	  the	  proliferation	  
of	  progenitor	  cells	  at	  early	  stages	  of	  neurogenesis	  (Raballo	  et	  al.,	  2000).	  Important	  is	  the	  spatial	  
and	  temporal	  presence	  of	  the	  various	  extrinsic	  cues,	  which	  can	  change	  over	  time	  and	  thereby	  
modify	   the	   NSCs	   behaviour	   and	   properties	   (Rozario	   and	   DeSimone,	   2010).	   Hence,	   the	  
interaction	  of	  various	  processes	  regulate	  cell	  fate	  determination:	  1)	  signalling	  pathways	  (Notch,	  
Wnt,	   Shh,	   FGF,	   etc.),	   2)	  transcriptional	   mechanisms	   (modulation	   gene	   expression	   by	  
transcription	   factors	   (TFs)	   or	   post-­‐transcriptional/-­‐translational	   regulations/modifications),	  
3)	  epigenetic	   modifications	   (DNA-­‐methylation,	   histone	   modification),	   4)	   environment	   (ECM)	  
(Martynoga	  et	  al.,	  2012,	  Paridaen	  and	  Huttner,	  2014).	  The	  proper	  construction	  of	   the	  brain's	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architecture	  is	  a	  highly	  organized	  and	  complex	  process,	  within	  the	  orchestration	  of	  the	  balance	  
between	  self-­‐renewal,	  proliferation	  and	  differentiation	   (Wang	  et	  al.,	   2012)	  plays	   the	  key	   role	  
with	  all	  its	  influencing	  intrinsic	  and	  extrinsic	  cues.	  
It	   is	  a	  well-­‐known	  and	  established	  method	   to	  cultivate	  NSCs	   in	   vitro	   as	  neurospheres	   (nsphs)	  
(Reynolds	   et	   al.,	   1992,	  Reynolds	   and	  Weiss,	   1992).	   The	  NSCs	   are	   isolated	   from	  embryonic	  or	  
adult	   brain	   and	   cultured	   under	   proliferative	   conditions	   as	   free-­‐floating	   cells,	   which	   then	  
proliferate	  and	  generate	  spherical	  aggregates,	  the	  so-­‐called	  neurospheres.	  The	  NSCs,	  cultivated	  
with	   this	  model	   system,	   retain	   their	   self-­‐renewal	   capacity	   as	  well	   as	   their	  multipotency	   over	  
several	  passages	  and	  are	  able	   to	  give	  rise	   to	  neurons,	  astrocytes	  and	  oligodendrocytes	  under	  
differentiating	  conditions	   (Reynolds	  et	  al.,	  1992,	  Reynolds	  and	  Weiss,	  1992).	  Hence,	   this	   is	  an	  
appropriate	  model	  system	  to	  examine	  the	  behaviour	  of	  NSCs	  in	  vitro.	  For	  the	  in	  vivo	  analysis	  of	  
NSCs	  in	  utero	  electroporation	  is	  one	  of	  the	  preferred	  techniques	  to	  manipulate	  NSC	  behaviour	  
by	  overexpression	  or	  knockdown	  of	  a	  protein	  of	  interest.	  Further	  details	  are	  mentioned	  in	  2.10	  
In	  Utero	  Electroporation.	  
1.2	  THE	  EXTRACELLULAR	  MATRIX	  
1.2.1	  THE	  EXTRACELLULAR	  MATRIX	  IN	  THE	  CENTRAL	  NERVOUS	  SYSTEM	  AND	  ITS	  COMPLEXITY	  OF	  
FUNCTIONS	  
The	  extracellular	  matrix	  (ECM)	  got	  more	  into	  research	  focus	  in	  the	  last	  decades,	  since	  it	  is	  clear	  
that	  ECM	  functions	  exceed	  being	  the	  simple	  surrounding	  of	  cells	  and	  only	  providing	  structural	  
stability	  (Rozario	  and	  DeSimone,	  2010,	  Burnside	  and	  Bradbury,	  2014,	  Levy	  et	  al.,	  2014,	  Hopkins	  
et	  al.,	  2015).	  Beyond	  regulating	  structural	  properties,	  the	  ECM	  bears	  biochemical	  signals	  as	  well	  
as	  physical	  signals	  (mechanotransduction),	  which	  taken	  as	  a	  whole	  result	   in	  a	  physical	   linkage	  
with	   the	   cytoskeleton	   and	   enable	   a	   bidirectional	   information	   flow	   among	   extra-­‐	   and	  
intracellular	  signals	  (Rozario	  and	  DeSimone,	  2010).	  
The	  ECM	  is	  produced	  and	  modified	  by	  its	  containing	  cells	  and	  their	  secreted	  factors.	  It	  mainly	  
consists	  of	  glycosaminoglycans	  (GAGs),	  proteoglycans	  (PGs)	  and	  glycoproteins	  (collagens	  +	  non-­‐
collagenous	  proteins)	   (Rozario	  and	  DeSimone,	  2010).	   In	   the	  CNS	  ECM,	  PGs	  and	  glycoproteins	  
are	  abundantly	  present,	  whereas	  collagens	  and	  fibronectin	  are	  rather	  present	  on	  specific	  ECM	  
structures	   (e.g.	   basement	  membrane	   (basal	   lamina)	  =	  BM,	   perineuronal	   net	  =	  PNN)	   (Burnside	  
and	  Bradbury,	   2014).	  Among	   the	  diffused	   composition	   in	   the	   interstitial	   space,	   the	  CNS	  ECM	  
can	   be	   arranged	   in	   the	   already	  mentioned	  distinct,	   condensed	   ECM	   forms	   like	   PNNs	   or	   BMs	  
(Lau	  et	  al.,	  2013).	  BMs	  function	  as	  boundaries	  between	  the	  meninges	  or	  CNS	  blood	  vessels	  and	  
the	  CNS	  parenchyma.	  They	  predominantly	  comprise	  collagens,	  laminins,	  fibronectin	  and	  play	  an	  
important	   role	   for	   the	   maintenance	   of	   the	   blood-­‐brain	   barrier	   (BBB)	   (Lau	   et	   al.,	   2013).	   The	  
collagens	   provide	   for	   example	   the	   physical	   stability	   towards	   tension	   (Rozario	   and	  DeSimone,	  
2010).	   PNNs	   surround	   cell	   somas,	   dendrites	   or	   axon	   segments	   of	   distinct	   neurons	   and	   are	  
detectable	   in	   later	  developmental	  stages	  as	   the	  critical	  period	  (Lau	  et	  al.,	  2013,	  Burnside	  and	  
Bradbury,	   2014).	   PGs	   are	   the	  major	   component	   of	   PNNs	   and	   are	   also	   implicated	   in	   the	   PNN	  
functions	   e.g.	   to	   regulate	   synaptic	   plasticity	   (Kwok	   et	   al.,	   2011,	   Lau	   et	   al.,	   2013).	   PNN	  
components	   are	   mainly	   CSPGs	   of	   the	   lectican	   family,	   hyaluronic	   acid,	   link	   proteins	   and	  
glycoproteins	   as	   tenascin	  R	   (Tn-­‐R)	   (Carulli	   et	   al.,	   2006,	   Deepa	   et	   al.,	   2006).	   CSPG	   rich	   PNNs	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restrict	  developmental	  plasticity	  and	   in	  case	  of	  elimination	  of	  PNN	  constituents	  such	  as	  CS	  or	  
link	  proteins	  the	  plasticity	  can	  be	  restored	  in	  adult	  CNS	  (Carulli	  et	  al.,	  2010,	  Kwok	  et	  al.,	  2011).	  
Another	   type	  of	   specialized	  ECM	  structures	  are	   the	  so-­‐called	   fractones	   (Mercier	  et	  al.,	  2002).	  
They	   are	   a	   specialized,	   extravascular,	   elongated	   and	  highly	   branched	   form	  of	   BMs	  with	   their	  
stem	  at	  capillaries	   in	   the	  SVZ	  of	  adult	  brain	  and	  are	   in	  contact	  with	  all	  cell	   types	  of	   the	  adult	  
niche	  (Mercier	  et	  al.,	  2002).	  The	  major	  components	  of	  the	  fractones	  are	  similar	  to	  normal	  BMs	  
and	  comprise	  laminin,	  nidogen,	  collagen	  and	  PGs	  (mainly	  HSPGs).	  It	  is	  proposed	  that	  fractones	  
promote	  GF	   (e.g.	   FGF	  2,	   BMP	  7)	   presentation	   to	  NSCs	   in	   their	   niche	   via	   the	  HSPGs	   and	   their	  
GAG-­‐chains	  (Kerever	  et	  al.,	  2007,	  Douet	  et	  al.,	  2012).	  The	  neural	   interstitial	  matrix	  exhibits	  as	  
key	   components	   hyaluronic	   acid	   (HA),	   PGs	   and	   glycoproteins	   such	   as	   tenascins	   (Lau	   et	   al.,	  
2013).	   Altogether,	   the	   ECM	   is	   serving	   as	   adhesive	   substrate	   for	   migration,	   is	   providing	  
structure,	   capable	   of	   binding/storing/sequestering	   signalling	   molecules	   (e.g.	   growth	  
factors	  =	  GFs)	  and	  sensing/transducing	  mechanical	  signals	  (mechanotransduction)	  (Rozario	  and	  
DeSimone,	   2010).	   The	   modification	   of	   the	   ECM	   constitution	   is	   besides	   the	   secretion	   and	  
generation	   of	   the	   matrix	   also	   accomplished	   via	   its	   degradation.	   This	   is	   performed	   by	   ECM	  
component	   degrading	   enzymes	   such	   as	   matrix	   metalloproteinases	   (MMPs)	   and	   by	   family	  
members	  of	  a	  disintegrin	  and	  metalloproteinase	  (ADAMs)	  (Rozario	  and	  DeSimone,	  2010).	  
Additionally,	  the	  ECM	  can	  function	  as	  a	  special	  microenvironment,	  called	  niche,	  in	  which	  stem	  
cells	  maintain	  their	  self-­‐renewal	  and	  proliferation	  capacity	  even	  into	  adulthood	  (Doetsch,	  2003,	  
Kriegstein	  and	  Alvarez-­‐Buylla,	  2009,	  Barry	  et	  al.,	  2014).	  In	  the	  CNS,	  there	  are	  few	  known	  niches,	  
where	  NSCs	  are	  maintained	  and	  retain	  their	  neuron	  generating	  capacity:	  the	  SVZs	  of	  the	  lateral	  
ventricles,	  the	  subgranular	  zone	  (SGZ)	  of	  the	  hippocampus	  and	  in	  the	  hypothalamus	  (Kriegstein	  
and	   Alvarez-­‐Buylla,	   2009,	  Martynoga	   et	   al.,	   2012,	   Dimou	   and	   Gotz,	   2014).	   The	   NSCs	   can	   be	  
separated	   in	   distinct	   types	   of	   NSCs	   building	   different	   pools	   of	   NSCs,	   which	   differ	   in	   their	  
regional	  identity	  and	  properties,	  thereby	  causing	  a	  distinct	  capacity	  to	  generate	  specialised	  and	  
regionalised	   NSCs	   in	   specific	   regions,	   respectively	   (Ninkovic	   and	   Gotz,	   2014).	   This	   effect	   is	  
provoked	  by	  intrinsic	  signals	  as	  well	  as	  various	  signals	  of	  the	  ECM.	  For	  instance,	  NSCs	  derive	  key	  
signals	  (e.g.	  IGF	  2,	  FGF	  2)	  from	  the	  cerebrospinal	  fluid	  (CSF)	  during	  development	  and	  adulthood,	  
which	  may	   function	   as	   a	   niche	   by	   globally	   providing	   secreted	   factors	   to	   the	   exposed	   apical,	  
ventricular	   domains	   of	   NSCs	   (Johansson	   et	   al.,	   2010,	   Lehtinen	   et	   al.,	   2011,	   Zappaterra	   and	  
Lehtinen,	  2012,	  Johansson	  et	  al.,	  2013).	  Concomitantly,	  there	  are	  also	  NSCs	  without	  contact	  to	  
the	  ventricle	  or	   the	   typical	  apico-­‐basal	  polarity	  of	  RGCs	   (Kriegstein	  and	  Alvarez-­‐Buylla,	  2009).	  
These	  NSCs	  receive	  signals	  from	  the	  meninges	  or	  blood	  vessels	  and	  their	  BMs,	  from	  other	  cells	  
like	  microglia	  or	  Cajal-­‐Retzius	  cells	  as	  well	  as	  from	  the	  neural	  interstitial	  matrix	  (Siegenthaler	  et	  
al.,	  2009,	  Paridaen	  and	  Huttner,	  2014)	  (Figure	  3).	  Blood	  vessels	  for	  example	  have	  an	  influence	  
on	   intermediate	   progenitor	   (IP)	   proliferation	   during	   embryonic	   development	   similar	   to	   the	  
impact	   on	   NSCs	   in	   the	   adult	   NSC	   niche	   (Paridaen	   and	   Huttner,	   2014).	   Microglia	   have	   been	  
identified	  to	  regulate	  the	  maintenance	  of	  RGCs	  and	  Cajal-­‐Retzius	  neurons	  secrete	  reelin,	  which	  
is	  well	  known	  to	  have	  an	  impact	  on	  neuronal	  migration	  and	  to	  promote	  symmetric	  proliferative	  
divisions	  and	  postpone	  neurogenesis	   (Jossin	  and	  Cooper,	  2011,	  Paridaen	  and	  Huttner,	   2014).	  
The	  signals	  of	  the	  basal	  BM	  play	  a	  role	  in	  self-­‐renewing	  potential	  of	  RGCs	  and	  bRGs	  (Paridaen	  
and	   Huttner,	   2014).	   RGC	   apical	   adhesion	   and	   proliferation	   is	   for	   instance	   influenced	   by	  
INTRODUCTION	   7	  
interstitial	  matrix	   components	   as	   laminin	   or	   syndecan-­‐1	   via	   integrin	   receptors	   (Loulier	   et	   al.,	  
2009,	  Wang	  et	  al.,	  2012).	  
Thus,	   the	   spatially	   and	   temporally	   regulated	   distinct	   ECM	   composition	   and	   its	   3-­‐dimensional	  
structure	  surrounding	  the	  NSCs	  imply	  numerous	  functions	  affecting	  the	  NSCs	  behaviour	  such	  as	  
cell	  migration,	  proliferation	  and	  differentiation	  by,	  for	  example,	  limiting	  morphogen	  diffusion	  or	  
providing	   signalling	  molecule	   binding	   sites	   (Rozario	   and	  DeSimone,	   2010).	   Only	   a	   few	   of	   the	  
various	  functions	  have	  already	  been	  mentioned,	  although	  it	  would	  be	  impossible	  to	  introduce	  
all,	  one	   last	  example	  will	  be	  described.	  The	  exogenous	  signalling	  molecules	  play	  an	   important	  
role	   in	   the	   manifold	   ECM	   functions	   like	   the	   establishment	   of	   morphogen	   gradients.	   A	   well-­‐
studied	   transcription	   factor	   is	   the	   paired	   box	   containing	   homeodomain	   transcription	   factor	  
Pax6,	   which	   is	   expressed	   in	   several	   CNS	   regions	   (e.g.	   forebrain)	   (Woodworth	   et	   al.,	   2012,	  
Paridaen	   and	   Huttner,	   2014).	   Among	   its	   functions	   concerning	   the	   regulation	   of	   regional	  
patterning,	   Pax6	   promotes	   RGC	   proliferation	   and	   also	   promotes	   neurogenesis	   (Osumi	   et	   al.,	  
2008,	  Paridaen	  and	  Huttner,	  2014).	  These	  in	  some	  kind	  opposing	  functions	  seem	  to	  be	  enabled	  
by	  alternative	  splicing	  of	  Pax6	  and	  by	   interplay	  with	  other	  transcription	  factors	   (Paridaen	  and	  
Huttner,	   2014).	   Pax6	   operates	   upstream	   of	   proneural	   genes,	   such	   as	   neurogenins,	   and	   also	  
directly	  to	  promote	  neurogenesis	  during	  development	  (Martynoga	  et	  al.,	  2012).	  The	  exogenous	  
signalling	   molecules	   and	   their	   signalling	   pathways	   can	   modulate	   each	   other's	   mode	   of	  
operation	   and	   exhibit	   an	   enormous	   crosstalk.	   The	   spatial	   and	   temporal	   presentation	   of	  
morphogens	   (Shh,	  Wnt,	  BMP,	  etc.)	  and	   transcription	   factors	   (Pax6,	  neurogenins,	  etc.)	  defines	  
progenitor	  identities,	  specifies	  neuronal	  subtypes	  by	  also	  influencing	  the	  sequential	  generation	  
of	  distinct	  neuronal	  subtypes	  of	  the	  cortical	  layers	  (Martynoga	  et	  al.,	  2012).	  
Altogether,	   the	   ECM	   is	   implicated	   during	   both,	   CNS	   development	   including	   processes	   like	  
neuro-­‐/gliogenesis,	   synaptogenesis,	   cell	  migration,	  axonal	  outgrowth	  and	  guidance	   (Bandtlow	  
and	  Zimmermann,	  2000,	  Faissner	  et	  al.,	  2010)	  as	  well	  as	  during	  adulthood	  in	  the	  cell	  survival,	  
plasticity,	  damage	  response	  and	  regeneration	  (Soleman	  et	  al.,	  2013).	  
1.2.2	  PROTEOGLYCANS	  IN	  THE	  EXTRACELLULAR	  MATRIX	  
Proteoglycans	  (PGs)	  and	  glycosaminoglycans	  (GAGs)	  are	  a	  major	  component	  of	  the	  ECM.	  They	  
are	  participating	  in	  the	  orchestration	  of	  the	  various	  signalling	  pathways	  and	  plenty	  of	  functions	  
in	  the	  complex	  3-­‐dimensional	  ECM	  meshwork	  that	  have	  already	  been	  generally	  described	  in	  the	  
previous	  section.	  Below,	  a	  focus	  on	  the	  structure	  and	  the	  specific	  relevance	  of	  PG	  involvement	  
is	  made.	  
PGs	  consist	  of	  a	  core	  protein	  and	  at	  least	  one	  but	  up	  to	  >	  100	  covalently	  attached	  GAG	  chains	  at	  
specific	   sites	   of	   the	   core	  protein	   (Esko	   et	   al.,	   2009).	  GAGs	   are	   linear	   polysaccharides	   built	   of	  
repeating	  disaccharide	  units.	  Depending	  on	  the	  disaccharide	  unit	  composition,	  the	  GAGs	  can	  be	  
distinguished	  into	  families:	  heparan	  sulfate	  (HS),	  chondroitin	  sulfate	  (CS),	  dermatan	  sulfate	  (DS)	  
and	   keratan	   sulfate	   (KS)	   (Bandtlow	   and	   Zimmermann,	   2000).	   PGs	   appear	   as	   cell	   surface	   PGs	  
(transmembrane	   or	   glycosylphosphatidylinositol	  (GPI)-­‐anchored)	   or	   become	   secreted	  
(Figure	  4).	  After	   the	  polymerization	  of	   the	  PGs	  and	  the	  GAGs,	   they	  can	  be	  highly	  modified	  by	  
epimerization,	   sulfation	   and	   other	  modifying	   enzymes	   (Habuchi,	   2000,	  Maeda,	   2015).	   These	  
processes	   will	   be	   further	   explained	   for	   CS-­‐GAGs	   in	   the	   following	   section.	   The	   enormous	  
structural	   complexity	  of	   PGs	  provides	   a	  big	  platform	   to	   create	   the	   functional	   diversity	  of	   the	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ECM,	  offered	  by	  different	  core	  proteins,	  variable	  number	  and	  types	  of	  attached	  GAGs	  and	  GAG	  
modifications	  (length,	  sulfation	  pattern)	  (Esko	  et	  al.,	  2009).	  
	  
	  
Figure	  4	  Scheme	  of	  the	  major	  proteoglycan	  types	  
Generally,	  PGs	  appear	  in	  3	  different	  forms:	  they	  can	  be	  transmembrane,	  GPI-­‐anchored	  (cell	  surface	  PGs)	  
or	  secreted	  (ECM	  PGs).	  They	  have	  a	  core	  protein	  (black)	  and	  attached	  GAG	  chains	  (dark	  green).	  The	  GAG	  
chains	  are	  able	  to	  bind	  signalling	  molecules,	  e.g.	  growth	  factors	  (blue).	  The	  number	  and	  type	  of	  attached	  
GAG	  chains	  varies	  between	  PG	  families	  and	  are	  only	  exemplarily	  depicted	  here.	  
	  
PGs	  can	  also	  be	  classified	  into	  different	  families	  by	  the	  structure	  and	  size	  of	  their	  core	  proteins:	  
lecticans	   (aggrecan,	   neurocan,	   brevican,	   versican),	   syndecans	   (syndecan	  1-­‐4),	   glypicans	  
(glypican	  1-­‐6)	   and	   other	   PGs	   (e.g.	   RPTPβ,	   phosphacan,	   NG2)	   (Bandtlow	   and	   Zimmermann,	  
2000).	  One	  specific	  and	  major	  compound	  of	  the	  ECM	  is	  hyaluronic	  acid	  (HA),	  which	  lacks	  a	  core	  
protein	  and	  is	  solely	  built	  of	  a	  long	  chain	  of	  non-­‐sulfated	  repeating	  disaccharide	  units,	  which	  is	  
directly	  synthesized	  at	  the	  plasma	  membrane	  and	  released	  into	  the	  ECM	  (Vigetti	  et	  al.,	  2014).	  
HA	   and	   PGs	   belonging	   to	   the	   HSPGs	   or	   CSPGs	   are	   the	   key	   components	   of	   the	   brain's	   ECM	  
(Zimmermann	   and	   Dours-­‐Zimmermann,	   2008,	   Esko	   et	   al.,	   2009,	   Maeda	   et	   al.,	   2011).	   Their	  
interaction	  with	  the	  ECM	  and	  the	  surrounded	  cells	  can	  function	  via	  the	  core	  protein	  and/or	  via	  
their	  GAGs.	  One	  well-­‐known	  function	  is	  caused	  by	  the	  GAGs'	  high	  density	  of	  negative	  charges,	  it	  
attracts	   osmotically	   active	   cations	   and	   can	   thereby	   generate	   hydrated	   matrices	   resistant	   to	  
mechanical	  compression	  or	  aiding	  in	  structural	  organization	  (Esko	  et	  al.,	  2009).	  Another	  known	  
function	   of	   PGs	   is	   to	   localize	   active	   molecules	   to	   particular	   places	   by	   binding	   to	   their	  
GAGs/sulfation	  motifs	  and	  thereby	  regulating	  signalling	  pathways	  (Deepa	  et	  al.,	  2004,	  Hacker	  et	  
al.,	   2005,	   Deepa	   et	   al.,	   2006,	   Alexopoulou	   et	   al.,	   2007,	   Soleman	   et	   al.,	   2013,	   Filmus	   and	  
Capurro,	   2014).	   One	   example	   is	   the	   binding	   and	   storing	   of	   TGFβ.	   By	   capturing	   TGFβ	   in	   a	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complex	   in	   the	   ECM,	   it	   is	   inaccessible	   for	   its	   receptors	   and	   released/secreted	   by	   proteolytic	  
cleavage	  or	  mechanical	  inputs	  (Rozario	  and	  DeSimone,	  2010).	  
Neurocan,	  phosphacan,	  versican	  are	  highly	  expressed	  for	  example	  in	  the	  marginal	  zone,	  the	  SVZ	  
or	   the	   subplate	   and	   are	   participating	   in	   the	   regulation	   of	   neuronal	   migration	   in	   the	   cortex	  
during	   development	   (Maeda,	   2015).	   Furthermore,	   syndecans	   and	   glypicans	   participate	   in	  
morphogen	  gradient	   establishment	   and	   influence	   the	   interaction	   range	  of	   secreted	   signalling	  
molecules	   in	  a	  passive	  way	  (Hacker	  et	  al.,	  2005).	  Syndecans	  are	  also	  implicated	  in	  modulating	  
the	  responsiveness	  of	  NSCs	  to	  Wnt	  ligands	  and	  in	  addition	  to	  that,	  the	  NSCs	  for	  instance	  highly	  
express	   syndecan	  1	   during	   cortical	   neurogenesis/development	   and	   its	   knockdown	   revealed	   a	  
reduced	   proliferation	   as	   well	   as	   a	   premature	   differentiation	   of	   NSCs	   (Wang	   et	   al.,	   2012).	  
Moreover,	   the	   expression	   of	   some	   transmembrane	   PGs	   is	   regulated	   in	   a	   specific	   way:	   for	  
instance,	   brevican	   is	   expressed	   by	   oligodendrocyte	   precursor	   cells	   (OPCs)	   during	   postnatal	  
development,	   when	   the	   OPCs	   start	   ensheathing	   axon	   fibers,	   whereas	   afterwards	   OPCs	  
downregulate	   and	   astrocytes	   begin	   brevican	   expression	   in	   the	   hippocampus	  while	   CNS	   fiber	  
tract	  development	  proceeds	  (Ogawa	  et	  al.,	  2001).	  A	  further	  PG,	  NG2,	  is	  e.g.	  highly	  expressed	  on	  
OPCs,	   on	  which	   it	   promotes	   proliferation	   as	  well	   as	  migration	   and	   also	   showed	   high	   affinity	  
binding	  sites	  for	  GFs	  such	  as	  FGF	  2	  and	  thereby	  acting	  as	  reservoir	  or	  co-­‐receptor	  (Wade	  et	  al.,	  
2014).	  Regarding	  PGs'	  influence	  on	  migration,	  it	  is	  known,	  that	  e.g.	  avian	  neural	  crest	  cells	  are	  
attracted	  by	  versican	  isoforms	  and	  avoid	  aggrecan	  containing	  matrix,	  whereby	  these	  effects	  are	  
triggered	  by	  the	  PG	  core	  and	  their	  attached	  GAG	  chains	  (Perissinotto	  et	  al.,	  2000).	  
1.3	  CHONDROITINSULFATE	  PROTEOGLYCANS	  
1.3.1	  CHONDROITINSULFATE	  PROTEOGLYCAN	  STRUCTURE	  AND	  THEIR	  MODIFICATION	  BY	  
CHONDROITINSULFOTRANSFERASES	  
Chondroitinsulfate	   proteoglycans	   (CSPGs)	   consist	   of	   a	   protein	   core	   which	   functions	   as	   a	  
backbone	   and	   can	   greatly	   differ	   in	   size	   and	   contain	   different	   family	   determining	   domains	  
(Bandtlow	  and	  Zimmermann,	  2000,	  Bartus	  et	  al.,	  2012).	  Covalently	   linked	  to	  the	  core	  protein,	  
CSPGs	  have	  at	  least	  one	  chondroitinsulfate	  (CS)	  glycosaminoglycan	  (GAG)	  chain	  attached	  via	  a	  
tetrasaccharide	   linker	   to	   a	   serine	   residue	   of	   the	   core	   protein	   (Silbert	   and	   Sugumaran,	   2002,	  
Mikami	  and	  Kitagawa,	  2013)	  (Figure	  5).	  The	  tetrasaccharide	  linker	  comprises	  xylose-­‐galactose-­‐
galactose-­‐glucoronic	  acid	  and	  becomes	  subsequently	  elongated	  into	  a	  mature	  CS-­‐GAG,	  whereas	  
the	   synthesis	   of	   the	   CS	   core	   protein	   and	   the	   linker	   assembly	   starts	   in	   the	   endoplasmatic	  
reticulum	   (ER),	   the	   maturation	   continues	   in	   the	   Golgi	   apparatus	   compartments	   with	   the	  
polymerization	  of	  the	  CS-­‐GAG	  chains	  and	  their	  sulfation	  by	  chondroitinsulfotransferases	  (Chsts)	  
(Kitagawa	  et	  al.,	  2001,	  Kwok	  et	  al.,	  2012).	  The	  CSPGs	  comprise	  several	   families/groups,	  which	  
are	   not	   consistently	   categorized,	   but	   always	   include	   the	   following	  members:	   lectican	   familiy	  
(neurocan,	   brevican,	   versican,	   aggrecan;	   mainly	   secreted,	   GPI-­‐anchored)	   (Bandtlow	   and	  
Zimmermann,	   2000),	   RPTPβ/phosphacan	   (transmebrane,	   secreted),	   small	   leucine-­‐rich	   PGs	  
(decorin,	  biglycan;	  secreted)	  (Galtrey	  and	  Fawcett,	  2007),	  testicans	  (secreted)	  (Schnepp	  et	  al.,	  
2005,	   Maeda,	   2015)	   and	   others	   (neuroglycan	  C,	   NG2,	   etc.;	   transmembrane)	   (Galtrey	   and	  
Fawcett,	  2007).	  Each	  group	  includes	  different	  isoforms	  or	  alternative	  splice	  variants,	  as	  well	  as	  
posttranslational	  modifications,	  e.g.	   cleaving/shedding	  of	  cell	   surface	  compartment	  of	   the	  PG	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protein	   core	   and	   thereby	   releasing	   soluble,	   active	   GAG-­‐containing	   ectodomains,	   which	   was	  
reported	   for	   syndecans	   and	   hypothesized	   for	  NG2	   (Manon-­‐Jensen	   et	   al.,	   2010,	   Burnside	   and	  
Bradbury,	  2014).	  
CS-­‐GAGs	  are	   linear,	  unbranched	   chains	  of	   repeating	  disaccharide	  units	  built	   of	   alternating	  N-­‐
acetylgalactosamine	   (GalNAc)	   and	   glucoronic	   acid	   (GlcA)	   sugars	   (Iozzo	   and	   Murdoch,	   1996,	  
Mikami	  and	  Kitagawa,	  2013).	  The	  number	  of	  attached	  CS-­‐GAGs	  can	  vary	   from	  1	  to	  100	  (Dyck	  
and	  Karimi-­‐Abdolrezaee,	  2015).	  The	  length	  of	  a	  CS-­‐GAG	  is	  variable	  as	  well	  and	  can	  possess	  over	  
100	   repeating	   disaccharide	   units	   (Galtrey	   and	   Fawcett,	   2007,	   Dyck	   and	   Karimi-­‐Abdolrezaee,	  
2015).	  Another	  step	  to	  create	  the	  great	  heterogeneity	  is	  the	  modification	  by	  epimerization	  and	  
sulfation.	   After	   epimerization	   of	   the	   GlcA	   to	   iduronic	   acid	   (IdoA)	   by	   C5-­‐epimerases,	   the	  
disaccharide	  unit	  is	  converted	  to	  dermatan	  sulfate	  (DS)	  (Sugahara,	  2003,	  Mikami	  and	  Kitagawa,	  
2013).	   The	   creation	   of	   the	   complex	   sulfation	   pattern	   of	   CS/DS-­‐GAGs	   is	   enabled	   by	   seven	  
chondroitinsulfotransferases	   (Chsts),	   which	   are	   expressed	   in	   the	   neurogenic	   regions	   of	   the	  
embryonic	  and	  adult	  CNS	  (Kusche-­‐Gullberg,	  2003,	  Akita	  et	  al.,	  2008).	  Chsts	  catalyze	  the	  transfer	  
of	   a	   sulfate	   group	   from	   3'-­‐phosphoadenosine	  5'-­‐phosphosulfate	   (PAPS)	   to	   a	   specific	   carbon	  
atom	   of	   the	   CS-­‐GAG	   sugars	   (Mikami	   and	   Kitagawa,	   2013).	   The	   specific	   sulfation	   by	   Chsts	  
generates	  five	  different	  units	   in	  principle,	  which	  can	  be	  mono-­‐	  (CS-­‐A,	  CS-­‐C)	  and	  disulfated	  (iB,	  
CS-­‐D,	  CS-­‐E),	  including	  the	  epimerized	  DS	  units	  (iA,	  iB,	  iE)	  (Sugahara	  and	  Mikami,	  2007,	  Mikami	  
and	   Kitagawa,	   2013,	   Dyck	   and	   Karimi-­‐Abdolrezaee,	   2015)	   (Figure	  5).	   The	   Chsts	   differ	   in	   their	  
sulfating	  position	  and	  are	  grouped	  according	  to	  the	  position	  where	  the	  sulfate	  is	  added	  to	  the	  
sugar	   molecule:	   the	   6th	   carbon	   atom	   of	   GalNAc	   can	   be	   sulfated	   by	   the	   Chst	  3	   or	   Chst	  7	  
(Uchimura	   et	   al.,	   1998,	   Kitagawa	   et	   al.,	   2000)	   and	   thereby	   generates	   the	  monosulfated	  CS-­‐C	  
unit.	  The	  second	  monosulfated	  CS-­‐unit	  CS-­‐A	  is	  sulfated	  by	  Chst	  11,	  Chst	  12	  or	  in	  the	  case	  of	  iA	  
by	  Chst	  14	  at	  the	  4th	  carbon	  atom	  of	  GalNAc	  (Hiraoka	  et	  al.,	  2000,	  Yamauchi	  et	  al.,	  2000,	  Evers	  
et	   al.,	   2001).	   These	   monosulfated	   CS-­‐units	   are	   the	   basis	   for	   the	   disulfated	   CS-­‐units.	   The	  
synthesis	  of	  CS-­‐D	  and	  iB	  is	  performed	  by	  the	  Chst	  Ust,	  which	  transfers	  a	  sulfate	  group	  to	  the	  2nd	  
carbon	  atom	  of	   the	  GlcA	  or	   IdoA	  of	   the	   corresponding	  monosulfated	  disaccharide	  units	  CS-­‐C	  
and	  iA	  (Kobayashi	  et	  al.,	  1999,	  Mikami	  and	  Kitagawa,	  2013).	  The	  last	  member	  of	  the	  Chsts	  is	  the	  
Chst	  GalNAc,	  which	  generates	  CS-­‐E	  or	  iE	  out	  of	  CS-­‐A	  or	  iA	  by	  adding	  a	  sulfate	  group	  to	  the	  4th	  
carbon	  atom	  of	  the	  GalNAc	  sugar	   (Ohtake	  et	  al.,	  2001).	  The	  Chsts	  are	  transmembrane	  type	   II	  
proteins,	  that	  are	   localized	  to	  the	  Golgi	  apparatus	  with	  the	  major	  and	  catalytically	  active	  part	  
positioned	  in	  the	  lumen	  of	  the	  Golgi	  cisterns	  (Kusche-­‐Gullberg,	  2003).	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Figure	  5	  Schematic	  overview	  of	  proteoglycan	  structure	  and	  the	  possible	  CS/DS-­‐unit	  outcome	  after	  sulfation	  and	  
epimerization	  
Chondroitin	   sulfate	   proteoglycans	   (CSPGs)	   consist	   of	   a	   core	   protein	   (green)	   and	   attached	  
glycosaminoglycan	  (GAG)	  chains.	  They	  are	  linked	  via	  a	  tetrasaccharide	  to	  specific	  serine	  residues	  of	  the	  
core	  protein.	  Chondroitin	  sulfate	  (CS)	  GAGs	  are	  built	  of	  repeating	  disaccharide	  units,	  namely	  glucoronic	  
acid	  (GlcA)	  and	  N-­‐acteylgalactosamine	  (GalNAc).	  GlcA	  can	  be	  epimerized	  to	  iduronic	  acid	  (IdoA)	  and	  the	  
generated	  CS-­‐unit	  is	  then	  named	  dermatan	  sulfate.	  Specific	  chondroitinsulfotransferases	  (Chsts)	  transfer	  
sulfate	  groups	  to	  distinct	  carbon	  atoms	  at	  specific	  sites	  and	  thereby	  generate	  distinguishable	  CS-­‐units:	  
monosulfated	  (C,	  A	  and	  iA)	  and	  disulfated	  (D,	  E,	  iB	  and	  iE).	  
1.3.2	  COMPLEXITY	  AND	  FUNCTION	  OF	  CHONDROITINSULFATES	  
PGs	  and	  their	  attached	  GAG	  chains	  are	  an	  important	  factor	  in	  a	  lot	  of	  cellular	  processes	  such	  as	  
for	   example	   neuronal	   migration,	   proliferation	   and	   differentiation	   of	   NSCs,	   axon	   pathfinding,	  
myelination,	  axon	  regeneration	  as	  well	  as	  maturation	  and	  plasticity	  of	  synapses	  (Maeda	  et	  al.,	  
2011,	  Soleman	  et	  al.,	  2013,	  Silver	  and	  Silver,	  2014,	  Theocharidis	  et	  al.,	  2014).	  In	  contrast	  to	  the	  
former	   understanding	   of	   CSs	   as	   simple	   repellents,	   the	   idea	   consolidates	   that	   the	   operating	  
mode	  of	  CS	  seems	  to	  be	  much	  more	  complex	  and	  works	  rather	  in	  a	  context-­‐dependent	  manner	  
by	  the	  structural	  PG/GAG	  chain	  diversity	   (Lindahl,	  2014,	  Maeda,	  2015).	   In	  the	  case	  of	  cellular	  
core protein
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migration	   it	   depends	   on	   the	   factors	   that	   are	   bound	   to	   the	   GAG	   chains,	   which	   causes	   CS	   to	  
operate	  either	  as	  a	  repellent	  or	  attractant	  in	  a	  sulfation	  pattern	  dependent	  manner	  (Shipp	  and	  
Hsieh-­‐Wilson,	  2007,	  Maeda,	  2015).	  
The	  sulfation	  pattern	  of	  PG	  GAG	  chains,	  including	  CS-­‐GAGs,	  with	  its	  manifold	  heterogeneity	  are	  
implicated	   in	   a	   lot	   already	  mentioned	   cellular	   processes.	   Isolated	   CS-­‐units	   show	   for	   instance	  
different	   binding	   affinities	   to	   distinct	   axon	   guidance	   molecules	   (e.g.	   CS-­‐E	   high	   affinity,	   CS-­‐A	  
weak	   binding	   (Shipp	   and	   Hsieh-­‐Wilson,	   2007))	   or	   GFs	   (e.g.	   CS-­‐E	   high	   affinity	   to	   NGF,	   BDNF	  
(Rogers	  et	  al.,	  2011)).	  Syndecans,	   for	  example,	  bind	  various	  GFs	   (FGF,	  PDGF,	  EGF,	  HGF,	  VEGF,	  
etc.)	  through	  their	  HS-­‐	  and	  CS-­‐chains	  (Carey,	  1997,	  Deepa	  et	  al.,	  2004).	  Syndecans	  are	  actually	  
belonging	   to	   the	  HSPG	   family,	   although	   also	  CS	   chains	   can	  be	   attached	   to	   their	   core	  protein	  
(Maeda,	   2015).	   Besides	   providing	   distinct	   functions	   for	   distinct	   tissues	   or	   providing	   niche	  
specificity	   by	   HS/CS	   complexity	   (length,	   sulfation	   pattern)	   (Haupt	   et	   al.,	   2009),	   also	   the	  
temporal	   and	   spatial	   regulation	   of	   HSPG/CSPG	   expression	   or	   their	   affinity	   to	   bind	   signalling	  
molecules	   changes	   during	   development	   and	   adulthood	   (Nurcombe	   et	   al.,	   1993,	   Akita	   et	   al.,	  
2008,	  Ishii	  and	  Maeda,	  2008b,	  Mizumoto	  et	  al.,	  2013).	  Loss	  of	  function	  studies	  of	  distinct	  CSPG	  
members	   of	   the	   lectican	   family	   (versican,	   aggrecan,	   neurocan,	   brevican)	   exhibited	   defects	   in	  
neural	  crest	  cell	  migration,	  synaptic	  plasticity,	  long-­‐term	  potentiation	  and	  also	  cartilage	  defects	  
(Rozario	  and	  DeSimone,	  2010).	  CSPGs	   interact	  with	  GFs,	  chemokines	  and	  guidance	  molecules	  
(Hirose	  et	  al.,	  2001,	  Kwok	  et	  al.,	  2012,	  Mizumoto	  et	  al.,	  2013).	  Highly	  sulfated	   (disulfated)	  CS	  
bind	  to	  FGFs	  (e.g.	  FGF	  2)	  or	  to	  guidance	  molecules	  as	  for	  instance	  slit,	  netrin,	  semaphorins	  in	  a	  
sulfation-­‐dependent	   manner	   (Maeda,	   2010,	   Mizumoto	   et	   al.,	   2013).	   The	   CSPGs	   expression	  
profiles	  possess	  distinct	  roles	  at	  distinct	  developmental	  time	  periods,	  although	  there	  is	  kind	  of	  
redundancy,	  shown	  by	  specific	  CSPG	  knockout	  experiments	  (e.g.	  neurocan,	  brevican)	  (Rauch	  et	  
al.,	   2005).	   It	   seems	   that	   the	   orchestration	   of	   CSPGs	   is	   important	   and	   the	  missing	   CSPGs	   are	  
supplemented	  by	  others	  of	  the	  at	  least	  16	  CSPGs,	  known	  so	  far	  (Herndon	  and	  Lander,	  1990).	  
Lecticans	  are	  mainly	  secreted	  PGs	  and	  the	  major	  constituents	  of	  the	  brain	  matrix	  (Carulli	  et	  al.,	  
2005,	  Maeda,	  2015).	  They	   interact	  with	   the	  ECM	  molecules	   in	   two	  ways:	  protein-­‐protein	  and	  
protein-­‐carbohydrate	  interaction.	  An	  example	  for	  protein-­‐protein	  interaction	  is	  the	  cooperation	  
of	   lecticans	  with	  tenascins	  (Tn-­‐C,	  Tn-­‐R),	  which	  are	  oligomeric	  glycoproteins.	  Together	  with	  HA	  
and	   link	   proteins	   they	   create	   the	   network	   surrounding	   the	   cells	   and	   thus	   form	   the	   basic	  
framework	  for	  the	  CNS	  ECM	  (Maeda,	  2015).	  Besides	  the	  secreted	  CSPGs,	  the	  lecticans,	  the	  CNS	  
comprises	   transmembrane	   CSPGs	   as	   for	   example	   several	   isoforms	   of	   receptor-­‐
type	  protein	  tyrosine	  phosphatase	  β	   (RPTPβ)	  or	  neuroglycan	  C	   (Maeda	  et	  al.,	  1994,	  Maurel	  et	  
al.,	   1994,	   Maeda,	   2015).	   One	   alternative	   splice	   variant	   of	   RPTP	  β	   is	   a	   secreted	   CSPG,	  
phosphacan	   (Maurel	   et	   al.,	   1994).	   Phosphacan	   is	   known	   to	   bind	   several	   proteins,	   midkine,	  
pleiotrophin,	   tenascins,	   contactin,	   NCAM	   (Peles	   et	   al.,	   1998),	   whereas	   it	   is	   shown,	   that	  
pleiotrophin	  and	  midkine	   interact	  via	   the	  HS-­‐	  and	  CS-­‐chains	   (Maeda	  et	  al.,	  2003,	  Muramatsu,	  
2014).	  Especially	  a	  higher	  amount	  of	  Ust	  generated	  CS-­‐D	  on	  phosphacan	  increased	  the	  binding	  
affinity	   to	   pleiotrophin	   (Maeda	   et	   al.,	   2003).	   Other	   studies	   indicated	   opposing	   effects	   of	  
phosphacan	   on	   neurite	   outgrowth,	   dorsal	   root	   ganglion	   (DRG)	   neurons	   were	   inhibited	   in	  
contrast	  to	  the	  promoting	  effect	  on	  hippocampal	  neuron	  growth	  in	  vitro	  (Faissner	  et	  al.,	  1994,	  
Garwood	  et	  al.,	  1999).	  In	  this	  case	  CS-­‐D	  seemed	  to	  act	  growth-­‐promoting	  (Clement	  et	  al.,	  1998).	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RPTP	  β/phosphacan	  bears	   a	   specific	   CS	   epitope,	  which	   can	  be	   recognized	  by	   the	  monoclonal	  
antibody	   (mAb)	   473HD	   (Faissner	   et	   al.,	   1994).	   Corresponding	   to	   the	   presence	   of	   473HD	   on	  
actively	  cycling	  RGCs/NSCs	  in	  neurogenic	  niches	  of	  the	  developing	  as	  well	  as	  in	  the	  adult	  brain,	  
the	  addition	  of	  the	  mAb	  473HD	  caused	  a	  decrease	  in	  the	  number	  of	  nsphs	  in	  vitro	  (von	  Holst	  et	  
al.,	   2006).	   The	   473HD	   motif	   contains	   at	   least	   one	   CS-­‐D	   unit	   and	   recognizes	   hexasaccharide	  
sequences,	  e.g.	  D-­‐A-­‐D,	  D-­‐A-­‐A	  (Ito	  et	  al.,	  2005,	  Sugahara	  and	  Mikami,	  2007).	  It	  could	  be	  shown,	  
that	   in	   the	   nsphs	   culture	   system	   CS-­‐B,	   CS-­‐D	   and	   CS-­‐E	   have	   the	   potential	   to	   support	   FGF-­‐
mediated	   cell	   proliferation	   of	   NSCs	   (Ida	   et	   al.,	   2006).	   Additionally,	   cell	   surface	   Ust	   sulfation	  
exhibited	   a	   high	   binding	   capacity	   and	   thereby	   promoted	   the	   FGF	  2	   responsiveness	   in	   cell	  
migration	  (Nikolovska	  et	  al.,	  2015).	  Another	  mAb,	  which	  detects	  CS-­‐D	  units,	   is	  MO-­‐225	  (Ito	  et	  
al.,	   2005).	   In	   western	   blot	   analysis	   MO-­‐225	   exhibits	   distinct	   bands	   in	   NSC,	   neurons	   and	  
astrocytes,	   varying	   in	   size	   and	   amount	   (Yamauchi	   et	   al.,	   2011)	   referring	   to	   the	   specific	  
regulation	   of	   sulfation	   and	   the	   structural	   heterogeneity	   during	   development.	   NSCs	   reveal	   a	  
lower	  expression	  of	  Ust	  and	  the	  C5	  epimerase	  than	  more	  differentiated	  cells	  like	  astrocytes	  or	  
neurons	   (Yamauchi	  et	  al.,	  2011).	  Furthermore,	  Ust	  expression	   increases	  e.g.	  during	  cerebellar	  
development	  and	  concomitantly	  the	  amount	  of	  CS-­‐B	  and	  CS-­‐D	  (Ishii	  and	  Maeda,	  2008b).	  More	  
and	  more	   focus	   on	   the	   GAG	   research	   emerges	   and	   unravelled	   their	   involvement	   in	   a	   lot	   of	  
signalling	  pathways	  and	  establishing	   the	  brain's	  architecture.	   For	   instance,	  CS-­‐E	  and	  CS-­‐D	  are	  
important	  for	  the	  correct	  neuronal	  positioning	  during	  developmental	  migration	  in	  the	  cerebral	  
cortex	  (Ishii	  and	  Maeda,	  2008a).	  
Chondroitinase	  ABC	  (ChABC)	  is	  a	  bacterial	  enzyme,	  which	  specifically	  cleaves	  CS-­‐GAGs	  from	  the	  
core	   protein	   and	   is	   often	   used	   to	   investigate	   the	   impact	   of	   missing	   sulfation	   and	   CS-­‐GAGs.	  
ChABC	   treatment	   of	   NSCs	   in	   vitro	   and	   in	   vivo	   resulted	   in	   decreased	   proliferation	   and	  
neurogenesis,	  whereas	  the	  number	  of	  astrocytes	  was	  increased	  in	  vitro,	  which	  means,	  that	  CS-­‐
sulfation	  plays	  a	  role	   in	   lineage	  decision	  of	  NSCs	  towards	  a	  neuronal	  or	  glial	   fate	  (Sirko	  et	  al.,	  
2007).	   Additionally,	   further	   ChABC	   studies	  with	  NSC	   revealed,	   that	   CS-­‐GAGs	   are	   essential	   for	  
FGF	  2-­‐mediated	  proliferation	  and	  maintenance	  of	  embryonic,	  cortical	  NSCs	  (Sirko	  et	  al.,	  2010).	  
Furthermore,	  in	  experiments,	  in	  which	  sulfation	  was	  blocked	  by	  addition	  of	  sodium	  chlorate	  to	  
neurosphere	  cultures,	   the	  expression	  of	   the	  473HD	  epitope	  was	   inhibited	  and	  the	  number	  of	  
nsphs	   was	   decreased	   (Akita	   et	   al.,	   2008).	   It	   was	   also	   shown,	   that	   changes	   in	   the	   CSPG	  
environment	   of	   hippocampal	   neurons	   by	   either	   ChABC	   or	   hyaluronidase,	   an	   HA	   degradation	  
enzyme,	  the	  synaptic	  plasticity	  was	  increased	  (Pyka	  et	  al.,	  2011).	  
ChABC	   is	   frequently	  mentioned	   in	   relation	   to	   CNS	   injury	   by	   enabling	   an	   increased	   plasticity,	  
regeneration	  and	  promoting	  structural	  and	  functional	  recovery	  after	  ChABC	  treatment	  (Galtrey	  
and	  Fawcett,	  2007,	  Soleman	  et	  al.,	  2013).	  
	  
1.3.3	  INVOLVEMENT	  OF	  CHONDROITINSULFATES	  IN	  HEALTH	  AND	  DISEASE	  	  
Because	  of	   the	  vast	  distribution	  of	  PGs	   in	  more	  or	   less	  every	  ECM	  a	  big	  variety	  of	   implicated	  
diseases	   occur	   by	  mutations	   or	   by	   imbalance	   of	   PG	   expression/PG-­‐related	   genes.	   As	   already	  
mentioned	  before,	  HSPGs	  and	  CSPGs	  are	  closely	  related	  and	  similar	  in	  structure,	  although	  they	  
have	   similar	   functions	   in	   development,	   they	   are	   involved	   in	   distinct	   types	   of	   diseases.	   For	  
instance,	   HSPGs	   play	   a	   role	   in	   Alzheimer's	   disease,	   PNNs	   are	   associated	   with	   epilepsy	   and	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several	  ECM	  components	  are	  upregulated	  in	  malignant	  glioma	  (Lau	  et	  al.,	  2013,	  Soleman	  et	  al.,	  
2013).	   Additionally,	   specific	   CSPG	   containing	   PNNs	  might	   have	   a	   neuroprotective	   function	   in	  
Alzheimer's	  disease,	  by	  isolating	  the	  neurons	  via	  HA	  and	  CS-­‐GAGs	  from	  external	  stress	  factors	  
or	   stimulating	   anti-­‐apoptotic	   signalling	   pathways	   (Soleman	   et	   al.,	   2013).	   After	   traumatic	   CNS	  
injury	   or	   demyelination,	   CSPG	   expression	   is	   increased	   and	   limits	   axonal	  
regeneration/remyelination	  by	  formation	  of	  the	  glial	  scar,	  which	  generally	  restricts	  CNS	  repair	  
(Bradbury	  et	  al.,	  2002,	  Morgenstern	  et	  al.,	  2002,	  Lau	  et	  al.,	  2012).	  Glial	  scars	  formed	  after	  CNS	  
injury	   are	   especially	   rich	   in	   CSPGs	   and	   so	   far	   supposed	   to	   be	   the	   key	   reason	   for	   the	  
regeneration	  failure,	  because	  the	  CSPGs	  in	  the	  glial	  scar	  inhibit	  the	  axon	  growth	  and	  restrict	  the	  
plasticity	   (Silver	  and	  Miller,	  2004,	  Silver	  and	  Silver,	  2014).	  The	  specific	  CSPG	  upregulation	  and	  
modification	   of	   their	   sulfation	   pattern	   can	   mediate	   the	   regulation	   of	   the	   effect	   on	   axonal	  
regeneration	   after	  CNS	   injury	   (Properzi	   et	   al.,	   2005).	   The	  upregulation	  of	  CSPGs	   in	   glial	   scars	  
also	  plays	  a	   role	   in	   ischemic	  stroke	  pathology	  and	  exhibits	  a	  specific	   regulation	  of	   the	  CSPGs:	  
direct	  at	  the	  lesion	  site	  CSPGs	  are	  upregulated,	  whereas	  more	  distant	  CSPGs	  are	  downregulated	  
in	  PNNs	  and	   thereby	  enabling	  kind	  of	   regeneration,	  namely	  axonal	   sprouting	   (Soleman	  et	  al.,	  
2013).	  But	  the	  implicated	  diseases	  concomitant	  with	  CS	  and	  CS-­‐related	  protein	  mutations	  range	  
from	  mood/mental	  disorders	  (e.g.	  schizophrenia,	  bipolar	  disorder)	  through	  autosomal	  recessive	  
short	  statue	  syndrome,	  intellectual	  disability	  to	  hydrops	  fetalis	  or	  cancer	  with	  wide	  spectra	  of	  
severity,	  respectively	  (Freeze,	  2009,	  Wade	  et	  al.,	  2013,	  Maeda,	  2015).	  Also	  an	   involvement	  of	  
PGs	  or	   specifically	   sulfated	  GAGs	   in	  physiological	   and	  pathological	   cellular	   processes	  by	   their	  
capacity	  to	  regulate	  GF	  signalling	  pathways,	  affecting	  for	  instance	  cancer,	  angiogenesis,	  fibrosis,	  
immunity	   and	   infectious	   diseases,	   has	   been	   described	   (Uyama	   et	   al.,	   2006,	   Iozzo	   and	  
Karamanos,	  2010).	  
Changes	   in	   the	   protein	   cores	   of	   PGs	   appear	   in	   cancer	   associated	   with	   the	   thereby	   caused	  
modifications	   of	   cell	   signalling	   pathways	   (Wade	   et	   al.,	   2013).	   A	   differentially	   regulated	  
expression	   of	   CS-­‐	   and	   HS-­‐related	   enzymes	   (biosynthesis,	   sulfation,	   desulfation)	   occurs	   in	  
glioblastoma	  and	  might	  be	  relevant	  as	  putative	  therapeutic	  target	  or	  function	  as	  biomarker	  in	  
disease	  classification	  (Wade	  et	  al.,	  2013).	  
Thus,	  for	  a	  healthy	  brain	  the	  correct	  spatiotemporal	  expression	  pattern	  of	  the	  various	  PGs	  and	  
their	  GAGs	  has	  to	  be	  orchestrated	  and	  kept	  in	  homeostasis.	  Therefore,	  ECM	  modification	  is	  an	  
important	   therapeutic	   target	   referring	   to	   the	   wide	   implication	   of	   the	   surrounding	   ECM	   e.g.	  
CSPGs	  and	  interaction	  with	  cytokines,	  GFs	  and	  receptors	  (Burnside	  and	  Bradbury,	  2014).	  A	  lot	  
of	   research	   is	  already	  going	  on	   in	   this	   field	  by	  using	  enzymes	  as	   for	   instance	  ChABC	  together	  
with	  cell	  transplantation,	  manipulating	  CSPG	  synthesis	  and	  expression	  of	  MMPs/ADAMTSs	  after	  
CNS	   injury	   or	   demyelinating/neurodegenerative	   diseases	   (Lau	   et	   al.,	   2013,	   Burnside	   and	  
Bradbury,	  2014).	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1.4	  AIM	  OF	  THE	  STUDY	  
The	  aim	  of	  this	  study	  was	  to	   investigate	  the	  involvement	  of	  the	  sulfation	  pattern	  modified	  by	  
the	  chondroitinsulfotransferase	  (Chst)	  Ust	  on	  the	  behaviour	  of	  neural	  stem	  cells	  (NSCs)	  in	  vitro	  
and	  in	  vivo	  during	  the	  development	  of	  the	  mouse	  central	  nervous	  system.	  
Since	   there	   is	   growing	  evidence,	   that	   the	  neural	   extracellular	  matrix	   (ECM)	   is	  participating	   in	  
various	   cellular	   processes	   and	   also	   chondroitin	   sulfate	   proteoglycans	   (CSPGs)	   are	   involved	   in	  
regulating	  cell	  behaviour	  and	  plasticity,	   I	  wanted	  to	  elucidate	  the	  role	  of	  a	  modified	  sulfation	  
pattern	   by	   the	   enzyme	   Ust	   on	   the	   self-­‐renewal	   capacity,	   differentiation	   and	   proliferation	   of	  
NSCs.	   It	  was	  shown,	   that	   inhibition	  of	   the	  sulfation	  by	  sodium	  chlorate	  or	   the	  degradation	  of	  
the	  CSPG	  glycosaminoglycan	  chains	  by	  chondroitinase	  ABC	  led	  to	  a	  decreased	  proliferation	  and	  
altered	   cell	   fate	   decisions	   of	   NSCs	   (Sirko	   et	   al.,	   2007,	   Akita	   et	   al.,	   2008,	   Sirko	   et	   al.,	   2010).	  
Additionally,	  first	  investigations	  of	  the	  impact	  of	  distinct	  Chst	  overexpression,	  in	  combination	  or	  
single	   transfected,	   revealed	   a	   tendency	   to	   promote	   neurogenesis	   after	   oversulfation	   in	   vitro	  
(Harrach,	  2010).	  Because	  the	  preliminary	  data	  exhibited	  only	  tendencies	  towards	  an	  increased	  
neurogenesis,	   I	   further	   elucidated	   the	   impact	   of	   a	   manipulated	   chondroitin	   sulfate	   (CS)	  
sulfation	  pattern	  on	  NSCs	  derived	  from	  E	  13.5	  mouse	  cortices	  by	  Ust	  overexpression	  concerning	  
NSCs	   self-­‐renewal,	   proliferation	   and	   cell	   fate	   decisions.	   Furthermore,	   the	   analysis	   of	   Ust	  
overexpression	   in	   vivo	   by	   in	   utero	   electroporation	   should	   reveal	   the	   impact	   of	   a	   modified	  
sulfation	   pattern	   on	   NSCs'	   behaviour.	   To	   enable	   future	   examinations	   of	   sulfation	   pattern	  
manipulations	  during	  development	  as	  well	  as	  during	   later	  developmental	  stages,	   I	  designed	  a	  
strategy	   for	   a	   conditional	   Ust	   knockout	  mouse	   line,	   including	   the	   design	   and	   cloning	   of	   the	  
targeting	  plasmid.	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2	  MATERIALS	  AND	  METHODS	  
2.1	  COMPANIES	  
Amersham	  pharmacia,	  Freiburg,	  Germany	  
AMS	  Biotechnology	  (Europe)	  Ltd	  (Amsbio),	  
Frankfurt,	  Germany	  
AppliChem,	  Darmstadt,	  Germany	  
Beckman	  Coulter,	  Krefeld,	  Germany	  
Becton	  Dickinson	  (BD	  Biosciences),	  Heidelberg,	  
Germany	  
bela-­‐pharm,	  Vechta,	  Germany	  
Bio-­‐Rad,	  Munich,	  Germany	  
Biochrom,	  Berlin,	  Germany	  
Charles	  River,	  Sulzfeld,	  Germany	  
Clontech,	  Saint-­‐Germain-­‐en-­‐Laye,	  France	  
Dianova,	  Hamburg,	  Germany	  
Enzo	  Life	  Sciences	  GmbH,	  Lörrach,	  Germany	  
Eppendorf,	  Hamburg,	  Germany	  
Fermentas	  (Thermo	  Scientific),	  Schwerte,	  
Germany	  
FineScienceTools	  (FST),	  Heidelberg,	  Germany	  
Fisher	  Scientific	  (Thermo	  Fisher),	  Nidderau,	  
Germany	  
GATC	  Biotech	  AG,	  Konstanz,	  Germany	  
GE	  Healthcare,	  Freiburg,	  Germany	  
GERBU,	  Heidelberg,	  Germany	  
Gibco	  (Invitrogen),	  Darmstadt,	  Germany	  
Gilson,	  Limburg-­‐Offheim,	  Germany	  
Greiner	  Bio-­‐One,	  Frickenhausen,	  Germany	  
Grüssing,	  Filsum,	  Germany	  
Harvard	  Apparatus	  (Hugo	  Sachs),	  March-­‐
Hugstetten,	  Germany	  
Heraeus,	  Hanau,	  Germany	  
Hirschmann	  Laborgeräte,	  Eberstadt,	  Germany	  
ibidi,	  Martinsried,	  Germany	  
Invitrogen,	  Karlsruhe,	  Germany	  
J.T.	  Baker,	  Deventer,	  Netherlands	  
Kisker	  Biotech,	  Steinfurt,	  Germany	  
Labnet	  International,	  Edison,	  NJ,	  USA	  
Leica	  Microsystems,	  Solms,	  Germany	  
LMS,	  Brigachtal,	  Germany	  
Lonza,	  Cologne,	  Germany	  
Macherey-­‐Nagel,	  Düren,	  Germany	  
Marienfeld,	  Lauda-­‐Koenigshofen,	  Germany	  
Medical	  Developments	  International	  (Cegla),	  
Montabaur,	  Germany	  
Menzel,	  Braunschweig,	  Germany	  
Merck/Merck	  Millipore,	  Darmstadt,	  Germany	  
Mo	  Bi	  Tec,	  Göttingen,	  Germany	  
NeoLab	  Migge,	  Heidelberg,	  Germany	  
Nepagene,	  Ichikawa-­‐City,	  Japan	  
New	  England	  Biolabs	  (NEB),	  Frankfurt,	  Germany	  
Novus	  Biologicals,	  Cambridge,	  United	  Kingdom	  
Nuaire	  (ibs	  tecnomara),	  Fernwald,	  Germany	  
Nunc	  (Thermo	  Scientific),	  Wiesbaden,	  Germany	  
Pan	  Biotech,	  Aidenbach,	  Germany	  
PeproTech,	  Hamburg,	  Germany	  
Peqlab,	  Erlangen,	  Germany	  
Polysciences	  Europe,	  Eppelheim,	  Germany	  
Qiagen,	  Hilden,	  Germany	  
Roche	  Diagnostics,	  Mannheim,	  Germany	  
Roth,	  Karlsruhe,	  Germany	  
Santa	  Cruz	  Biotechnology,	  Heidelberg,	  Germany	  
Sarstedt,	  Nümbrecht,	  Germany	  
SERVA,	  Heidelberg,	  Germany	  
Sicgen,	  Cantanhede,	  Portugal	  
Siemens	  Healthcare,	  Erlangen,	  Germany	  
Sigma-­‐Aldrich	  Chemie,	  Taufkirchen,	  Germany	  
Starlab,	  Hamburg,	  Germany	  
Sutter	  Instrument,	  Lambrecht,	  Germany	  
Tecan,	  Mainz,	  Germany	  
Th.	  Geyer,	  Renningen,	  Germany	  
Thermo	  Fisher	  Scientific	  Biosciences,	  St.	  Leon-­‐
Rot,	  Germany	  
VWR	  International,	  Bruchsal,	  Germany	  
Worthington	  (CellSystems),	  Troisdorf,	  Germany	  
Zeiss,	  Oberkochen,	  Germany	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2.2	  MATERIALS	  
2.2.1	  EQUIPMENT	  
AGFA	  Curix	  60,	  Siemens	  Healthcare	  
Amersham	  Hyperfilm	  ECL,	  GE	  Healthcare	  
Axiophot,	  Zeiss	  
Centrifuge	  5415R,	  Eppendorf	  
Centrifuge	  584R,	  Eppendorf	  
CO2	  incubator,	  Nuaire	  
Komesaroff	  Anaesthetic	  Machine,	  Medical	  
Developments	  International	  
Leica	  CM	  3050S	  cryostat,	  Leica	  
Leica	  DM	  6000,	  Leica	  
Micropipette	  Puller	  Model	  P-­‐97,	  Sutter	  
Instrument	  
Microplate	  Reader	  Mode	  550,	  BioRad	  
Mini	  Centrifuge,	  LMS	  
Mini-­‐Protean	  Tetra	  Cell,	  BioRad	  
NanoDrop,	  Peqlab	  
PerfectBlue	  Gel	  System	  Mini	  S,	  M,	  Peqlab	  
Pipetman	  M,	  Gilson	  
Pipetus,	  Hirschmann	  
Power	  Station	  300,	  Labnet	  International	  
Sunrise	  Microplate	  Reader,	  Tecan	  
Thermomixer	  Compact,	  Eppendorf	  
Trans-­‐Blot	  SD	  Semi-­‐Dry	  Transfer	  Cell,	  BioRad	  
	  
2.2.2	  CHEMICALS	  





Albumin,	  Bovine,	  Fraction	  V,	  Sigma	  
Ampicillin	  sodium	  salt,	  Roth	  
APS,	  J.T.	  Baker	  
B27	  Serum-­‐Free	  Supplement,	  Invitrogen	  
Bactotryptone,	  BD	  
Betaine	  solution,	  5	  M	  PCR	  reagent,	  Sigma	  
BrdU	  (5-­‐Bromo-­‐2’-­‐deoxyuridine),	  Sigma	  
Bromophenol	  blue,	  SERVA	  
CaCl2	  x	  2	  H2O,	  Sigma	  
Citric	  acid,	  Grüssing	  
Complete	  Mini;	  Protease	  Inhibitor	  Cocktail,	  
Roche	  
D-­‐Glucose,	  Sigma	  
DMSO	  (Dimethyl	  sulfoxide),	  Sigma	  
Donkey	  serum,	  Millipore	  
EDTA,	  Merck/Roth	  
EdU	  (5-­‐ethynyl-­‐2’-­‐deoxyuridine),	  Invitrogen	  
EGTA,	  AppliChem	  
Ethanol,	  Sigma	  
Fast	  Green	  FCF,	  Sigma	  
Fetal	  calf	  serum	  (FCS),	  Biochrom	  
GeneRuler	  100bp	  Plus	  DNA	  Ladder,	  Fermentas	  
GeneRuler	  1kb	  Plus	  DNA	  Ladder,	  Fermentas	  
Glycerol,	  J.T.	  Baker	  
Glycine,	  Roth	  
Heparin	  sodium	  salt,	  Sigma	  
HEPES	  1M,	  Invitrogen	  
Hoechst	  33258,	  Sigma	  
Horse	  serum,	  Biochrom	  
Isopropanol,	  Sigma	  
Kanamycin	  Sulfate,	  Invitrogen	  
KCl,	  Sigma	  
KH2PO4,	  AppliChem/GERBU	  
L-­‐Cystein	  hydrochloride,	  Sigma	  
L-­‐Glutamin,	  Sigma	  
Laminin-­‐1	  (EHS	  cells),	  Invitrogen	  
Methanol,	  Sigma	  
MgCl2,	  J.T.	  Baker	  
MgSO4	  x	  7	  H2O,	  J.T.	  Baker	  
Milk	  Powder,	  Roth	  
Na-­‐carbonate,	  AppliChem/Grüssing	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Na-­‐citrate,	  AppliChem	  
Na-­‐deoxycholate,	  AppliChem	  
Na2HPO4	  x	  2	  H2O,	  AppliChem	  
NaCl,	  Sigma	  
Normal	  Goat	  Serum	  (NGS),	  Invitrogen	  
Novaminsulfon,	  bela-­‐pharm	  
PageRuler	  Plus	  Prestained	  Protein	  Ladder,	  
Fisher	  Scientific	  
Paraformaldehyde	  (PFA),	  J.T.	  Baker	  
Pen/Strep	  (P/S),	  Gibco	  
PMSF,	  Roth/Sigma	  
Poly-­‐L-­‐Ornithine	  Hydrobromide,	  Sigma	  
SDS,	  SERVA	  
Shandon	  Immu-­‐Mount,	  Fisher	  Scientific	  
Sodium	  chlorate,	  Sigma	  
Sucrose,	  Roth	  
TEMED,	  Roth	  
Tissue	  freezing	  medium	  (Jung),	  Leica	  
Tris,	  Roth	  
Tris-­‐HCl,	  Roth	  
Triton	  X	  100,	  AppliChem	  
Trypsin	  Inhibitor,	  Sigma	  
Tween20,	  AppliChem	  
Yeast	  Extract,	  Roth	  
	  
2.2.3	  MEDIA	  
BME	  (Basal	  Medium	  Eagle)	   Sigma	  
DMEM	   Invitrogen	  
L15	  Leibovitz	  Medium	   Sigma	  
MEM	  HEPES	  Modification	   Sigma	  
Nutrient	  Mixture	  F12-­‐Ham	   Sigma	  
PBS	   Sigma	  
	  
2.2.4	  PLASTIC	  WARE	  
100	  cm2	  culture	  flask	  (T100)	   Nunc	  
100	  mm	  petri	  dish	   Sarstedt	  
15	  ml	  tube	   Greiner	  Bio-­‐One	  
25	  cm2	  culture	  flask	  (T25)	   Nunc	  
35	  mm	  petri	  dish	   Nunc	  
4-­‐well	  multiwell	  dish	  (35	  mm)	   Greiner	  Bio-­‐One	  
50	  ml	  tube	   Greiner	  Bio-­‐One	  
6-­‐well	  plate	   Greiner	  Bio-­‐One	  
60	  mm	  petri	  dish	   Nunc	  
75	  cm2	  culture	  flask	  (T75)	   Nunc	  
Cell	  Cultureware	  24-­‐Well	   Becton	  Dickinson	  
flexiPerm	  slides	   Sarstedt	  
Microloader	   Fisher	  Scientific	  
Microplate	  96	  Well	   Greiner	  Bio-­‐One	  
µ-­‐Chamber	  12	  well	   ibidi	  
µ-­‐Slide	  8	  well	   ibidi	  
	  
2.2.5	  ENZYMES/GROWTH	  FACTORS	  
Chondroitinase	  ABC	   Amsbio	  
Deoxyribonuclease	  I	   Worthington	  
DNaseI	  (RNase	  free)	   Mo	  Bi	  Tec	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Epidermal	  growth	  factor	  (EGF)	   PeproTech	  
Fast	  Digest	  AleI	  (OliI)	   Fermentas	  
Fibroblast	  growth	  factor-­‐2	  (FGF	  2)	   PeproTech	  
FseI	   New	  England	  Biolabs	  
Kapa	  Hifi	  Polymerase	   Peqlab	  
Papain	   Worthington/Sigma	  
Proteinase	  K	   Roth	  
RNase-­‐Free	  DNase	  Set	   Qiagen	  
T4	  Ligase	   Fermentas	  
	  
2.2.6	  KITS	  
Bromo-­‐2-­‐deoxy-­‐uridine	  Labeling	  and	   Detection	  
Kit	  I	  
Roche	  
Click-­‐iT	  EdU	  Alexa	  Fluor	  488	  Imaging	  Kit	   Invitrogen	  
Click-­‐iT	  EdU	  Alexa	  Fluor	  647	  Imaging	  Kit	   Invitrogen	  
DC	  Protein	  Assay	  Kit	  II	   BioRad	  
dNTP	  Set	   Fermentas	  
First	  Strand	  cDNA	  Synthesis	  Kit	   Fermentas	  
NucleoBond	  Xtra	  Maxi	  Plus	  EF	   Macherey-­‐Nagel	  
P3	  Primary	  Cell	  4D	  Nucleofector	  X	  Kit	  L	   Lonza	  
P3	  Primary	  Cell	  4D	  Nucleofector	  X	  Kit	  S	   Lonza	  
PARIS-­‐Kit	   Invitrogen	  
QIAprep	  Spin	  Miniprep	  Kit	   Qiagen	  
QIAquick	  PCR	  Purification	  Kit	   Qiagen	  
RNeasy	  Mini	  Kit	   Qiagen	  
SuperSignal	  West	  Pico	   Fisher	  Scientific	  
	  
2.2.7	  PLASMIDS	  
pCR®II-­‐TOPO®	   Invitrogen	  
pEasyflox	   AG	  Müller,	  University	  of	  Heidelberg	  
pEGFP	  N1	   Clontech	  
pXL201-­‐3xFLAG	   AG	  Alvarez-­‐Bolado,	  University	  of	  Heidelberg	  
pUst-­‐EGFP	  N1	  (Ust)	   AG	   von	   Holst,	   Richard	   Sturm,	   University	   of	  
Heidelberg	  
pUst-­‐EGFP	  N1	  mutated	  (Ust	  mut)	   AG	   von	   Holst,	   Denise	   Harrach,	   University	   of	  
Heidelberg	  





Antigen	   Clone	   Produced	  
in	  
Specificity	   Isotype	   Dilutio
n	  
Company	   Order	  Nr	  
473HD	   	   rat	   	   IgM	   1:100-­‐
1:300	  
Faissner	   et	  
al.,	  1994	  
	  




MATERIALS	  AND	  METHODS	  20	  
Primary	  Antibodies	  
Antigen	   Clone	   Produced	  
in	  
Specificity	   Isotype	   Dilutio
n	  
Company	   Order	  Nr	  
Ctip2	   25B6	   rat	   ms,	  GP,	  h,	  
zf	  
IgG2a	   1:1000	   abcam	   ab18465	  
GFAP	   G-­‐A-­‐5	   mouse	   	   IgG1	   1:300	   Sigma	   G	  3893	  
GFP	   	   rabbit	   	   	   1:300	   Millipore	   AB3080	  
GFP-­‐FITC	   	   goat	   wt,	   rGFP,	  
eGFP	  
	   1:500	   Biomol	  
(Rockland)	  
600-­‐102-­‐215	  
Ki67	   	   rabbit	   	   	   1:100-­‐
1000	  
Millipore	   AB9260	  
mCherry	  
(tdTomato)	  
	   goat	   	   IgG	   1:250	   Sicgen	   AB0081-­‐200	  
Nestin	   rat-­‐301	   mouse	   ms,	  rat	   IgG1	   1:500	   Millipore	   MAB353	  




abcam	   ab177487	  
O4	   O4	   mouse	   	   IgM	   1:50	   Sigma	   O7139	  





Pax6	   	   mouse	   	   IgG	   1:100	   Stoykova	  et	  
al	  
	  
tGFP	   2H8	   mouse	   	   IgG2b	   1:2000	   VWR	   ORIGTA1500
41	  
Ust	   	   rabbit	   	   IgG	   1:300	   abcam	   Ab137624	  
VGlut1	   	   guinea	  
pig	  
rat	   IgG	   1:1000	   Millipore	   AB5905	  
α-­‐Tubulin	   DM1A	   mouse	   	   IgG1	   1:5000-­‐
10000	  
Sigma	   T6199	  
Transgolgin-­‐
97	  
	   mouse	   	   IgG1	   1:250	   Dr.	  C.	  Hartmann-­‐Fatu,	  ZMB	  
Uni	  Duisburg-­‐Essen	  
βIII-­‐Tubulin	   2G10	   mouse	   	   IgG2a	   1:300	   Sigma	   T8578	  
	  
Secondary	  Antibodies	  
Species	  Reactivity	   Produced	  in	   Conjugation	   Specificity	   Dilution	   Company	  
α	  goat	   donkey	   Cy3	   IgG	  (H+L)	   1:500	   Dianova	  
α	  goat	   donkey	   Cy2	   	   1:250	   Dianova	  
α	  goat	   donkey	   HRP	   IgG	   1:10000	   Santa	  Cruz	  
α	  guinea	  pig	   goat	   633	  Alexa	   IgG	  (H+L)	   1:500	   Invitrogen	  
α	  mouse	   goat	   Cy3	   IgG	  +	  IgM	  (H+L)	   1:500	   Dianova	  
α	  mouse	   goat	   HRP	   IgG	  +	  IgM	  (H+L)	   1:5000	   Dianova	  
α	  mouse	   goat	   Cy3	   IgG	  (H+L)	   1:500	   Dianova	  
α	  mouse	   donkey	   Cy2	   IgM	  (µ	  chain)	   1:250	   Dianova	  
α	  mouse	   sheep	   Cy2	   IgG	  (H+L)	   1:250	   Dianova	  
α	  mouse	   goat	   647	  Alexa	   IgG	  +	  IgM	  (H+L)	   1:500	   Dianova	  
α	  mouse	   goat	   Cy5	   IgM	  (µ	  chain)	   1:500	   Dianova	  
α	  mouse	   donkey	   Cy2	   IgG	   1:250	   Dianova	  
α	  mouse	   donkey	   Cy3	   IgM	  (µ	  chain)	   1:500	   Dianova	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Secondary	  Antibodies	  
Species	  Reactivity	   Produced	  in	   Conjugation	   Specificity	   Dilution	   Company	  
α	  mouse	   goat	   647	  Alexa	   IgG	  (H+L)	   1:500	   Invitrogen	  
α	  rabbit	   goat	   Cy3	   IgG	  (H+L)	   1:500	   Dianova	  
α	  rabbit	   goat	   HRP	   IgG	  (H+L)	   1:5000	   Dianova	  
α	  rabbit	   goat	   Cy2	   IgG	  (H+L)	   1:300	   Dianova	  
α	  rabbit	   donkey	   Cy5	   IgG	  (H+L)	   1:500	   Dianova	  
α	  rabbit	   goat	   647	  Alexa	   IgG	   1:300	   Dianova	  
α	  rat	   goat	   Cy3	   IgM	  (µ	  chain)	   1:500	   Dianova	  
α	  rat	   goat	   HRP	   IgM	  (µ	  chain)	   1:5000	   Dianova	  
α	  rat	   goat	   647	  Alexa	   IgM	  (µ	  chain)	   1:500	   Dianova	  
α	  rat	   donkey	   Cy3	   IgG	   1:500	   Dianova	  
	  
2.2.9	  ALL	  OTHER	  CONSUMABLES	  
0,22	  µm	  sterile	  filters	   Millipore	  
0,4	  µm	  sterile	  filters	   Millipore	  
Borosilicate	   Capillaries,	   thin	  wall	  with	   filament	  
(OD	  1.2	  mm,	  ID	  0.94	  mm,	  length	  100	  mm)	  
Harvard	  Apparatus	  
Cover	  Slip	  circles,	  9	  mm	   Menzel	  
dNTP	  mix	   Fermentas	  
ECL	   GE	  Healthcare	  
Menzel	  Adhesion	  slides	  SuperFrostPlus	   Menzel/Fisher	  Scientific	  
Parafilm	  M	   Roth	  
PVDF	  membrane	  (Immobilon®	  P)	   Millipore	  
Roti-­‐Free	  Stripping	  buffer	   Roth	  
Whatman	  paper	  (3	  mm	  Chr)	   Fisher	  Scientific	  
	  
2.3	  COMPOSITION	  OF	  MEDIA,	  BUFFERS	  AND	  OTHER	  REAGENTS	  
2.3.1	  CELL	  CULTURE	  
Digestion	  buffer	   30	  U/ml	  Papain,	  40	  µg/ml	  DNase,	   0,24	  mg/ml	  L-­‐
Cysteine	  in	  MEM	  
Neurosphere	  differentiation	  medium	   Neurosphere	  medium,	  1	  %	  (v/v)	  FCS	  
Neurosphere	  medium	   DMEM/F12	   (1:1),	   0,2	  mg/ml	   L-­‐Glutamin,	  
2	  %	  (v/v)	  B27,	  100	  U/100	  µg/ml	  Pen/Strep	  
Ovomucoid	   L-­‐15	   Medium,	   1	  mg/ml	   Trypsin	   Inhibitor,	  
50	  µg/ml	  BSA,	  40	  µg/ml	  DNase	  
Phosphate-­‐buffered-­‐Saline	  (PBS)	   137	  mM	  NaCl,	  3	  mM	  KCl,	  
6,5	  mM	  Na2HPO4*2H2O,	  1,5	  mM	  KH2PO4	  
	  
2.3.2	  IMMUNOCYTO-­‐	  AND	  IMMUNOHISTOCHEMISTRY	  
4	  %	  (w/v)	  PFA	   4	  %	  (w/v)	  Paraformaldehyde,	  1xPBS;	  pH	  7,3	  
Citrate	  buffer	   2	  mM	  Citric	  acid,	  8	  mM	  Na-­‐citrate	  
Krebs-­‐Ringer-­‐HEPES	  (KRH)	   125	  mM	  NaCl,	  4,8	  mM	  KCl,	   1,3	  mM	  CaCl2*2H2O,	  
1,2	  mM	  MgSO4*7H2O,	   1,2	  mM	  KH2PO4,	  
5,6	  mM	  D-­‐Glucose,	  25	  mM	  HEPES;	  pH	  7,3	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KRH/A	   KRH,	  0,1	  %	  (w/v)	  BSA	  
PBS/A	   PBS,	  0,1	  %	  (w/v)	  BSA	  
PBS/Glycerol	   PBS	  +	  Glycerol	  (1:1)	  
PBT	  1	   PBS,	  1	  %	  (w/v)	  BSA,	  0,1	  %	  (v/v)	  Triton	  X-­‐100	  
Phosphate-­‐buffered-­‐Saline	  (PBS)	   137	  mM	  NaCl,	  3	  mM	  KCl,	  
6,5	  mM	  Na2HPO4*2H2O,	  1,5	  mM	  KH2PO4	  
	  
2.3.3	  MOLECULAR	  BIOLOGY	  
DNA	  loading	  buffer	  (6x)	   0,25	  %	  Bromophenol	  blue,	  30	  %	  Glycerol	  in	  H2O	  
LB-­‐Medium	   10	  g	  NaCl,	  10	  g	  Bactotryptone,	  5	  g	  Yeast	  extract	  
in	  1	  l	  H2O	  
LB-­‐Medium	  with	  Agar	   LB-­‐Medium	  with	  15	  g	  Agar	  
Tail	  buffer	  for	  genomic	  DNA	   100	  mM	  TrisHCl	  pH	  8,5,	   5	  mM	  EDTA,	   0,2	  %	  SDS,	  
200	  mM	  NaCl	  
Tris-­‐acetate-­‐EDTA	  Electrophoreses	  buffer	  (TAE)	   40	  mM	  Tris-­‐acetate,	  1	  mM	  EDTA	  
2.3.4	  PROTEIN	  BIOCHEMISTRY	  
Blocking	  buffer	   5	  %	  (w/v)	  Milkpowder	  in	  TBST	  
Cell	  lysis	  buffer	   50	  mM	  Tris-­‐Cl	  pH	  7,5,	   150	  mM	  NaCl,	  
5	  mM	  EDTA,	   5	  mM	  EGTA,	   1	  %	  (v/v)	  Triton	  X-­‐100,	  
0,1	  %	  (v/v)	  Na-­‐deoxycholate,	  0,1	  %	  (v/v)	  SDS	  
Laemmli	  sample	  buffer	  (SDS)	  5x	   156	  mM	  Tris-­‐HCl	   pH	  7,4,	   5	  %	  (w/v)	  SDS,	  
0,25	  %	  (w/v)	  Bromophenol	   blue,	   25	  %	  Glycerol,	  
12,5	  %	  (v/v)	  β-­‐mercaptoEtOH,	  H2O	  
Running	  buffer	  (SDS-­‐PAGE)	   25	  mM	  Tris,	  192	  mM	  Glycine,	  0,1	  %	  (v/v)	  SDS	  
TBS	   19	  mM	  Tris-­‐Cl,	  137	  mM	  NaCl;	  pH	  7,4	  
TBST	   TBS,	  0,05	  %	  (v/v)	  Tween	  20	  
Transfer	  buffer	  (Semi	  Dry	  Blot)	   25	  mM	   Tris	  pH	  8,2-­‐8,4,	   0,1	  %	  (v/v)	  SDS,	  
192	  mM	  Glycine,	  20	  %	  (v/v)	  Methanol	  
Transfer	  buffer	  (Tank	  Blot;	  Fairbanks)	   40	  mM	  Tris,	   20	  mM	  Sodium	   acetate,	   2	  mM	  
EDTA,	   pH	  7,4;	   10	  %	  (v/v)	  Methanol,	  
0,05	  %	  (v/v)	  SDS	  
	  
2.4	  CELL	  CULTURE	  
2.4.1	  CULTIVATION	  OF	  MOUSE	  NEURAL	  STEM	  CELLS	  
Mouse	  neural	  stem	  cells	   (NSCs)	  were	  obtained	  by	  dissecting	   the	  cortices	  of	  E13-­‐E14.5	  mouse	  
embryos	   to	  generate	  cultures	  of	   free-­‐floating	  neurospheres.	  The	  embryos	  were	  derived	   from	  
timed	   pregnancies	   of	   NMRI	  mice	   obtained	   from	   Charles	   River.	   The	   age	   of	   the	   embryos	  was	  
determined	   by	   Theiler	   stages	   (Theiler	   (1989)).	   Embryos	   of	   stages	   from	   E12.5	   (Theiler	   20)	   to	  
E14.5	   (Theiler	   22)	   were	   used.	   The	   cortical	   hemispheres	   were	   dissected	   in	   MEM	   and	   the	  
meninges	   were	   removed.	   The	   cortices	   were	   collected	   in	   1	  ml	   MEM	   and	   then	   digested	   for	  
25	  min	   at	   37°C	   by	   adding	   1	  ml	   filter-­‐sterilized	   MEM	   with	   Papain	   (30	  U/ml),	   L-­‐Cysteine	  
(240	  µg/ml)	  and	  DNase	  (40	  µg/ml).	  The	  tissue	  was	  gently	  triturated	  to	  a	  single	  cell	  suspension.	  
The	  digestion	  was	  stopped	  by	  an	  equal	  volume	  of	  ovomucoid.	  The	  cells	  were	  pelleted	  for	  5	  min	  
at	  180	  x	  g	  and	  afterwards	  resuspended	  in	  neurosphere	  (Nsph)	  growth	  medium.	  The	  cells	  were	  
plated	  (100.000	  cells/ml)	  in	  T25	  flasks	  in	  4	  ml	  Nsph	  growth	  medium	  with	  the	  growth	  factors	  EGF	  
(10	  ng/ml),	  FGF	  2	  (10	  ng/ml)	  and	  the	  cofactor	  Heparin	  (0,5	  U/ml)	  and	  incubated	  at	  37°C	  and	  5	  %	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CO2.	  After	  5	  days	  of	  cultivation	  the	  cells	  were	  passaged	  to	  generate	  secondary	  neurospheres.	  
Therefore,	  the	  primary	  neurospheres	  were	  pelleted	  for	  5	  min	  at	  80	  x	  g	  and	  digested	  with	  450	  µl	  
T/E	  for	  3	  min	  at	  37°C.	  By	  adding	  the	  same	  volume	  of	  ovomucoid	  the	  digestion	  was	  stopped.	  In	  
order	  to	  generate	  a	  single	  cell	  suspension,	   the	  cells	  were	  gently	  triturated	  and	  again	  pelleted	  
for	   5	  min	   at	   120	  x	  g.	   Afterwards,	   the	   cells	  were	   plated	   (50.000	  cells/ml)	   in	   T25	   flasks	   in	   4	  ml	  
Nsph	  growth	  medium	  and	  the	  above	  mentioned	  growth	  factors.	  After	  4	  days	  of	  cultivation	  the	  
secondary	  neurospheres	  were	  treated	  as	  described	  before	  to	  generate	  tertiary	  neurospheres.	  
Thereby,	  106	  cells	  were	  plated	  in	  T75	  flasks	  in	  12	  ml	  nsph	  growth	  medium	  and	  growth	  factors	  
were	  added	  at	  the	  same	  concentration	  as	  listed	  above.	  After	  another	  3	  days	  of	  incubation	  the	  
Nsphs	  were	  used	  for	  transfection	  and	  following	  procedures.	  
2.4.2	  TRANSFECTION	  OF	  THE	  NSCS	  
Isolated	  NSCs	  from	  mouse	  tissue	  were	  expanded	  in	  cell	  culture	  under	  proliferative	  conditions.	  
For	  the	  transfection	  of	  the	  NSCs	  a	  single	  cell	  suspension	  was	  prepared	  by	  digestion	  with	  T/E	  for	  
2-­‐3’	   at	   37°C.	   The	   addition	   of	   an	   equal	   volume	   of	   Ovomucoid	   stopped	   the	   digestion.	   The	  
appropriate	  amount	  of	  cells	  was	  transfected	  with	  Lonza’s	  P3	  Primary	  Cell	  4D	  Nucleofector	  X	  Kit	  
S	  (5	  x	  105)	  or	  L	  (5	  x	  106)	  according	  to	  the	  manufacturer's	  instructions.	  0,5	  µg	  Plasmid	  was	  used	  
for	   Kit	   S	   and	   5	  µg	   Plasmid	   for	   Kit	   L	   with	   the	   transfection	   pulse	   DS	  113.	   For	   an	   improved	  
regeneration	   the	   cells	   have	   been	   transferred	   into	   Nsphs-­‐medium	   to	   recover	   for	   1	  d	   in	   the	  
incubator.	  
2.4.3	  DIFFERENTIATION	  ASSAY	  
	  
Figure	  6	  Differentiation	  Assay	  Timescale	  
For	   the	   differentiation	   of	  NSCs	   4-­‐well	  multiwell	   dishes,	   flexiPERM	   slides,	   µ-­‐Slide	   8	  well	   or	   µ-­‐
Chamber	   12	   well	   have	   been	   prepared.	   They	   were	   sequentially	   coated	   for	   1	  h	   with	   P-­‐Orn	  
[10	  µg/ml	   in	  H2O]	   followed	  by	  Laminin	   [10	  µg/ml	   in	  PBS].	  The	  transfected	  NSCs	  could	  rest	   for	  
24	  h	   after	   transfection	   in	   the	   incubator	  with	   Nsph	   growth	  medium.	   Afterwards,	   a	   single	   cell	  
suspension	   was	   prepared	   as	   described	   in	   the	   cultivation	   conditions	   of	   NSCs	   and	  
20.000	  cells/well	   (4-­‐well,	   flexiPERM,	  8	  well)	  or	  10.000	  cells/well	   (12	  well)	  have	  been	  plated	   in	  
differentiation	  medium.	  As	  soon	  as	  the	  cells	  attached	  to	  the	  bottom	  of	  the	  wells,	  the	  dish	  was	  
floated	   with	   1,6	  ml	   differentiation	  medium	   and	   left	   for	   3	  d	   in	   the	   incubator	   to	   differentiate	  
(4	  well).	   The	   following	   analysis	   of	   the	   differentiation	   of	   NSC-­‐derived	   cell	   types	   and	   the	  
expression	  of	  the	  used	  constructs	  were	  performed	  by	  immunocytochemical	  stainings.	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2.4.4	  CLONAL	  DENSITY	  ASSAY	  
	  
Figure	  7	  Clonal	  Density	  Assay	  Timescale	  
To	  define	  the	  amount	  of	  Nsph	  forming	  cells	  within	  the	  transfected	  NSCs	  a	  Clonal	  Density	  Assay	  
was	  performed.	  After	  the	  recovery	  from	  the	  transfection,	  2500	  cells/T25	  flask	  have	  been	  plated	  
in	  2	  ml	  Nsph	  growth	  medium	  with	  distinct	  concentrations	  of	  the	  growth	  factors	  FGF	  2	  [2	  ng/ml],	  
EGF	  [2	  ng/ml]	  and	  Heparin	  [0,0625	  U/ml].	  After	  one	  week	  the	  number	  of	  Nsphs	  was	  evaluated	  
under	  a	  light	  microscope	  and	  documented.	  
2.4.5	  PROLIFERATION	  ASSAY	  
The	  proliferative	  capacity	  of	  the	  transfected	  NSCs	  was	  checked	  by	  the	  EdU	  proliferation	  assay.	  
Therefore,	   the	   transfected	   cells	   have	   been	   plated	   following	   the	   same	   procedure	   as	   in	   the	  
differentiation	  assay,	  but	  before	  fixing	  the	  cells	  with	  PFA,	  the	  cells	  were	  pulsed	  for	  2-­‐3	  h	  with	  




For	   the	   immunological	  antigen	  detection	  of	   cultured	  NSCs	  after	   the	  differentiation	  assay,	   the	  
medium	  of	   the	  NSCs	  has	  been	   removed	  and	   for	  a	   staining	  of	   cell	   surface	  molecules	   the	   cells	  
were	  washed	  with	  KRH/A.	  The	  primary	  antibodies	  for	  the	  cell	  surface	  molecules	  were	  incubated	  
for	  25	  min	  in	  KRH/A	  at	  RT.	  Afterwards	  the	  cells	  were	  fixed	  with	  4	  %	  PFA	  for	  10	  min	  at	  RT.	  Two	  
washing	   steps	  with	   PBS/A	  were	   followed	   by	   a	   permeabilization	  with	   PBT	  1	   for	   30	  min	   at	   RT.	  
After	   another	   two	   washing	   steps	   with	   PBS/A,	   the	   cells	   have	   been	   incubated	   overnight	   with	  
primary	  antibodies	  in	  PBS/A	  at	  4°C.	  The	  next	  day,	  the	  cells	  were	  washed	  twice	  with	  PBS/A	  and	  
secondary	  antibodies	  were	   incubated	  for	  1	  h	   in	  PBS/A	  at	  RT.	  The	  cells	  were	  washed	  with	  PBS	  
twice	   and	   mounted	   with	   PBS/Glycerol	   for	   subsequent	   immunofluorescence	   microscopy	  
analysis.	  
2.5.2	  PROLIFERATION	  
The	  proliferation	  of	  the	  NSCs	  after	  transfection	  was	  examined	  by	  using	  the	  EdU	  assay.	  Here,	  the	  
base	   analogue	   EdU	   was	   added	   to	   the	   cultures	   for	   2-­‐3	  h	   before	   fixing	   the	   cells	   after	   the	  
differentiation	   assay.	   The	   pulse	   and	   the	   EdU	   staining	   were	   performed	   as	   described	   in	   the	  
manufacturer’s	   instructions.	   For	  additional	  antigen	  detection	   the	  procedure	  was	  expanded	   in	  
the	   following	   way:	   After	   the	   fixation	   for	   10	  min	   with	   4	  %	  PFA	   at	   RT	   the	   cells	   have	   been	  
incubated	   for	   20	  min	   with	   PBT	  1	   and	   then	   washed	   twice	   with	   the	   washing	   buffer.	   The	   EdU	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reaction	   cocktail	   incubation	   was	   followed	   by	   another	   two	   washing	   steps	   with	   PBS/A	   and	  
incubation	   of	   the	   primary	   antibodies	   in	   PBS/A	   overnight	   at	   4°C.	   The	   next	   day	   the	   cells	  were	  
washed	  with	  PBS/A	  twice	  and	  the	  secondary	  antibodies	  were	  incubated	  for	  1	  h	  at	  RT	  in	  PBS/A.	  
To	  finish	  the	  staining,	  the	  cells	  were	  washed	  twice	  with	  PBS	  and	  mounted	  with	  PBS/Glycerol.	  
2.6	  IMMUNOHISTOCHEMISTRY	  
2.6.1	  DIFFERENTIATION	  
The	  cryo	  sections	  were	  thawed	  at	  RT	  and	  rehydrated	  in	  PBS	  for	  10	  min.	  For	  permeabilization,	  
the	  slides	  have	  been	  incubated	  in	  PBS	  with	  0,5	  %	  Triton	  X-­‐100	  for	  20	  min.	  The	  slides	  have	  been	  
washed	  for	  another	  10	  min	  in	  PBS	  and	  afterwards	  incubated	  for	  1	  h	  at	  RT	  with	  blocking	  solution	  
(PBS	  +	  10	  %	  serum	  +	  3	  %	  BSA).	  Primary	  antibodies	  have	  been	  incubated	  overnight	  at	  4°C	  in	  PBS	  
with	  3	  %	  BSA.	  On	  the	  next	  day	  the	  slides	  have	  been	  washed	  with	  PBS/A	  twice	  for	  5	  min,	  before	  
the	   slides	   have	   been	   incubated	   with	   the	   secondary	   antibodies	   for	   1	  h	   at	   RT	   in	   PBS/A.	   After	  
another	  two	  washing	  steps	  with	  PBS	  the	  slides	  have	  been	  mounted.	  
For	  the	  primary	  antibodies	  that	  need	  an	  antigen	  retrieval	  treatment	  the	  following	  steps	  came	  
ahead	  of	  the	  rest	  of	  the	  procedure:	  The	  thawed	  slides	  have	  been	  boiled	  in	  citrate	  buffer	  until	  
the	  temperature	  reached	  90°C,	  then	  put	  aside	  until	   the	  temperature	  reached	  about	  60°C	  and	  
subsequently	  washed	  in	  PBS.	  
2.6.2	  PROLIFERATION	  
The	   cryo	   sections	   were	   thawed	   at	   RT	   and	   washed	   in	   PBS	   +	   3	  %	  BSA	   twice	   for	   5	  min.	   After	  
permeabilization	   for	   20	  min	   in	   PBS	   with	   0,5	  %	  Triton	  X-­‐100,	   the	   slides	   were	   incubated	   again	  
twice	  for	  5	  min	  with	  PBS	  +	  3	  %	  BSA.	  Then,	  the	  EdU	  cocktail	  incubated	  for	  30	  min	  as	  described	  in	  
the	   manual	   of	   the	   kit.	   After	   another	   two	   washing	   steps	   with	   PBS	   +	   3	  %	  BSA,	   the	   sections	  
incubated	  with	  the	  primary	  antibodies	  overnight	  at	  4°C	  in	  the	  washing	  buffer.	  On	  the	  next	  day	  
the	  secondary	  antibodies	   incubated	  for	  1	  h	  at	  RT	  in	  PBS/A	  after	  washing	  the	  slides	  twice	  with	  
the	  same	  buffer.	  The	  slides	  were	  washed	  twice	   in	  PBS,	   followed	  by	  mounting	   them	   in	   Immu-­‐
Mount.	  
2.7	  MOLECULAR	  BIOLOGY	  
2.7.1	  RNA	  ISOLATION	  AND	  CDNA	  SYNTHESIS	  
Total	  RNA	  was	  isolated	  from	  pelleted	  NSCs	  or	  Nsphs.	  Therefore,	  the	  RNeasy	  Mini	  Kit	  including	  
QIAshredder	   columns	  were	  used	  according	   to	   the	  manufacturer’s	   instructions.	  Depending	  on	  
the	  used	  cell	  amount	  a	  volume	  of	  30-­‐50	  µl	  was	  used	  for	  elution.	  
cDNA	  was	  transcribed	  from	  isolated	  RNA	  with	  the	  First	  Strand	  cDNA	  Synthesis	  Kit	  as	  described	  
in	  the	  instructions.	  
2.7.2	  POLYMERASE	  CHAIN	  REACTION	  (PCR)	  
The	  polymerase	   chain	   reaction	  was	  always	  performed	  with	  a	  PCR	   reaction	  mix	  mentioned	   in	  
the	   table	   below	   with	   distinct	   conditions	   for	   PCR	   reaction	   program	   depending	   on	   the	   used	  
primers	   (see	   also	   2.8	   Oligonucleotide	   Primers).	   The	   optimal	   conditions	  were	   tested	   for	   each	  
primer	  pair	  separately.	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PCR	  reaction	  mix	  
template	  DNA	   0,5-­‐1	  µl	  
dNTPs	  (5	  nmol)	   0,5	  µl	  
forward	  primer	  (5	  pmol)	   0,5	  µl	  
reverse	  primer	  (5	  pmol)	   0,5	  µl	  
10x	  buffer	   2,5	  µl	  
Taq	  polymerase	   0,5-­‐1	  µl	  
(Betaine	  solution	   5	  µl)	  
H2O	   x	  µl	  
Total	  volume	   25	  µl	  
	  
PCR	  reaction	  program	   	  
1.	  denaturation	   94°C	   5	  min	   	  
2.	  denaturation	   94°C	   30	  sec	  
25-­‐45	  cycles	  3.	  annealing	   see	  2.8	   30-­‐60	  sec	  
4.	  elongation	   72°C	   30-­‐90	  sec	  
5.	  elongation	   72°C	   5	  min	   	  
6.	  cooling	   4°C	   ∞	   	  
	  
2.7.3	  ISOLATION	  OF	  PLASMID	  DNA	  
Plasmid	  DNA	  was	  isolated	  from	  3	  ml	  bacterial	  cultures	  with	  the	  QIAprep	  Spin	  Miniprep	  Kit	  and	  
from	   500	  ml	   cultures	   with	   the	   NucleoBond	   Xtra	   Maxi	   Plus	   EF	   Kit	   according	   to	   the	  
manufacturers’	  instructions.	  The	  DNA	  was	  eluted	  with	  H2O	  and	  stored	  at	  -­‐20°C.	  
2.7.4	  RESTRICTION	  ENZYME	  DIGESTION	  
Plasmid	  DNA	  or	   PCR	  products	  were	   cut	  with	   specific	   restriction	   enzymes	   as	   described	   in	   the	  
manufacturers’	   instructions	  and	  with	   the	   following	   standard	  procedure:	  A	  distinct	   amount	  of	  
DNA	  was	  mixed	  with	  the	  specific	  restriction	  enzyme,	  the	  appropriate	  restriction	  buffer	  and	  H2O	  
in	  a	  volume	  of	  10-­‐20	  µl	  and	  was	  digested	  for	  the	  recommended	  time	  at	  37°C.	  The	  reaction	  was	  
usually	  stopped	  by	  inactivating	  the	  enzymes	  at	  70-­‐80°C	  for	  10-­‐20	  min.	  
2.7.5	  SITE-­‐DIRECTED	  MUTAGENESIS	  OF	  UST	  
For	   inactivation	  of	  the	  catalytic	  active	   lysine	  of	  Ust,	  a	  site-­‐directed	  mutagenesis	  of	  Ust	  on	  the	  
pEGFP-­‐N1	  plasmid	  was	  performed.	  The	  lysine	  was	  mutated	  with	  special	  primers	  (Ust	  mut	  K-­‐>A	  
forw/rev)	  into	  a	  catalytically	  inactive	  alanine.	  For	  the	  PCR	  Pfu	  polymerase	  was	  used	  and	  100	  ng	  
of	  the	  plasmid	  DNA.	  The	  PCR	  product	  was	  digested	  with	  DpnI	  for	  1	  h	  at	  37°C.	  After	  the	  digested	  
PCR	  product	  was	  checked,	  a	  transformation	  was	  performed,	  clones	  were	  picked,	  plasmid	  DNA	  
isolated	  and	  sequenced	  by	  Sanger	  sequencing.	  
	  
2.8	  OLIGONUCLEOTIDE	  PRIMERS	  
All	  primers	  were	  synthesized	  by	  Sigma	  and	  are	  listed	  in	  the	  following	  table	  (inserted	  restriction	  
sites	  are	  highlighted	  in	  red).	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Primer	   Sequence	  5’-­‐3’	   Annealing	  
Temp	  
3’arm	  full	  forw	   CGCTAAGCTTGTCAACTGTGCCGCCTTCG	   	  
3’arm	  full	  rev	   CAGCCTCGAGAGCCTATCTCTACTGAAGATCAATCC	   	  
3’arm	  seq	  rev’	   GCAGAATGGCAGAGAATGAAGAGG	   57-­‐65°C	  
5’arm	  full	  forw	   GCAGATCGATGCTTGGCAACTCCCATCTCC	   60-­‐62°C	  
5’arm	  full	  rev	   ATGCGGCCGCTATCCGAGAACAGGGCTGC	   60-­‐62°C	  
5’arm	  seq	  forw	   CCTGACCACTGACCTCACTTCC	   55-­‐59°C	  
A	   CCAGGACCAGATTGTCAGAAGAGG	   61-­‐65°C	  
B’	   ATGTGGAATGTGTGCGAGGC	   59-­‐65°C	  
C	   CGATTAAGTGTGTTTGATAGAGCAGC	   59-­‐65°C	  
D	   CCTCCCTCGTCTTACAAGCACTCC	   57-­‐65°C	  
E	   CCTTCTGAGTTGTGTGGGCTGG	   60-­‐65°C	  
F’	   GGAATTTACACCCTCCCTCAGC	   61-­‐65°C	  
KO	  element	  full	  forw	   CCTGTTCTCGGATAGGTCTCTGG	   60-­‐62°C	  
KO	  element	  full	  rev	   CGAAGTCGACGCACAGTTGACTGGCACC	   60-­‐62°C	  
KO	  seq	  forw	   GTCAAGGAGGTGGAGCGAGAGG	   65°C	  
KO	  seq	  rev	   CGTGGTGGCCGTGACAGC	   65°C	  
Ust	  mut	  K-­‐>A	  forw	   GTACAACAGAGTTGGCGCGTGTGGCAGTCGTACC	   60°C	  
Ust	  mut	  K-­‐>A	  rev	   GGTACGACTGCCACACGCGCCAACTCTGTTGTAC	   60°C	  
Ust	  Sonde	  forw	   GCAACTTTGGCGGTCAGAGG	   64°C	  
Ust	  Sonde	  rev	   GGTCCTGGAGCAGAGCCTGG	   64°C	  
GFP	  forw	   ATGGTGAGCAAGGGCGAGG	   63°C	  
GFP	  rev	   TTACTTGTACAGCTCGTCCATGCC	   63°C	  
tdTomato	  forw	   CATGGCACCGGCAGCAC	   60°C	  
tdTomato	  rev	   TCACTTGTCATCGTCATCCTTG	   60°C	  
	  
2.9	  PROTEIN	  BIOCHEMISTRY	  
2.9.1	  PROTEIN	  ISOLATION	  AND	  QUANTITATION	  
For	  cell	   lysis,	  Nsphs	  or	  single	  cell	  suspension	  were	  pelleted	  and	  directly	  put	  on	  ice	  for	  protein	  
isolation	  or	  frozen	  for	  storage.	  Depending	  on	  the	  cell	  amount,	  distinct	  amounts	  of	   lysis	  buffer	  
with	  1	  %	  protease	  inhibitor	  (40-­‐140	  µl)	  were	  added	  and	  incubated	  for	  1	  h	  on	  ice.	  The	  lysate	  was	  
cleared	  by	  centrifugation	  at	  16.000	  x	  g	  for	  30	  min	  at	  4°C.	  The	  supernatant	  was	  transferred	  into	  
a	  fresh	  tube	  on	  ice.	  
Protein	  concentration	  was	  determined	  using	  the	  BioRad	  DC	  Protein	  Assay	  Kit	  II	  according	  to	  the	  
manufacturer’s	  instructions.	  
2.9.2	  SDS-­‐PAGE	  
SDS-­‐PAGEs	   were	   performed	   with	   BioRad’s	   Mini-­‐Protean	   Tetra	   Cell	   electrophoresis	   system.	  
Therefore,	   the	  samples	  have	  been	  heated	   in	  Laemmlis	   sample	  buffer	  at	  95°C	   for	  5	  min.	  After	  
loading	   the	   gel	   (8	  %	   or	   10	  %	   gels),	   the	   protein	   separation	   was	   accomplished	   by	   a	   constant	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For	  2	  gels:	   8	  %	  separation	  gel	   10	  %	  separation	  gel	   5	  %	  stacking	  gel	  
H2O	   4,66	  ml	   4	  ml	   2,7	  ml	  
Acrylamide	   2,64	  ml	   3,3	  ml	   670	  µl	  
1,5	  M	  Tris	  pH	  8,8	   2,5	  ml	   2,5	  ml	   –	  
1	  M	  Tris	  pH	  6,8	   –	   –	   500	  µl	  
10	  %	  SDS	   100	  µl	   100	  µl	   40	  µl	  
10	  %	  APS	   100	  µl	   100	  µl	   40	  µl	  
TEMED	   4	  µl	   4	  µl	   4	  µl	  
	  
2.9.3	  WESTERN	  BLOT	  
For	  blotting	   the	  proteins	  onto	  a	  methanol-­‐activated	  PVDF	  membrane,	   the	  SDS	  gel,	  Whatman	  
paper	  and	   the	  membrane	  were	  collected	   in	   transfer	  buffer.	  Depending	  on	   the	  method	   (Semi	  
Dry	  or	  Tank	  Blot),	  the	  gel,	  the	  PVDF	  membrane	  and	  the	  Whatman	  paper	  were	  stratified	  or	  the	  
Tank	  Blot	  sandwich	  was	  prepared.	  For	  the	  Semi	  Dry	  blotting	  a	  constant	  current	  of	  75	  mA	  per	  gel	  
1	  h	  15	  min	  was	  used	  to	  transfer	  the	  proteins	  to	  the	  membrane.	  The	  Tank	  Blot	  was	  performed	  
overnight	  at	  4°C	  with	  a	  constant	  voltage	  of	  9	  V.	  
After	  the	  transfer,	  the	  membrane	  was	  incubated	  with	  5	  %	  blocking	  buffer	  for	  1	  h	  at	  RT.	  Primary	  
antibodies	   were	   incubated	   overnight	   at	   4°C	   after	   a	   short	   washing	   step	   with	   TBST.	   The	  
membrane	  was	  washed	   3	   times	   for	   20	  min	  with	   TBST	   before	   incubating	   the	  HRP	   conjugated	  
secondary	   antibodies	   for	   1	  h	   in	   blocking	   buffer	   at	   RT.	   After	   another	   3x15	  min	  washing	   steps	  
with	   TBST,	   the	   membrane	   was	   incubated	   with	   ECL	   reagent	   and	   Amersham	   Hyperfilms	   of	  
different	  exposure	  times	  were	  developed	  in	  a	  developing	  machine.	  
2.10	  IN	  UTERO	  ELECTROPORATION	  
2.10.1	  ANIMALS	  
For	   the	   in	  utero	  experiments	   timed	  pregnant	  C57BL/6	  mice	  were	  used.	  They	  were	  purchased	  
either	  from	  Charles	  River	  Laboratories	  or	  Janvier.	  
2.10.2	  GLASS	  CAPILLARIES	  
Injection	  capillaries	  were	  pulled	  with	  a	  micropipette	  puller	  from	  Sutter	  Instrument.	  Therefore,	  
borosilicate	  capillaries	  were	  used	  and	  pulled	  as	  thin	  and	  long	  as	  possible	  to	  minimize	  any	  injury	  
to	  the	  embryo.	  
2.10.3	  PLASMID	  PREPARATION	  
For	  the	  plasmid	  DNA	  injection	  into	  the	  lateral	  ventricle,	  the	  plasmid	  was	  isolated	  as	  described	  in	  
2.7.3	  and	  eluted	  in	  water.	  The	  plasmid	  was	  diluted	  in	  PBS	  to	  a	  concentration	  of	  1-­‐2	  µg/µl	  and	  
the	   dye	   fast	   green	   FCF	   was	   added	   to	   enable	   the	   visualization	   of	   the	   injected	   DNA	   in	   the	  
ventricle	  system.	  
2.10.4	  SURGICAL	  PROCEDURE	  
The	   anaesthesia	   of	   the	   pregnant	   mice	   at	   embryonic	   day	   E12.5	   was	   initiated	   by	   isoflurane	  
inhalation,	   as	   recommended	   by	   the	   Institut	   für	   Labortierkunde	   der	   Universität	   Zürich	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(http://www.ltk.uzh.ch/de).	   Anaesthesia	   was	   maintained	   by	   isoflurane	   inhalation	   via	   an	  
anaesthetic	  machine	  with	  a	  face	  mask.	  
The	   next	   step	   was	   to	   open	   the	   abdomen,	   take	   and	   hold	   the	   uterus	   with	   a	   forceps.	   After	  
visualizing	  the	  ventricle	  system	  of	  the	  embryo,	  one	  injected	  the	  plasmid	  DNA	  into	  the	  lateral	  or	  
third	  ventricle	  of	   the	  embryo.	  The	  correct	   injection	  could	  be	  controlled	  by	   the	  distribution	  of	  
the	  green	  dyed	  DNA.	  	  
To	  transfer	   the	   injected	  DNA	   into	  the	  neuroepithelial	  cells	  of	   the	  central	  nervous	  system	  one	  
needed	  to	  generate	  an	  electric	  field.	  The	  electroporation	  took	  place	  after	  injecting	  the	  embryos	  
by	   using	   tweezer	   electrodes.	   Thereby,	   the	   positive	   pole	   of	   the	   electrode	  was	   placed	   on	   the	  
area,	  that	  should	  be	  targeted,	  whereas	  the	  negative	  electrode	  was	  placed	  somewhere	  on	  the	  
opposite	  site	  of	  the	  embryo.	  The	  given	  pulse	  was	  the	  following:	  
50	  Volt/	  50	  msec(on)/	  950	  msec(off)/	  5	  pulse.	  
After	   the	   electroporation,	   the	   uterus	   was	   placed	   back	   as	   accurately	   as	   possible	   into	   the	  
peritoneal	  cavity	  as	  it	  had	  been	  situated	  before.	  To	  finish	  the	  surgery,	  first	  the	  muscle	  layer	  and	  
then	  the	  skin	  were	  sewed	  with	  absorbing	  yarn	  and	  a	  strong	  analgesic	  (Metamizol)	  was	  injected	  
into	  the	  peritoneal	  cavity.	  The	  whole	  procedure	  is	  depicted	  in	  the	  scheme	  in	  Figure	  8.	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2.10.5	  ANALYSIS	  
Analysis	  group	  1:	  The	  mice	  were	  injected	  with	  EdU	  (100	  mg/1	  kg	  bodyweight)	  one	  day	  after	  the	  
in	  utero	  electroporation	  at	  E13.5.	  Two	  days	  after	  the	  surgery	  at	  E14.5	  the	  mice	  were	   injected	  
with	  the	  base	  analogue	  BrdU	  (100	  mg/kg	  bodyweight)	  two	  hours	  before	  they	  were	  sacrificed.	  
Analysis	  group	  2/3:	  Since	  the	  pregnant	  mice	  in	  this	  analysis	  groups	  directly	  ate	  or	  expulsed	  the	  
newborn	  pups,	  no	  examination	  of	  changes	  in	  the	  cortical	  development	  of	  transfected	  mice	  was	  
possible	  at	  postnatal	  stages.	  
The	  brains	  of	  the	  embryos	  were	  fixed	  with	  4	  %	  PFA	  for	  2-­‐4	  h	  at	  4°C.	  After	  incubating	  the	  brains	  
first	  in	  15	  %	  sucrose	  and	  then	  in	  30	  %	  sucrose	  solution	  overnight	  at	  4°C,	  the	  brains	  were	  frozen	  
and	  cut	  using	  a	  cryostat	  for	  the	  following	  immunohistochemical	  stainings	  (see	  2.6.1	  and	  2.6.2).	  
Figure	   9	   shows	   the	   classification	   criterea	   for	   further	   analysis	   of	   the	   in	   utero	   electroporation	  
data.	   It	   was	   distinguished	   between	   cortex	   electroporated	   and	   not	   electroporated	   as	   well	   as	  
midline	  electroporated	  and	  not	  electroporated.	   In	  addition	   to	   the	   total	  analysis	  of	   the	  whole	  
hemispheres,	   the	   analysis	   was	   divided	   along	   the	   rostrocaudal	   axis.	   The	   criterea	   to	   split	   into	  
either	  rostral	  or	  caudal	  slices	  are	  shown	  in	  Figure	  9	  B,	  whereat	  the	  appearance	  of	  the	  ganglionic	  
eminence	  was	  important.	  
	  
Figure	  9	  Scheme	  for	  the	  analysis	  of	  the	  in	  utero	  electroporation	  data	  
A:	  Schematic	  frontal	  view	  of	  an	  in	  utero	  electroporated	  mouse	  brain	  E	  14.5.	  Areas	  in	  red	  are	  the	  target	  
areas	  for	  electroporation.	  Areas	  included	  in	  the	  analysis	  are	  marked	  with	  green	  rectangles.	  B:	  Schematic	  
overview	  for	  the	  classification	  of	  the	  slices	  into	  rostral	  and	  caudal	  by	  the	  appearance	  of	  the	  ganglionic	  
eminence.	  The	  green	  areas	  are	  cross	  sections	  through	  the	  brain	  and	  are	  shown	  in	  frontal	  below	  with	  the	  
according	   ganglionic	   eminence	   appearance.	   OB=olfactory	   bulb,	   MGE=medial	   ganglionic	   eminence,	  
LGE=lateral	  ganglionic	  eminence,	  CGE=caudal	  ganglionic	  eminence.	  
2.11	  UST	  CONDITIONAL	  KNOCKOUT	  MOUSE	  STRATEGY	  
2.11.1	  ISOLATION	  OF	  GENOMIC	  DNA	  FROM	  MOUSE	  TAILS	  
For	   isolation	   of	   genomic	  DNA,	   the	   tips	   of	  mouse	   tails	  were	   cut	   and	   incubated	   in	   500	  µl	   lysis	  
buffer	   (tail	   buffer	   +	   proteinase	   K	   [50	  µg/ml])	   overnight	   at	   55°C,	   400	  rpm	   in	   an	   Eppendorf	  
Thermomixer.	  The	  next	  day,	  500	  µl	  Isopropanol	  were	  added	  and	  the	  tube	  was	  inverted	  to	  mix	  
thoroughly.	   For	   30	  min	   the	   mixture	   was	   cooled	   down	   to	   -­‐80°C	   and	   then	   centrifuged	   at	   full	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washed	  with	  300	  µl	  70	  %	  EtOH.	  The	  tube	  was	  centrifuged	  again	  for	  15	  min	  with	  full	  speed	  at	  4°C	  
and	  the	  supernatant	  carefully	  removed.	  The	  pellet	  was	  air-­‐dried	  at	  RT	  and	  was	  resuspended	  in	  
60-­‐80	  µl	   of	   10	  mM	  TrisHCl	  pH	  8,0.	   To	   resolve	   the	  pellet,	   the	   tube	  was	   incubated	  overnight	   at	  
55°C	  and	  400	  rpm	  in	  the	  Thermomixer.	  The	  isolated	  genomic	  DNA	  was	  stored	  at	  -­‐20°C.	  
2.11.2	  GENOTYPING	  OF	  UST	  MUTANT	  MICE	  
The	   conditions	   for	   genotyping	   of	   Ust	   mutant	   mice	   were	   established	   with	   genomic	   DNA	   of	  
embryonic	   stem	   cells	   (ESCs)	   kindly	   provided	   by	   Simone	   Reimer	   (AG	   Müller,	   University	   of	  
Heidelberg).	  Therefore	  20	  ng	  of	  genomic	  DNA	  were	  used	  as	  template	  for	  genotyping	  PCR	  and	  
for	   cloning	   the	   knockout	   plasmid	   inserts.	   The	   different	   primer	   combinations	   and	   sizes	   are	  
shown	  in	  Figure	  10	  and	  the	  following	  table.	  
2.11.3	  STRATEGY	  
Ust	   is	  encoded	  by	  an	  enormously	   large	  gene	  with	  a	  size	  of	  about	  314.000	  kb	   (Figure	  10).	  The	  
first	  line	  in	  the	  figure	  shows	  the	  whole	  gene	  with	  its	  8	  exons	  and	  very	  large	  introns	  in	  between.	  
In	   the	   second	   line	   the	   introns	   are	   shortened	   for	   a	   better	   visualization	   of	   the	  Ust	   exons.	   The	  
complete	  deletion	  of	  the	  Ust	  gene	  is	  because	  of	  the	  enormous	  size	  not	  feasible.	  Besides	  being	  
the	  start	  of	  transcription,	  exon	  1	  is	  encoding	  the	  transmembrane	  region	  (red	  rectangle),	  which	  
is	   naturally	   localized	   to	   the	  Golgi	   apparatus	   cisterns.	   Exon	  3	   and	   exon	  5	   contain	   the	   catalytic	  
domain	  (blue	  circle)	  and	  the	  binding	  sites	  for	  the	  sulfate	  donor	  PAPS	  (yellow	  rectangle).	  So	  far,	  
no	  splice	  variants	  of	  Ust	  are	  known.	  Hence,	  the	  deletion	  of	  the	  first	  exon	  should	  be	  sufficient	  to	  
stop	   the	   transcription	   of	   Ust.	   Even	   for	   the	   case	   there	   would	   be	   a	   splice	   variant	   of	   Ust,	   the	  
deletion	   of	   the	   first	   exon	   abolishes	   the	   transmembrane	   region	   of	   the	   protein,	   thereby	   no	  
localization	  to	  its	  normal	  occurrence	  in	  the	  Golgi	  apparatus	  could	  take	  place.	  The	  knockout	  of	  
exon	  3	  or	  exon	  5	  might	  produce	  a	   truncated	  protein	  variant,	  which	  would	  still	  be	   localized	  to	  
the	  Golgi	  apparatus	  with	  an	  unknown	  effect	  on	  sulfation.	  For	  this	  reason	  I	  designed	  a	  knockout	  
strategy	  to	  conditionally	  delete	  the	  first	  exon	  of	  Ust	  as	  depicted	  in	  the	  following	  figure	  (Figure	  
10).	  
To	  generate	  the	  targeting	  plasmid	  I	  used	  the	  pEasyflox	  plasmid,	  which	  was	  kindly	  provided	  by	  
AG	  Ulrike	  Müller	  in	  Heidelberg.	  For	  the	  integration	  of	  the	  floxed	  exon	  into	  the	  genomic	  DNA	  via	  
homolog	  recombination,	   two	  recombination	  arms	  are	  necessary.	  One	  arm	  is	   flanking	  the	  first	  
exon	   at	   the	   5'end	   (5'arm:	   1,7	  kb)	   and	   the	   other	   arm	   at	   the	   3'end	   (3'arm:	   4,4	  kb).	   These	  
recombination	   arms	   flank	   the	   KO	   element	   (2	  kb),	   which	   is	   composed	   of	   the	   first	   exon,	   the	  
beginning	  of	   the	   first	   intron	  and	  about	  600	  bp	  upstream	  of	   the	   first	  exon	   to	   include	  possible	  
promoter	  regions.	  The	  correct	  homolog	  recombination	  can	  be	  controlled	  by	  positive	  selection	  
(neomycin	  resistence)	  as	  well	  as	  by	  negative	  selection	  (HSV-­‐TK=herpes	  simplex	  virus-­‐thymidine	  
kinase).	   The	   selected	   clones	   can	   be	   further	   analysed	   by	   genotyping	   PCR	   and/or	   southern	  
blotting	  (probe)	  with	  the	  respective	  fragment	  sizes	  listed	  in	  the	  table	  underneath	  the	  figure	  and	  
the	   corresponding	   primers	   (2.8	   Oligonucleotide	   Primers).	   In	   the	   correctly	   targeted	   locus	   the	  
neomycin	  cassette	  will	  be	  removed	  by	  Cre	  recombination.	  This	  can	  also	  be	  screened	  by	  PCR	  and	  
reveals	  the	  correct	  recombination	  events.	  The	  finally	  selected,	  correct	  ESC	  clone	  (Ustflox)	  can	  
be	  used	  for	  the	  injection	  into	  the	  blastocyst	  to	  generate	  the	  future	  Ust	  conditional	  KO	  mouse	  
line.	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Figure	  10	  Strategy	  for	  conditional	  Ust	  knockout	  mouse	  line	  
Fragment	  size	  (bp)	  
	   WT	   targeted	   Ustflox	   Ust	  KO	  
AB’	   -­‐-­‐	   1934	   -­‐-­‐	   -­‐-­‐	  
AD	   1946	   3941	   1950	   -­‐-­‐	  
CB’	   -­‐-­‐	   207	   -­‐-­‐	   -­‐-­‐	  
CD	   219	   2214	   223	   -­‐-­‐	  
CF’	   2282	   4341	   2350	   318	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2.12	  IMAGE	  ACQUISITION	  AND	  STATISTICAL	  ANALYSIS	  
2.12.1	  IMAGEJ	  (FIJI)	  AND	  ADOBE	  PHOTOSHOP	  
In	  vitro	  experiments:	  
-­‐	   Quantification	   of	   immunopositive	   cells	   was	   performed	   with	   the	   ImageJ	   Cell	   Counter	   by	  
counting	  4	  images	  per	  experiment	  for	  each	  condition.	  
-­‐	  Quantification	  of	  band	  intensity	  of	  western	  blots	  or	  PCRs	  was	  performed	  by	  using	  the	  ImageJ	  
software	   (Analyze-­‐>Gels-­‐>Select/Plot	   Lanes).	   Therefore,	   equally	   sized	   rectangles	   (Rectangular	  
Selection	  Tool;	  Select	  First/Next	  Lane)	  were	  set	  to	  surround	  the	  bands	  to	  measure,	  afterwards	  
plotted	  and	   then	   the	  area	  of	   the	  peak	  was	  destined	  with	   the	  Wand	   (tracing)	  Tool.	  All	   values	  
were	  normalized	  to	  actin	  or	  α-­‐tubulin.	  
	  
IUE	  experiments:	  
-­‐	  Thickness	  measurements	  for	  the	  ventricular	  zone	  and	  the	  cortical	  plate	  were	  performed	  with	  
ImageJ	   (Fiji).	   Therefore	   5	   different	  measurements	  were	  made	  per	   cortex	  or	  midline	   for	   each	  
image	   and	   then	   the	   average	  was	   calculated.	   Besides,	   the	   different	   slices	   of	   one	   hemisphere	  
were	  grouped	  to	  1	  n.	  
-­‐	  The	  overview	  pictures	  were	  stitched	  together	  with	  Adobe	  Photoshop	  (File-­‐>Scripts-­‐>Load	  Files	  
into	  Stack...).	  
2.12.2	  ILASTIK	  
Ilastik:	  Interactive	  Learning	  and	  Segmentation	  Toolkit	  (Kreshuk	  et	  al.,	  2011)	  
The	   quantification	   of	   the	   different	   immunohistochemically	   detected	   cell	   amounts	   of	   the	   IUE	  
slices	  was	   performed	  with	   the	   Ilastik	   software	   version	   1.1.5	   (www.ilastik.org).	   Therefore,	   for	  
each	   staining	   a	   teach	   file	   was	   generated,	   within	   which	   the	   program	   was	   taught	   how	   to	  
distinguish	   background	   from	   signal.	   After	   this	   training	   was	   successfully	   accomplished,	   the	  
images	  were	   loaded	   into	   the	  program	  and	   the	   total	   cell	   density	   per	   image	  was	  obtained.	  All	  
obtained	  values	  were	  normalized	  to	  the	  corresponding	  total	  cell	  amount	  (Hoechst).	  
2.12.3	  STATISTICAL	  ANALYSIS	  
The	  statistical	  analysis	  was	  done	  with	  GraphPad	  Prism	  5	  by	  using	  the	  appropriate	  statistical	  test	  
as	  mentioned	  in	  the	  corresponding	  figure	  legend	  (either	  t-­‐test	  or	  1way	  ANOVA	  and	  Bonferroni’s	  
Multiple	  Comparison	  Test).	  1way	  ANOVA	  or	  one	  sample	  t-­‐test	  were	  used	  for	  statistical	  analysis	  
of	   normalized	   data.	   In	   each	   case	   at	   least	   3	   independent	   experiments	   had	   been	   performed,	  
otherwise	   it	   is	   indicated	   in	  the	  figure	  or	  the	   legend.	  All	  data	  are	  expressed	  as	  mean	  ±	  SD	  and	  
the	  p-­‐value	  is	  given	  as	  the	  following:	  *P	  <	  0,05;	  **P	  <	  0,01;	  ***P	  <	  0,001.	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3	  RESULTS	  
3.1	  CHONDROITINSULFOTRANSFERASE	  UST	  OVEREXPRESSION	  AND	  ITS	  FUNCTIONALITY	  
The	   chondroitinsulfotransferase	   (Chst)	   Ust	   (uronyl-­‐2-­‐sulfotransferase)	   belongs	   to	   a	   group	   of	  
enzymes	  that	  determines	  the	  sulfation	  pattern	  of	  chondroitin	  and	  dermatan	  sulfates	  (CS/DS)	  in	  
the	  extracellular	  matrix	  (ECM).	  These	  sulfation-­‐modifying	  enzymes	  are	  endogenously	  localized	  
in	  the	  Golgi	  apparatus,	  where	  they	  transfer	  sulfate	  groups	  to	  the	  sugar	  chains	  of	  proteoglycans	  
(Kobayashi	  et	  al.,	   1999,	  Kusche-­‐Gullberg,	  2003).	   The	   functional	  principle	  and	   the	   influence	  of	  
the	  sulfation	  pattern	  on	  cells	  and	  their	  behaviour	  are	  not	  well	  understood	  yet.	  To	  get	  a	  better	  
insight	  into	  the	  effect	  of	  the	  sulfation	  pattern	  on	  cell-­‐behaviour,	  I	  investigated	  the	  influence	  of	  
Ust	  overexpression	  on	  neural	  stem	  cell	  (NSC)	  behaviour	   in	  vitro	  and	   in	  vivo.	  For	  this	  purpose	  I	  
generated	   in	  our	   research	  group	   several	   constructs	   to	   induce	  a	   forced	  expression	  of	  Ust	  and	  
thereby	  modify	  the	  sulfation	  rate	  of	  CS-­‐glycosaminoglycans	  (GAGs).	  
3.1.1	  OVEREXPRESSION	  AND	  FUNCTIONALITY	  OF	  UST	  IN	  VITRO	  
For	  the	  analysis	  of	  Ust	  overexpression,	  two	  different	  types	  of	  constructs	  were	  used.	  One	  type	  
induces	  the	  expression	  of	  a	  functional	  wild	  type	  protein	  of	  Ust.	  The	  other	  construct	  generates	  a	  
mutated	  version	  of	  Ust	  (Ust	  mut).	  Ust	  mut's	  catalytically	  active	  domain	  is	  mutated	  and	  not	  able	  
to	  transfer	  sulfate	  groups	  to	  the	  glycosaminoglycan	  (GAG)	  chains	  anymore.	  Two	  different	  types	  
of	   plasmids	  were	   used	   to	   insert	   the	   coding	   DNA	   sequence	   (CDS)	   of	   Ust:	   pEGFP	  N1	   (N1)	   and	  
pXL201-­‐3xFLAG	  (XL).	  N1	  Ust	  and	  N1	  Ust	  mut	  were	  cloned	  as	  fusion	  proteins	  with	  EGFP	  and	  for	  
this	   reason	   the	  EGFP	   signal	   is	   localized	   in	   the	  Golgi	   apparatus.	   The	  empty	   vectors	   (N1	  or	  XL)	  
served	  as	  controls,	  whereas	  Ust	  mut	  was	  used	  as	  a	  negative	  control	  to	  see	  whether	  the	  effects	  
of	  Ust	  overexpression	  originate	  from	  a	  clogged	  Golgi	  apparatus	  or	  from	  the	  modified	  sulfation	  
pattern.	   The	   localization	   of	   the	   EGFP	   signals	   after	   overexpressing	   the	   different	   constructs	   is	  
exemplarily	   depicted	   in	   Figure	   11.	   Panel	  A	   displays	   transfected	  NSCs	   3	  d	   after	   differentiation	  
and	  panel	   B	   frontal	   sections	  of	   E14.5	  mouse	  brains	   2	  d	   after	   in	   utero	   electroporation.	   Figure	  
11	  A	  shows	   representative	   images	  of	   transfected	  NSCs	  after	  an	   immunocytochemical	   staining	  
against	   the	   oligodendrocyte	   precursor	   cell	  marker	   O4.	   The	   EGFP	   signal	   of	   the	   N1	   plasmid	   is	  
cytoplasmatic	  in	  the	  control	  situation	  (N1),	  while	  the	  dotted	  GFP	  staining	  close	  to	  the	  nucleus	  
indicates	  the	  localization	  of	  the	  Ust	  and	  Ust	  mut	  fusion	  proteins	  in	  the	  Golgi	  apparatus.	  As	  it	  is	  
shown	   in	   the	   upper	   part	   of	   Figure	   11	   C,	   EGFP	   is	   the	   fluorescent	   protein	   of	   the	   N1	   plasmid,	  
whereas	  the	  XL	  plasmid	  contains	  tdTomato	  as	   fluorescent	  marker	   (lower	  part	  of	  Figure	  11	  C).	  
tdTomato	   is	   localized	   in	   the	   cytoplasm	   for	   the	   empty	   vector	   (XL)	   as	  well	   as	   for	   Ust	   (XL	   Ust)	  
(lower	  panel	  of	  Figure	  11	  A	  and	  in	  B),	  because	  of	  an	  inserted	  internal	  ribosome	  entry	  site	  (IRES)	  
in	   the	   vector	   (Figure	   11	  C).	   XL	  Ust	   also	   exhibits	   a	   dotted	   EGFP	   signal	   in	   the	  Golgi	   apparatus,	  
because	   the	   Ust-­‐EGFP	   fusion	   protein	   of	   the	   N1	   plasmid	   was	   subcloned	   into	   the	   XL	   plasmid	  
(Figure	   11	  A,	   C).	   The	   EGFP	   signal	   of	   the	   fusion	   proteins	   from	   the	   N1-­‐based	   constructs	   was	  
poorly	  visible	  in	  the	  in	  vivo	  experiments.	  In	  the	  end,	  the	  constructs	  based	  on	  N1	  were	  only	  used	  
for	   the	   in	   vitro	   analysis,	   whereas	   the	   XL-­‐based	   constructs	  were	   used	   for	   in	   vitro	   and	   in	   vivo	  
experiments	  to	  have	  a	  better	  overview	  of	  the	  electroporated	  areas.	  For	  the	  successive	  analysis	  
steps	  of	  the	  in	  vivo	  experiments,	  the	  poorly	  visible	  EGFP	  signal	  of	  XL	  Ust	  was	  neglected	  to	  gain	  
an	  additional	  colour	  channel	  for	  expanded	  staining	  opportunities.	  



















































Figure	  11	  Expression	  of	  different	  Ust	  constructs	  in	  vitro	  and	  in	  vivo	  
A:	   Immunocytochemical	   stainings	   for	   oligodendrocyte	   precursor	   cells	   (O4+)	   and	   GFP.	   For	   in	   vitro	  
experiments	  pEGFP	  N1	  and	  pXL	  constructs	  were	  used.	  The	   images	  display	  the	   intracellular	  distribution	  
of	  the	  EGFP	  signal	  in	  neural	  stem	  cells	  3	  d	  after	  their	  transfection	  with	  the	  denoted	  constructs.	  EGFP	  of	  
the	  control	  plasmid	  N1	  and	  tdTomato	  of	  the	  XL	  constructs	  are	  cytoplasmatically	   localized.	  Ust	  and	  Ust	  
mut	  plasmids	  express	  a	   fusion	  protein,	  which	   is	   localized	   in	   the	  Golgi	  apparatus.	  Ust	  mut	   functions	  as	  
negative	   control,	   which	   is	   not	   functional	   because	   of	   a	   mutated	   catalytic	   domain.	   B:	  
Immunohistochemical	   staining	   for	   GFP.	   In	   vivo	   experiments	   were	   performed	   with	   the	   XL	   plasmid	  
constructs.	   XL	   control	   only	   has	   a	   tdTomato	   signal,	   whereas	   XL	   Ust	   also	   exhibits	   the	   Ust-­‐EGFP	   fusion	  
protein.	  C:	  Plasmid	  maps	  of	  the	  used	  constructs	  are	  depicted.	  Scale	  bar	  =	  100	  µm.	  
Figure	  12	  Localization	  of	  Ust-­‐EGFP	  fusion	  protein	  in	  the	  Golgi	  apparatus	  
A	  +	  B:	   Immunocytochemical	   staining	   for	   transgolgin-­‐97	   and	   GFP	   of	   transfected	   NSCs	   after	   3	  d	   of	  
differentiation.	  A:	  The	  EGFP	   in	  the	  control	  plasmid	  N1	   is	  cytoplasmatically	   localized	  and	  thus	  does	  not	  
co-­‐localize	  with	   the	  Golgi	   apparatus	   as	   shown	   in	   the	   inset	   in	  A’.	  B:	   The	  Ust-­‐EGFP	   fusion	   proteins	   are	  
localized	   in	   the	   Golgi	   apparatus	   which	   is	   identified	   by	   the	   co-­‐localization	   with	   the	   Golgi	   marker	  
transgolgin-­‐97	  in	  the	  inset	  B’.	  A	  +	  B	  scale	  bar	  =	  100	  µm,	  A’	  +	  B’	  scale	  bar	  =	  10	  µm.	  
	  
The	   correct	   targeting	   of	   the	   fusion	   protein	   to	   the	   Golgi	   apparatus	   was	   confirmed	   by	   a	  
transgolgin-­‐97	  co-­‐localization	  staining	  that	  is	  exemplarily	  shown	  for	  N1	  and	  Ust	  in	  Figure	  12.	  In	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the	  control	   (N1),	  no	  co-­‐localization	  with	   the	  Golgi	  marker	   transgolgin-­‐97	   is	   visible	  because	  of	  
the	  cytoplasmatic	  distribution	  of	  the	  GFP	  signal	  (Figure	  12	  A).	  Whereas	  Ust	  shows	  a	  co-­‐localized	  
signal	  with	  transgolgin-­‐97	  in	  the	  Golgi	  apparatus	  of	  the	  transfected	  cells	  (Figure	  12	  B).	  
	  
	  
Figure	  13	  Modifying	  the	  sulfation	  pattern	  by	  Ust	  overexpression	  in	  vitro	  
A:	  Immunocytochemical	  staining	  for	  473HD	  and	  GFP	  of	  transfected	  NSCs	  after	  3	  d	  of	  differentiation.	  The	  
GFP	  signal	  is	  located	  in	  the	  Golgi	  apparatus	  for	  Ust	  and	  Ust	  mut.	  N1	  shows	  a	  cytoplasmatic	  GFP	  signal.	  
The	  overexpression	  of	  Ust	  leads	  to	  an	  increase	  in	  473HD	  reactivity,	  which	  is	  an	  antibody	  that	  recognizes	  
a	   specific	   sequence	   of	   sulfated	   CS-­‐GAGs,	   including	   the	   D-­‐unit.	   The	   overexpression	   of	   the	   mutated	  
version	   of	   Ust	   shows	   that	   the	   473HD	   reactivity	   is	   not	   altered	   in	   comparison	   to	   the	   control.	   Scale	  
bar	  =	  100	  µm.	  B/C:	  The	  increased	  CS-­‐GAGs’	  sulfation	  upon	  forced	  Ust-­‐EGFP	  expression	  was	  detected	  by	  
western	  blot	  analysis.	  Blots	  and	  corresponding	  quantifications	  are	  shown.	  Data	  are	  expressed	  as	  mean	  
values	  ±	  SD,	   statistics	   were	   performed	   by	   1way	   ANOVA	   (N1	   constructs)	   or	   one	   sample	   t-­‐test	   (XL	  
constructs)	  with	  the	  data	  normalized	  to	  the	  control	  (N1	  or	  XL).	  
	  
The	  directed	  modification	  of	  the	  sulfation	  pattern	  by	  Ust	  overexpression	  was	  confirmed	  by	  CS-­‐
GAG	  epitope	  detection.	  The	  overexpression	  of	  Ust	  led	  to	  an	  increase	  in	  473HD	  reactivity,	  which	  
recognizes	   a	   specific	   sequence	   of	   sulfated	   CS-­‐GAGs,	   including	   the	   D-­‐unit.	   The	   D-­‐unit	   is	   a	  
sulfated	  CS-­‐unit	  that	  is	  generated	  by	  the	  enzymatic	  activity	  of	  Ust	  and	  the	  473HD	  antibody	  can	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therefore	   be	   used	   as	   readout	   of	   Ust	   functionality	   and	   for	   a	   quantitative	   readout.	   Figure	   13	  
exemplarily	  shows	  the	  directed	  modification	  of	  the	  sulfation	  pattern	  by	  overexpression	  of	  Ust	  
in	   panel	   A.	   It	   displays	   an	   immunocytochemical	   staining	   of	   transfected	   NSCs	   after	   3	  d	   of	  
differentiation	  with	  the	  N1	  based	  constructs.	  The	  473HD	  reactivity	  was	  strongly	  increased	  after	  
Ust	   overexpression	   in	   comparison	   to	   the	   control	   N1	   and	   Ust	   mut.	   The	   quantification	   of	  
construct	   functionality	   revealed	   a	   1,4-­‐fold	   for	   N1	  Ust	   (Figure	   13	  B)	   and	   a	   1,6-­‐fold	   for	   XL	  Ust	  
(Figure	   13	  C)	   higher	   473HD	   reactivity	   in	   comparison	   to	   the	   control	   (N1	   or	   XL).	   This	   was	  
determined	   by	   473HD	   western	   blot	   analysis.	   The	   473HD	   reactivity	   was	   normalized	   to	   the	  
expression	  of	   the	  housekeeping	   gene	  α-­‐tubulin	   (α-­‐tub).	  Additionally,	   the	  GFP	   signal	   could	  be	  
detected	   in	   the	  western	   blot	   analysis	   for	  N1	   (25	  kD)	   and	   the	   fusion	  proteins	   (47	  kD	   +	   25	  kD)	  
(Figure	  13	  B).	  
	  
3.1.2	  OVEREXPRESSION	  AND	  FUNCTIONALITY	  OF	  UST	  IN	  VIVO	  
The	  functionality	  of	  the	  used	  constructs	  was	  also	  analysed	  after	  in	  utero	  electroporation.	  Figure	  
14	  shows	  frontal	  overviews	  of	   in	  utero	  electroporated	  brain	  sections	  (E14.5)	  of	  XL	  (A)	  and	  Ust	  
(B)	  2	  d	  after	  electroporation.	  The	  boxed	  areas	  are	  shown	  at	  higher	  magnifications	  in	  A',	  A'',	  B'	  
and	  B''.	  The	  tdTomato	  signal	  can	  be	  seen	  in	  the	  cortex	  (A'	  and	  B')	  and	  the	  midline	  (A''	  and	  B''),	  
whereas	  the	  473HD	  signal	  was	  just	  weakly	  visible.	  But	  in	  comparison	  to	  the	  control,	  the	  473HD	  
signal	   was	   slightly	   more	   visible	   in	   the	   electroporated	   midline	   area	   after	   Ust	   overexpression	  
(Figure	   14	   B'').	   However,	   the	   altered	   473HD	   expression	   in	   vivo	   was	   not	   as	   conclusive	   as	  
obtained	   in	   the	   in	   vitro	   experiments	  and	  was	   therefore	  neglected	   for	  a	  quantitative	  analysis.	  
There	  was	  no	  obvious	  local	  increase	  of	  the	  473HD	  signal,	  where	  transfected	  cells	  overexpressed	  
Ust.	  The	  endogenous	  473HD	  expression	  in	  the	  control	  seemed	  to	  be	  predominantly	  in	  the	  pial	  
basal	  membrane,	  distributed	  generally	   in	   the	  ganglionic	  eminence,	  cortex	  and	   in	   the	  midline,	  
although	   the	   signal	   appeared	   less	   dominant	   in	   the	   cortical	   plate.	   The	   tdTomato	   signal	   in	   the	  
cortex	  was	  mainly	  localized	  in	  the	  growing	  cortical	  plate	  and	  to	  a	  lesser	  extent	  in	  the	  adjacent	  
intermediate	  zone	  2	  d	  after	  in	  utero	  electroporation,	  whereas	  in	  the	  ventricular	  zone	  almost	  no	  
transfected	   cells	   resided.	   In	   the	   electroporated	   midlines	   was	   the	   tdTomato	   signal	   localized	  
closer	   to	   the	  cortical	   surface	   than	  to	   the	  ventricular	  cavity	  and	  the	   transfected	  cells	  exhibit	  a	  
rather	  neuronal-­‐like	  morphology.	  Anyway,	  the	  tdTomato	  signal	   intensity	  was	  more	  prominent	  
in	  the	  control	  situation	  than	  after	  Ust	  overexpression.	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Figure	  14	  Modifying	  the	  sulfation	  pattern	  by	  Ust	  overexpression	  in	  vivo	  
A	  +	  B:	   Immunohistochemical	   staining	   for	   473HD	   of	   E14.5	   mouse	   frontal	   sections	   2	  d	   after	  
electroporation.	  A:	  The	  electroporation	  with	  the	  control	  plasmid	  XL	  shows	  tdTomato	  signal	  in	  the	  cortex	  
and	   the	  midline.	  The	  boxed	  areas	   show	  higher	  magnifications	  of	   the	  cortex	   (A’)	  and	   the	  midline	   (A’’).	  
473HD	   immunoreactivity	   is	   poorly	   visible	   in	   both	   areas.	  B:	   After	   electroporation	   with	   Ust,	   tdTomato	  
signal	  can	  be	  seen	  in	  the	  expected	  areas,	  cortex	  (B’)	  and	  midline	  (B’’).	  The	  overexpression	  of	  Ust	  might	  
slightly	  increase	  473HD	  reactivity,	  most	  visible	  in	  the	  area	  of	  the	  midline	  (B’’).	  A,	  B	  scale	  bar	  =	  250	  µm,	  
A',	  A'',	  B',	  B''	  scale	  bar	  =	  50	  µm.	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3.2	  MODIFICATION	  OF	  THE	  SULFATION	  PATTERN	  OF	  NEURAL	  STEM	  CELLS	  IN	  VITRO	  
3.2.1	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  NSC	  DIFFERENTIATION	  
For	   the	   analysis	   of	   the	   impact	   of	   the	   modified	   sulfation	   pattern	   on	   NSC	   differentiation	   a	  
differentiation	   assay	   was	   performed.	   The	   timeline	   of	   the	   differentiation	   assay	   is	   shown	   in	  
Figure	   15	  A.	   NSCs	   were	   obtained	   from	   mouse	   cortices	   at	   E13.5	   and	   cultivated	   until	   the	   3rd	  
passage.	  The	  neurosphere-­‐derived	  NSCs	  were	  electroporated	  with	  the	  corresponding	  construct	  
and	  after	  one	  day	  of	  recovery	  cultured	  under	  differentiating	  conditions	  for	  3	  d.	  The	  subsequent	  
immunocytochemical	  staining	  revealed	  the	  differentiation	  into	  distinct	  NSC-­‐derived	  cell	  types.	  
Figure	  15	  B	  shows	  exemplarily	  the	  differentiaton	  of	  NSCs	   into	  oligodendrocyte	  precursor	  cells	  
(O4+)	  and	  neurons	  (βIII-­‐tubulin+),	  which	  were	  electroporated	  with	  N1-­‐based	  constructs,	  and	  the	  
respective	  quantification	  of	  N1	  and	  also	  of	  the	  XL	  experiments	  (Figure	  15	  C).	  Figure	  16	  gives	  an	  
insight	   into	   the	   amount	   of	   astrocytes	   (GFAP+)	   and	   progenitor	   cells	   (Nestin+)	   present	   in	   the	  
transfected	  cell	  cultures.	  Ust	  overexpression	  induced	  a	  significantly	  reduced	  differentiation	  into	  
oligodendrocytes	   (N1	  =	  1,	   Ust	  =	  0,53	  ±	  0,06,	   Ust	   mut	  =	  0,78	  ±	  0,31;	   n	  =	  4)	   and	   a	   significant	  
increase	   in	   the	   generation	   of	   neurons	   compared	   to	   the	   controls	   (N1	  =	  1,	   Ust	  =	  1,27	  ±	  0,18,	  
Ust	  mut	  =	  1,06	  ±	  0,09;	   n	  =	  4)	   (Figure	   15	  C).	   The	   XL	   construct	   experiments	   exhibited	   the	   same	  
trends	  regarding	  the	  decreased	  differentiation	  into	  oligodendrocytes	  (XL	  =	  1,	  Ust	  =	  0,93	  ±	  0,79;	  
n	  =	  4)	  and	  the	  increased	  neurogenesis	  (XL	  =	  1,	  Ust	  =	  1,34	  ±	  0,44;	  n	  =	  4).	  
For	  the	  generation	  of	  astrocytes	  and	  neural	  progenitors	  no	  difference	  could	  be	  observed	  after	  
modifying	  the	  sulfation	  pattern	  by	  overexpressing	  Ust	  (Figure	  16).	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Figure	   15	   Impact	   of	   a	   modified	   sulfation	   pattern	   upon	   Ust	   overexpression	   on	   mouse	   neural	   stem	   cell	  
differentiation:	  O4	  and	  βIII-­‐tubulin	  
A:	   Experimental	   timeline	   of	   the	   differentiation	   assay.	   B:	   Transfected	   NSCs	   are	   shown	   after	   3	  d	   of	  
differentiation	  as	  exemplarily	  shown	  for	  the	  N1	  constructs.	  The	  cells	  were	  stained	  with	  cell	  type-­‐specific	  
antibodies	   against	   O4	   (oligodendrocyte	   precursor	   cells)	   and	   βIII-­‐tubulin	   (neurons).	   The	   GFP	   signal	   is	  
located	  in	  the	  Golgi	  apparatus	  for	  Ust	  and	  Ust	  mut.	  N1	  shows	  a	  cytoplasmatic	  expression	  of	  GFP.	  Scale	  
bar	  =	  100	  µm.	   C:	   Quantification	   of	   the	   different	   cell	   types.	   Data	   are	   expressed	   as	   (normalized)	  mean	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values	  ±	  SD,	  statistics	  were	  performed	  by	  1way	  ANOVA,	  (N1	  constructs)	  or	  t-­‐test/one	  sample	  t-­‐test	  (XL	  
constructs)	  with	  *p	  =	  ≤	  0,05	  and	  **p	  ≤	  0,01,	  n	  =	  4.	  
	  
	  
Figure	   16	   Impact	   of	   a	   modified	   sulfation	   pattern	   upon	   Ust	   overexpression	   on	   mouse	   neural	   stem	   cell	  
differentiation:	  GFAP	  and	  Nestin	  
A:	  Transfected	  NSCs	  are	  shown	  after	  3	  d	  of	  differentiation	  as	  exemplarily	  shown	  for	  the	  N1	  constructs.	  
The	   cells	  were	   stained	  with	   cell	   type-­‐specific	   antibodies	   against	  GFAP	   (astrocytes)	   and	  Nestin	   (neural	  
progenitors).	   The	   GFP	   signal	   is	   located	   in	   the	   Golgi	   apparatus	   for	   Ust	   and	   Ust	   mut.	   N1	   shows	   a	  
cytoplasmatic	   GFP	   signal.	   Scale	   bar	  =	  100	  µm.	   B:	   Quantification	   of	   the	   different	   cell	   types.	   Data	   are	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expressed	  as	  (normalized)	  mean	  values	  ±	  SD,	  statistics	  were	  performed	  by	  1way	  ANOVA	  (N1	  constructs,	  
n	  =	  4)	  or	  t-­‐test/one	  sample	  t-­‐test	  (XL	  constructs,	  n	  =	  4).	  
	  
3.2.2	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  NSC	  SELF-­‐RENEWAL	  AND	  PROLIFERATION	  
To	   assess	   the	   NSC	   proliferation	   capacities	   after	  modifying	   the	   sulfation	   pattern	   I	   performed	  
several	  experiments.	  At	  first,	  the	  transfected	  NSCs	  were	  pulsed	  with	  EdU	  for	  2-­‐3	  h	  after	  plating	  
to	   check,	   whether	   there	   is	   a	   change	   in	   EdU	   incorporation.	   Afterwards,	   the	   cells	   that	  
incorporated	  EdU	  were	  counted	  (Figure	  17).	  The	  statistical	  analysis	  revealed,	  that	  there	  was	  no	  
significant	   difference	   in	   the	   number	   of	   EdU+,	   proliferating	   NSCs	   upon	  Ust	   overexpression,	   in	  
comparison	   to	   the	   control	   situations.	   These	   results	   are	   in	   agreement	  with	   the	  data	  obtained	  
from	  the	  differentiation	  assay,	  where	  no	  significant	  change	  in	  the	  number	  of	  neural	  progenitor	  
cells	  (Nestin+)	  was	  reported.	  The	  additional	  control	  Ust	  mut	  exhibited,	  that	  the	  obtained	  effects	  
were	  specifically	  due	  to	  the	  modified	  sulfation	  pattern	  upon	  Ust	  overexpression	  and	  not	  caused	  
by	  clogging	  the	  Golgi	  apparatus	  with	  a	  mass	  of	  overexpressed	  fusion	  proteins.	  Therefore,	  Ust	  
mut	  was	  not	  further	  included	  in	  the	  subsequent	  analysis	  procedures.	  
	  
	  
Figure	  17	  Proliferation	  of	  neural	  stem	  cells	  after	  Ust	  overexpression	  
The	   EdU	   proliferation	   assay	  was	   performed	   by	   giving	   an	   EdU	   pulse	   2-­‐3	  h	   before	   fixing	   the	   cells.	   The	  
quantification	   shows	   no	   significant	   difference	   between	   control	   and	   Ust	   overexpression.	   Data	   are	  
expressed	  as	  mean	  values	  ±	  SD,	  statistics	  were	  performed	  by	  1way	  ANOVA	  (N1	  constructs)	  or	  t-­‐test	  (XL	  
constructs).	  
Subsequently,	   NSC	   self-­‐renewal	   capacity	   was	   analysed	   by	   clonal	   density	   assay	   experiments.	  
Figure	  18	  A	  depicts	   the	  timeline	  of	   the	  clonal	  density	  assay.	  The	  experimental	   timeline	  of	   the	  
clonal	   density	   assay	   is	   the	   same	   procedure	   as	   the	   differentiation	   assay	   until	   the	  
electroporation,	  followed	  by	  1	  d	  recovery.	  Then,	  for	  the	  proliferation	  assay	  the	  cells	  are	  plated	  
under	  proliferative	  conditions	  for	  7	  d	  with	  the	  listed	  growth	  factors	  (Figure	  18	  B).	  There	  was	  no	  
significant	  change	  in	  the	  responsiveness	  to	  the	  added	  growth	  factors,	  although	  there	  might	  be	  
a	   trend	   towards	   a	   higher	   responsiveness	   to	   FGF	  2	   and	   heparin	   after	   Ust	   overexpression	  
(N1	  =	  6,9	  ±	  3,2	  %,	  n	  =	  4;	  Ust	  =	  9,5	  ±	  2,6	  %,	  n	  =	  2).	   Besides,	   a	   very	   small	   but	   significant	   increase	  
for	  the	  generation	  of	  nsphs	  without	  supplemented	  growth	  factors	  could	  be	  observed,	  whether	  





Figure	  18	  Self-­‐renewal	  of	  neural	  stem	  cells	  after	  Ust	  overexpression	  
A:	  Experimental	  timeline	  of	  the	  clonal	  density	  assay	  (CDA).	  B:	  For	  the	  CDA	  transfected	  cells	  were	  plated	  
and	  cultured	  under	  proliferating	  conditions	  with	  the	  listed	  growth	  factors	  (EGF,	  FGF	  2,	  Hep	  =	  heparin)	  at	  
a	   concentration	   of	   2	  ng/ml	   for	   7	  d.	   No	   difference	   was	   observed	   for	   the	   distinct	   conditions.	   Data	   are	  
expressed	  as	  mean	  values	  ±	  SD,	  statistics	  were	  performed	  by	  t-­‐test	  (N1	  constructs,	  N1	  n	  =	  4,	  Ust	  n	  =	  2;	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3.3	  MODIFICATION	  OF	  THE	  SULFATION	  PATTERN	  BY	  IN	  UTERO	  ELECTROPORATION	  IN	  VIVO	  
3.3.1	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  CORTICAL	  PLATE	  AND	  VENTRICULAR	  ZONE	  
DEVELOPMENT	  IN	  VIVO	  
To	   confirm	   the	  promising	   in	   vitro	   results	   I	   pursued	   the	   idea	  of	   an	  Ust	  overexpression	   in	   vivo	  
analysis.	  The	  effect	  of	  Ust	  overexpression	  on	   in	  vivo	  cortical	  development	  was	  investigated	  by	  
in	  utero	  electroporation	  of	  the	  Ust	  construct	  into	  the	  embryonic	  cortex	  and	  the	  analysis	  of	  the	  
influence	   of	   the	   subsequently	  modified	   sulfation	   pattern	   on	   the	   anatomy	   of	   the	   developing	  
cortex	  and	  its	  neuronal	  and	  NSC	  numbers.	  The	  in	  utero	  electroporation	  was	  analysed	  2	  d	  after	  
the	   procedure.	   Figure	   19	  A	   depicts	   a	   schematic	   drawing	   of	   an	   in	   utero	   electroporated	   E14.5	  
mouse	   brain.	   Usually	   two	   areas	   were	   hit	   by	   the	   electric	   pulse	   that	   was	   given	   during	   the	  
electroporation	  procedure:	  the	  cortex	  on	  the	  one	  side	  and	  the	  midline	  in	  the	  other	  hemisphere	  
(red).	  The	  thickness	  of	  the	  cortical	  plate	  was	  analysed	  by	  measuring	  the	  thickness	  of	  the	  region	  
of	  NeuN+-­‐cells	  from	  the	  lateral	  to	  the	  medial	  side	  (white	  lines).	  For	  each	  region,	  the	  thickness	  
was	  measured	  at	  5	  different	  spots	  in	  an	  apical	  to	  pial	  direction	  and	  the	  average	  was	  calculated	  
for	  the	  cortex	  and	  the	  midline,	  respectively.	  In	  the	  quantification	  for	  the	  cortex	  (Figure	  19	  B)	  a	  
trend	   towards	   a	   radially	   thinner	   cortical	   plate	   was	   revealed	   for	   Ust	   electroporated	   mice	   in	  
comparison	  to	  the	  control.	  The	  effect	  was	  visible	   for	   the	  electroporated	  side	  of	   the	  cortex	  as	  
well	  as	   for	   the	  contralateral	  non-­‐electroporated	  side,	  but	   it	  was	  only	   significantly	  different	   in	  
the	  more	  rostral	  brain	  (XL	  =	  206,3	  ±	  27,6	  µm,	  n	  =	  4;	  Ust	  =	  161,8	  ±	  22,1	  µm,	  n	  =	  5)	  (Figure	  19	  C).	  
Figure	  19	  D	  depicts	  the	  quantification	  of	  the	  effect	  on	  the	  midline.	  The	  same	  trend	  towards	  a	  
shorter	   cortical	  plate	   can	  be	  observed	  after	  Ust	  overexpression.	  This	  effect	  was	   significant	   in	  
the	   more	   caudal	   brain	   sections	   for	   the	   electroporated	   midline	   (XL	  =	  114,4	  ±	  12,5	  µm,	   n	  =	  6;	  
Ust	  =	  96,7	  ±	  12,9	  µm,	  n	  =	  5).	  At	  first	  glance,	  this	  effect	  appears	  counterintuitive	  concerning	  the	  
increased	  neurogenesis	   obtained	   in	   the	  differentiation	   assay	   and	  will	   be	   further	   discussed	   in	  
the	  following	  discussion	  section.	  
	  
The	  ventricular	  zone	  contains	  mainly	  Pax6+	  radial	  glia	  cells	  during	  early	  developmental	  stages	  
(Martynoga	  et	  al.,	  2012).	   In	  order	  to	  explore	  the	  impact	  of	  the	  altered	  sulfation	  pattern	  upon	  
Ust	  overexpression	  on	  radial	  glia	  cell	   fate,	   I	  analysed	  the	   thickness	  of	   the	  ventricular	  zone	  by	  
measuring	   the	   Pax6+-­‐cells	   containing	   area	   in	   the	   cortex	   and	   the	   midline	   after	   in	   utero	  
electroporation.	   Figure	   20	  A	   shows	   a	   schematic	   overview	   of	   a	   frontal	   section	   after	   in	   utero	  
electroporation.	   The	   electroporated	   areas	   are	   indicated	   in	   red.	   The	   measured	   area	   for	   the	  
thickness	   of	   the	   ventricular	   zone	   is	   depicted	   in	   Figure	   20	  B	  with	  white	   lines.	   Pax6+-­‐area	  was	  
determined	   similarly	   to	   the	   thickness	   of	   the	   cortical	   plate.	   Cortex	   and	  midline,	   each	   with	   5	  
measurements,	  were	  analysed	  and	  average	  values	  were	  calculated.	  The	  quantification	  is	  shown	  
for	   the	  cortex	   in	  Figure	  20	  C	  and	   for	   the	  midline	   in	  Figure	  20	  D.	  The	  results	  do	  not	   indicate	  a	  
change	  in	  the	  thickness	  of	  the	  ventricular	  zone	  after	  Ust	  overexpression	  in	  comparison	  to	  the	  
control	   for	  the	  cortex	  and	  midline	  on	  the	  electroporated	  sides	  as	  well	  as	  on	  the	  contralateral	  
sides	   and	   were	   somewhat	   expected	   regarding	   the	   unmodified	   proliferation/self-­‐renewal	  





Figure	  19	  Impact	  of	  a	  modified	  sulfation	  pattern	  after	  Ust	  overexpression	  on	  the	  thickness	  of	  the	  cortical	  plate	  
A:	  A	  schematic	  frontal	  view	  of	  an	   in	  utero	  electroporated	  mouse	  brain	  at	  E14.5	   is	  shown.	  Areas	   in	  red	  
are	   the	   targeted	   areas	   of	   the	   electroporation.	   B:	   Frontal	   view	   of	   hemispheres	   after	   in	   utero	  
electroporation	  is	  depicted.	  The	  thickness	  of	  the	  cortical	  plate	  (white	  lines)	  was	  calculated	  as	  average	  of	  
5	  for	  each	  region,	  cortex	  and	  midline.	  Afterwards	  average	  values	  were	  calculated.	  Different	  slices	  of	  one	  
brain	  were	  grouped	  as	  one	  experiment	  and	  calculated	  as	  total	  or	  divided	  into	  rostral	  and	  caudal	  regions	  
(see	   also	   Figure	   9).	   Scale	   bar	  =	  250	  µm.	   C/D:	   Quantification	   of	   cortical	   plate	   thickness	   in	   cortex	   and	  
midline,	  respectively.	  Data	  are	  expressed	  as	  mean	  values	  ±	  SD,	  statistics	  were	  performed	  by	  t-­‐test	  with	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Figure	   20	   Impact	   of	   a	  modified	   sulfation	  pattern	   after	  Ust	   overexpression	  on	   the	   thickness	  of	   the	   ventricular	  
zone	  
A:	  A	  schematic	  frontal	  view	  of	  an	  in	  utero	  electroporated	  mouse	  brain	  (E	  14.5)	  is	  shown.	  Areas	  in	  red	  are	  
the	  targeted	  areas	  of	  the	  electroporation.	  B:	  Frontal	  view	  of	  hemispheres	  after	  in	  utero	  electroporation	  
is	  depicted.	  The	  thickness	  of	  the	  ventricular	  zone	  was	  calculated	  by	  measuring	  5	  times	  for	  each	  region,	  
cortex	   and	   midline,	   the	   thickness	   of	   the	   ventricular	   zone	   (white	   lines).	   Scale	   bar	  =	  250	  µm.	   C/D:	  
Quantification	  of	  ventricular	   zone	   thickness	   in	  cortex	  and	  midline,	   respectively.	  Data	  are	  expressed	  as	  




3.3.2	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  PROLIFERATION	  IN	  VIVO	  
To	  explore	  whether	  altered	  proliferation	  was	  the	  cause	  of	  the	  reduced	  cortical	  plate	  thickness,	  
proliferation	  was	  analysed	  by	  using	  the	  EdU-­‐incorporating	  method	   in	  vivo.	  The	   in	  vitro	   results	  
showed	  no	  significant	  effect	  on	  the	  numbers	  of	  proliferating,	  EdU-­‐incorporating	  cells	  after	  Ust	  
overexpression	   (Figure	   17	  D).	   EdU	   was	   injected	   1	  d	   before	   sacrificing	   the	   mice	   and	   its	  
incorporation	   was	   analysed	   afterwards	   (Figure	   21).	   The	   immunohistochemical	   staining	   was	  
quantified	   (Figure	   21	  C).	   As	   expected,	   there	   was	   no	   significant	   difference	   between	   the	   two	  
experimental	  conditions.	  Thus,	  proliferation	  did	  not	  induce	  the	  reduced	  cortical	  plate	  thickness.	  
Additionally,	   proliferative	   capacity	   was	   not	   influenced	   by	   the	   modification	   of	   the	   sulfation	  
pattern	  upon	  Ust	  overexpression	  and	  in	  vitro	  proliferation	  data	  was	  confirmed.	  
	  
	  
Figure	  21	  Impact	  of	  Ust	  overexpression	  on	  the	  proliferation:	  EdU	  
A:	   Overview	   of	   a	   frontal	   brain	   section	   of	   a	   XL	   in	   utero	   electroporated	   brain	   (E14.5)	   is	   shown.	  
Proliferating	   cells	   are	   detected	  by	   EdU	   staining	   and	   the	   percentage	  of	   EdU+-­‐cells	   in	   the	   cortex	   or	   the	  
midline	  area	  was	  determined.	  The	  EdU	  pulse	  was	  given	  1	  d	  before	  sacrificing	  the	  mice.	  B:	  Frontal	  brain	  
section	   of	   an	  Ust	   in	   utero	   electroporated	   brain	   at	   E14.5.	   Scale	   bar	  =	  250	  µm.	  C:	   Quantification	   of	   the	  
amount	  of	  EdU+-­‐cells.	  Data	  are	  expressed	  as	  mean	  values	  ±	  SD,	  statistics	  were	  performed	  by	  t-­‐test	  with	  
*p	  =	  ≤	  0,05	  and	  **p	  ≤	  0,01,	  n	  =	  4-­‐6	  embryos,	  2-­‐12	  slices	  per	  embryo.	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3.3.3	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  NSC	  DIFFERENTIATION	  DURING	  CORTICAL	  
DEVELOPMENT	  IN	  VIVO	  
The	   overexpression	   of	   Ust	   caused	   a	   modified	   CSPG	   sulfation	   pattern,	   which	   ultimately	  
diminished	  the	  size	  of	  the	  cortical	  plate	  in	  a	  radial	  dimension.	  The	  effect	  may	  be	  either	  due	  to	  a	  
reduced	   number	   of	   NeuN+-­‐neurons	   in	   the	   cortical	   plate	   or	   a	   consequence	   of	   more	   densely	  
packed	   cells	   in	   this	   area.	   The	   amount	   of	   neurons	  was	   detected	   by	   an	   immunohistochemical	  
staining	   for	   NeuN.	   Afterwards,	   the	   number	   of	   NeuN+-­‐cells	   was	   calculated	   with	   the	   program	  
ilastik	   (compare	   2.10.5	   Analysis	   and	   2.12.2	   Ilastik)	   and	   depicted	   as	   percent	   of	   the	   total	   cell	  
amount	   (Hoechst).	   Panel	  A	   and	   B	   of	   Figure	   22	   show	   representative	   frontal	   sections	   of	   E14.5	  
mice	   brain	   and	   their	   corresponding	   insets	   of	   the	   electroporated	   areas,	   cortex	   (A’	  +	  B’)	   and	  
midline	   (A’’	  +	  B’’).	   The	   quantification	   of	   the	   sections	   along	   the	   total	   brain	   revealed	   a	  
significantly	  decreased	  number	  of	  neurons	  in	  the	  midline	  (XL	  =	  24,9	  ±	  6,9	  %,	  Ust	  =	  16,8	  ±	  4,7	  %;	  
n	  =	  6)	  and	  showed	  the	  same	  trend	  for	  the	  cortex	  area	  (Figure	  22	  C).	  After	  a	  subsequent	  division	  
along	   the	   rostrocaudal	   axis,	   the	   effect	   of	   a	   decreased	   number	   of	   neurons	   became	   more	  
pronounced	   for	   the	  more	   caudal	   cortex	   sections	   (XL	  =	  25,9	  ±	  11,0	  %,	  n	  =	  6;	  Ust	  =	  16,5	  ±	  5,3	  %,	  
n	  =	  4),	  while	   it	   even	   significantly	  decreased	  with	   respect	   to	   the	  more	   rostral	  midline	   sections	  
(XL	  =	  25,0	  ±	  6,3	  %,	   Ust	  =	  16,2	  ±	  4,7	  %;	   n	  =	  6).	   The	   results	   obtained	   from	   the	   thickness	  
measurements	   match	   the	   numbers	   of	   NeuN+-­‐cells	   and	   still	   appear	   counterintuitive	   (see	  
Discussion).	  
	  
The	  most	  abundant	   cell	   types	  during	   cortical	  development	  at	   around	  E14	  are	   radial	   glia	   cells	  
and	   the	   newly	   generated	   neurons.	   For	   this	   reason,	   also	   the	   amount	   of	   radial	   glia	   cells	   was	  
determined	   in	   the	   in	   utero	   electroporated	   sections,	   whereas	   astrocytic	   cell	   analysis	   was	  
excluded,	   because	   no	   differences	   in	   the	   amount	   of	   GFAP+	   astrocytes	   were	   obtained	   in	   the	  
differentiation	  assay	   in	  vitro.	  Oligodendrocyte	  precursor	  cells	  (O4+)	  were	  not	  analysed	  as	  well,	  
justified	  by	  their	  incidental	  occurrence	  during	  neurogenesis	  peak	  time.	  
Accordingly,	   I	   also	   wanted	   to	   clarify	   if	   there	   is	   a	   change	   in	   the	   number	   of	   radial	   glia	   cells.	  
Therefore,	   the	  number	  of	   Pax6+-­‐cells	   using	   the	   ilastik	   software	   (compare	  2.10.5	  Analysis	   and	  
2.12.2	   Ilastik)	   was	   determined.	   Figure	   23	   shows	   immunohistochemical	   stainings	   of	   XL-­‐
electroporated	   (A)	   and	   Ust-­‐electroporated	   (B)	   sections	   of	   mice	   brains	   at	   E14.5.	   The	   higher	  
magnifications	   depict	   the	   electroporated	  midline	   areas.	   The	   quantification	   of	   the	   Pax6+-­‐cells	  
revealed	  a	  higher	  number	  of	  radial	  glia	  cells	  after	  Ust	  overexpression,	  especially	  visible	   in	  the	  
more	  caudal	  midline	  sections	   (XL	  =	  26,0	  ±	  4,1	  %,	  n	  =	  4;	  Ust	  =	  34,4	  ±	  2,3	  %,	  n	  =	  3).	  These	   results	  
were	   unexpected,	   although	   this	   minor	   effect	   somehow	   coincides	   with	   the	   very	   small	   but	  
significant	   higher	   generation	   of	   nsphs	   without	   supplemented	   growth	   factors	   and	   might	  
therefore	   correspond	   to	   a	   promoted	   self-­‐renewal	   capacity	   of	   Pax6+	   radial	   glia	   cells	   after	  Ust	  




Figure	  22	  Impact	  of	  Ust	  overexpression	  on	  the	  amount	  of	  NeuN+-­‐cells	  
A:	   Frontal	   brain	   section	   of	   XL	   in	   utero	   electroporated	   brain	   (E14.5)	  with	   higher	  magnifications	   of	   the	  
electroporated	  cortex	  (A’)	  and	  the	  midline	  (A’’).	  Neurons	  are	  detected	  by	  NeuN	  staining	  and	  the	  amount	  
of	  NeuN+-­‐cells	   in	   the	   cortex	  or	   the	  midline	  area	  was	  obtained	  by	  using	   the	  program	   ilastik	   (compare:	  
2.10.5	  Analysis	   and	   2.12.2	   Ilastik).	  B:	   Frontal	   brain	   section	   of	  Ust	   in	   utero	   electroporated	   brain	   E14.5	  
with	  magnifications	  of	  the	  electroporated	  cortex	  (B’)	  and	  the	  midline	  (B’’).	  A,	  B	  scale	  bar	  =	  250	  µm;	  A',	  
A'',	   B',	   B''	   scale	   bar	  =	  150	  µm.	  C:	   Quantification	   of	   the	   amount	   of	   NeuN+-­‐cells.	   Data	   are	   expressed	   as	  
mean	  values	  ±	  SD,	  statistics	  were	  performed	  by	  t-­‐test	  with	  *p	  =	  ≤	  0,05	  and	  **p	  ≤	  0,01,	  n	  =	  6-­‐8	  embryos,	  
2-­‐12	  slices	  per	  embryo.	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Figure	  23	  Impact	  of	  Ust	  overexpression	  on	  the	  amount	  of	  Pax6+-­‐cells	  
A:	   Frontal	  brain	   section	  of	  XL	   in	  utero	   electroporated	  brain	   (E14.5)	  with	  a	  higher	  magnification	  of	   the	  
electroporated	  midline	  (A’).	  Radial	  glia	  cells	  are	  detected	  by	  Pax6	  staining	  and	  the	  amount	  of	  Pax6+-­‐cells	  
in	  the	  cortex	  or	  the	  midline	  area	  was	  calculated	  by	  using	  the	  ilastik	  software	  (compare:	  2.10.5	  Analysis	  
and	   2.12.2	   Ilastik).	   B:	   Frontal	   brain	   section	   of	   Ust	   in	   utero	   electroporated	   brain	   (E14.5)	   with	  
magnifications	  of	  the	  electroporated	  midline	  (B’).	  A,	  B	  scale	  bar	  =	  250	  µm;	  A',	  B'	  scale	  bar	  =	  150	  µm.	  C:	  
Quantification	  of	  the	  amount	  of	  Pax6+-­‐cells	   in	  the	  cortex	  and	  the	  midline.	  Data	  are	  expressed	  as	  mean	  
values	  ±	  SD,	  statistics	  were	  performed	  by	  t-­‐test	  with	  *p	  =	  ≤	  0,05	  and	  **p	  ≤	  0,01,	  cortex	  n	  =	  1-­‐2	  embryos,	  





In	  the	  present	  study,	  the	  impact	  of	  a	  modified	  CSPG	  sulfation	  pattern	  upon	  Ust	  overexpression	  
on	  NSC	  behaviour	  was	  investigated.	  Therefore,	  a	  wild	  type	  protein	  form	  and	  a	  sulfation	  inactive	  
form	  of	  Ust	  were	  used	  for	  cortical	  E13.5	  NSC	  electroporation	  experiments.	  The	  differentiation	  
assay	   revealed	   an	   increase	   of	   βIII+-­‐neurons	   (19	  %)	   and	   a	   decrease	   of	   O4+-­‐oligodendrocytic	  
precursor	  cells	  (46	  %)	  after	  Ust	  overexpression,	  whereas	  the	  amount	  of	  neural	  precursor	  cells	  
(Nestin+)	  and	  astrocytes	  (GFAP+)	  remained	  constant.	  The	  analyses	  of	  NSC	  proliferation	  and	  self-­‐
renewal	   unfortunately	   exhibited,	   besides	   a	   very	   small	   but	   significant	   increased	   self-­‐renewal	  
without	  the	  addition	  of	  GFs,	  no	  obvious	  changes	  in	  the	  present	  study.	  
To	  confirm	  the	  obtained	  in	  vitro	  results,	  an	  in	  vivo	  analysis	  by	  using	  in	  utero	  electroporation	  was	  
performed.	   Initially,	   the	   analysis	   of	   the	   mainly	   appearing	   layers	   of	   the	   developing	   cortex	  
revealed	   a	   thinner	   cortical	   plate,	   while	   the	   ventricular	   zone	   thickness	   remained	   stable.	   This	  
difference	   in	   CP	   thickness	   was	   not	   caused	   by	   altered	   proliferation	   rates.	   Afterwards,	   the	  
analysis	  of	  the	  NeuN+-­‐neurons	  confirmed	  the	  thinner	  CP	  by	  a	  decreased	  amount	  of	  neurons.	  In	  
contrast	  to	  the	  stable	  VZ	  thickness,	  there	  was	  a	  slight	  increase	  in	  the	  number	  of	  Pax6+-­‐RGCs.	  
I	   focused	   on	   the	   analysis	   of	   Ust	   because	   of	   several	   reasons.	   Ust	   overexpression	   has	   not	   yet	  
been	   analysed	   in	   neural	   stem	   cells	   referring	   to	   their	   differentiation	   and	   proliferation	   during	  
development.	  Ust	  is	  not	  redundant	  and	  has	  only	  one	  variant	  generating	  two	  distinct	  disulfated	  
CS-­‐units	  (CS-­‐D	  and	  iB).	  So	  far,	  it	  seems	  that	  disulfated	  sugar	  units	  have	  a	  greater	  impact	  on	  the	  
regulation	  of	   signalling	  molecule	  binding	   capacities	  and	   therefore	  exhibit	   a	  potentially	  higher	  
biological	  relevance	  than	  monosulfated	  sugar	  units	  (Maeda	  et	  al.,	  2003,	  Bao	  et	  al.,	  2005,	  Ida	  et	  
al.,	  2006,	  Ishii	  and	  Maeda,	  2008a).	  
	  
4.1	  FUNCTIONALITY	  OF	  UST	  OVEREXPRESSION	  
The	  expression	  of	  the	  Ust	  fusion	  proteins	  was	  localized	  to	  the	  Golgi	  apparatus	  and	  corresponds	  
to	  the	  endogenous	  localization	  of	  Chsts	  (Kusche-­‐Gullberg,	  2003).	  The	  transfection	  efficiency	  for	  
Ust	  was	  always	  lower	  than	  for	  the	  empty	  control	  vectors	  and	  even	  for	  the	  negative	  control	  Ust	  
mut.	  So,	   the	  overexpression	  of	  a	  relatively	  big	   fusion	  protein	   in	   the	  Golgi	  apparatus	  does	  not	  
seem	   to	   be	   the	   general	   reason	   for	   the	   reduced	   transfection	   efficiency.	   It	   is	   not	   clear,	   if	   the	  
lower	   transfection	   efficiency	   is	   due	   to	   a	   lower	   expression	   level	   or	   if	   the	   modified	   sulfation	  
pattern	   after	   Ust	   overexpression	   caused	   more	   cells	   to	   undergo	   apoptosis	   and	   thereby	   the	  
amount	   of	   transfected	   cells	   was	   reduced.	   If	   cell	   death	   is	   the	   reason,	   then	   a	   potentially	  
disturbed	   homeostasis	   of	   Chsts	   expression	   and	   compensatory	   regulations	   of	   Ust	   and	   other	  
Chsts	  should	  be	  analysed	  to	  unfold	  possible	  implications	  in	  cell	  survival	  signalling	  pathways.	  Yet,	  
a	  role	  for	  specific	  CSPG	  sulfation	  in	  cell	  death	  commitment	  remains	  to	  be	  determined,	  although	  
the	  implication	  of	  CSPGs	  e.g.	  versican	  already	  has	  been	  shown	  (LaPierre	  et	  al.,	  2007,	  Wight	  et	  
al.,	  2014).	  
The	   functionality	  of	  Ust	  overexpression	  was	   confirmed	  by	   the	  473HD	  epitope	  detection.	   This	  
analysis	  is	  feasible	  because	  the	  473HD	  antibody	  recognizes	  specific	  sulfation	  pattern	  sequences	  
(Ito	  et	  al.,	  2005),	  which	  contain	  CS-­‐D	  units	  and	  is	  therefore	  an	  appropriate	  marker	  for	  sulfation	  
pattern	  modification	  concerning	  changes	  involving	  CS-­‐D	  units.	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4.2	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  NSC	  DIFFERENTIATION	  
4.2.1	  NSC	  DIFFERENTIATION	  IN	  VITRO	  
Ust	  overexpression	  led	  to	  an	  increased	  neurogenesis	  (βIII+)	  and	  a	  decreased	  oligodendrogenesis	  
(O4+)	  in	  NSC	  differentiation	  at	  E13.5.	  Accordingly,	  ChABC	  treatment	  in	  vitro	  studies	  revealed	  an	  
impaired	   neurogenesis	   and	   a	   favoured	   gliogenesis	   (GFAP+):	   1)	   ChABC	   treatment	   of	   nsphs	  
reduced	   the	   amount	   of	   about	   13	  %	   neurons	   (βIII+)	   to	   4	  %,	   whereas	   the	   number	   of	   GFAP+-­‐
astrocytes	   increased	   from	   4	  %	   to	   11	  %,	   2)	   even	   more	   pronounced	   was	   the	   effect	   of	   ChABC	  
treatment	  on	  nsphs	  generated	  from	  473HD-­‐immunoselected	  NSCs:	  80	  %	  neurons	  were	  reduced	  
to	  20	  %	  and	  10	  %	  astrocytes	  were	  increased	  to	  40	  %	  (Sirko	  et	  al.,	  2007).	  The	  very	  high	  amount	  
of	  about	  80	  %	  neurons	  generated	  by	  473HD-­‐seleceted	  precursor	  cells	  had	  already	  been	  shown	  
(von	  Holst	  et	  al.,	  2006).	  Especially	  the	  data	  obtained	  from	  473HD-­‐selected	  precursor	  cells	  imply	  
a	   role	   of	   the	   sulfation	   pattern	   on	   NSC	   differentiation	   and	   supports	   the	   reported	   results	  
concerning	  neurogenesis	  of	   the	  present	  study.	   It	  appears,	   that	  Ust	  overexpression	  suffices	   to	  
modulate	   the	   increased	  generation	  of	  neurons	  and	   if	  Ust	  generated	  CS-­‐units	  are	  missing	   less	  
neurons	  are	  generated.	   Interestingly,	   the	  amounts	  of	  GFAP+	  astrocytes	  and	  neural	  progenitor	  
cells	   (Nestin+)	  were	  not	  altered	  upon	  Ust	  overexpresseion	   in	  the	  present	  study,	   in	  contrast	  to	  
the	   reported	   favoured	   astrocytogenesis	   (Sirko	   et	   al.,	   2007).	   Moreover,	   Chst	   knockout	   (KO)	  
studies	  reported	  impaired	  neuronal	  differentiation	  upon	  Chst	  14	  deficiency	  (Bian	  et	  al.,	  2011).	  
Chst	  14	   generates	   the	   iA-­‐unit	   and	   is	   thereby	   probably	   part	   of	   the	   473HD	   epitope,	   which	  
resulted	  in	  a	  significant	  decrease	  of	  473HD	  expression	  after	  Chst	  14	  KO,	  confirming	  the	  473HD	  
sulfation	  pattern	  implication	  in	  the	  regulation	  of	  NSC	  differentiation	  processes.	  
Regarding	  gliogenesis,	  there	  was	  no	  change	  observed	  in	  the	  amount	  of	  GFAP+-­‐astrocytes	  upon	  
Ust	   overexpression	   and	   therefore	   an	   involvement	   of	   increased	   CS-­‐D	   and	   CS-­‐B	   units	   in	   the	  
sulfation	   pattern	   can	   be	   excluded	   as	   an	   astrocytogenesis	   promoting	   factor.	   There	   was	   no	  
analysis	  of	  oligodendrocytogenesis	  in	  the	  mentioned	  studies,	  whereas	  it	  appears	  plausible,	  that	  
Ust	   overexpression	   can	  modulate	   the	   generation	   of	   oligodendrocytes	   as	   it	   reduced	   the	  O4+-­‐
precursor	  cell	  amount	  about	  46	  %.	  Additionally,	  the	  endogenous	  expression	  level	  of	  Ust	  raises	  
from	   E14	   to	   P7	   and	   declines	   afterwards	   again	   (Ishii	   and	   Maeda,	   2008a),	   leading	   to	   the	  
assumption	   that	  Ust	   is	   involved	  during	   the	  peak	  of	  neurogenesis	  going	  along	  with	   the	  switch	  
when	  the	  transition	  to	  gliogenesis	  appears.	  Other	  studies	  revealed	  an	  increased	  Ust	  expression	  
level	  in	  more	  differentiated	  cells	  (neurons	  and	  astrocytes)	  than	  in	  NSCs	  (Yamauchi	  et	  al.,	  2011).	  
The	  additional	  control	  Ust	  mut	  exhibited,	  that	  the	  obtained	  effects	  were	  specifically	  due	  to	  the	  
modified	  sulfation	  pattern	  upon	  Ust	  overexpression	  and	  not	  caused	  by	  for	  example	  clogging	  the	  
Golgi	   apparatus	   with	   a	   mass	   of	   overexpressed	   fusion	   proteins.	   Therefore,	   Ust	   mut	   was	   not	  
further	  included	  in	  the	  subsequent	  analysis	  procedures.	  
4.2.2	  NSC	  DIFFERENTIATION	  IN	  VIVO	  
To	   support	   the	   obtained	   in	   vitro	   results	   concerning	   the	   increased	   neurogenesis,	   NSC	  
differentiation	  was	  also	  analysed	  in	  vivo,	  whereas	  gliogenesis	  analyses	  by	  detecting	  GFAP+	  and	  
O4+	  cells	  were	  excluded	  for	  the	  following	  reasons:	  1)	  there	  was	  no	  difference	  in	  the	  numbers	  of	  
GFAP+	  astrocytes	  revealed	   in	  vitro,	  2)	  gliogenesis	  starts	  at	   later	  stages	  at	  around	  E18	  and	  O4+	  
oligodendrocyte	  precursor	   cells	  are	  only	   sparsely	  present	  at	   the	  examined	   time	  point	   (E14.5)	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and	  therefore	  the	  minor	  change	  of	  cell	  numbers	  exhibits	  probably	  no	  biological	  relevant	  effect.	  
So,	  I	  restricted	  the	  analysis	  to	  the	  most	  abundant	  cell	  types	  during	  neurogenesis,	  RGCs	  and	  the	  
generated	  neurons	  (Martynoga	  et	  al.,	  2012,	  Paridaen	  and	  Huttner,	  2014).	  
The	   analysis	   of	   NeuN+	   cell	   numbers	   revealed	   that	   the	   thinner	   CP	   is	   caused	   by	   a	   reduced	  
neuronal	  cell	  amount	  in	  this	  area.	  This	  result	  appears	  counterintuitive	  to	  the	  reported	  increase	  
in	   the	   number	   of	   βIII-­‐neurons	   in	   the	   differentiation	   assay	   in	   vitro.	   Corresponding	   to	   the	  
concomitant	   increase	   in	  Pax6+	  RGCs	   in	  vivo	   it	   seems	  plausible,	   that	  Ust	  overexpression	  keeps	  
RGCs	   in	   their	   self-­‐renewing	   state	   and	   thereby	   less	   neurons	   are	   generated.	   The	   Ust	  
overexpression	  effect	  might	  be	  caused	  by	  prolonged	  cell	  cycle	   length,	  as	   it	   is	  known	  to	  occur	  
during	   the	   transition	   of	   NECs	   to	   RGCs	   with	   the	   start	   of	   neurogenesis	   in	   vivo	   and	   under	  
proliferative	  conditions	  in	  the	  clonal	  density	  assay	  in	  vitro	  (Takahashi	  et	  al.,	  1995,	  Calegari	  et	  al.,	  
2005,	   Paridaen	   and	   Huttner,	   2014).	   Furthermore,	   it	   promotes	   the	   generation	   of	   neuronal	  
lineage	  restricted	  cells	  under	  differentiating	  conditions	  in	  the	  differentiation	  assay	  in	  vitro.	  The	  
contradictory	   results	   from	   the	   in	   vitro	   and	   in	   vivo	   experiments	   might	   be	   caused	   by	   the	  
differences	  in	  the	  ECM	  structure	  and	  composition.	  The	  in	  vitro	  ECM	  lacks	  the	  3D	  characteristics	  
and	  differs	  in	  the	  composition	  compared	  to	  in	  vivo	  conditions	  because	  of	  2D	  culture	  dishes	  and	  
the	  selected	  NSC	  pool	  used	  for	  the	  experiments.	  Hence,	  the	  in	  vitro	  ECM	  is	  less	  complex	  in	  its	  
structure	  and	  molecular	  composition.	  However,	  this	   issue	  might	  be	  solved	  by	  using	  3D	  matrix	  
scaffolds	  in	  culture	  dishes.	  Additionally,	  the	  analysed	  time	  points	  were	  time-­‐delayed	  and	  might	  
be	  a	  reason	  for	  the	  altered	  experimental	  outcome.	  The	  in	  vitro	  experiments	  comprised	  a	  longer	  
analysis	  time	  period	  of	  3	  d	  as	  well	  as	  a	  later	  developmental	  stage	  of	  the	  used	  NSCs	  from	  E13.5	  
to	  E16.5,	  when	  neurogenesis	   already	  proceeded.	   The	   localization	  of	  Ust	  expression	  at	   E14	   in	  
the	  developing	  cerebral	  cortex	  was	  detected	  mainly	  in	  the	  ventricular	  zone	  and	  in	  the	  cortical	  
plate	  (Ishii	  and	  Maeda,	  2008a),	  where	  the	  obtained	  effects	  in	  the	  present	  study	  were	  located.	  
The	  analysis	  of	  the	  Pax6+	  RGCs	  is	  further	  described	  in	  the	  discussion	  part	  on	  NSC	  self-­‐renewal	  
and	  proliferation	  in	  vivo.	  
4.3	  IMPACT	  OF	  UST	  OVEREXPRESSION	  ON	  NSC	  SELF-­‐RENEWAL	  AND	  PROLIFERATION	  
4.3.1	  NSC	  SELF-­‐RENEWAL	  AND	  PROLIFERATION	  IN	  VITRO	  
Self-­‐renewal	  of	  NSCs	  was	  examined	  by	   clonal	  density	  assay	   (CDA).	   This	   assay	  determines	   the	  
amount	   of	   NSCs	   that	   are	   capable	   of	   generating	   new	   neurospheres	   under	   proliferative	  
conditions,	  meaning	  by	  self-­‐renewing	  and	  thereby	  generating	  more	  NSCs.	  In	  the	  present	  study,	  
there	  was	  no	  effect	  on	  self-­‐renewal	  with	  supplemented	  growth	  factors,	  although	  there	  was	  a	  
small	  but	  significant	  effect	  without	  any	  GFs	  (w/o).	  If	  this	  effect	  has	  any	  potential	  biological	  role	  
remains	  to	  be	  elucidated.	  
In	   former	  experiments	   I	   could	   show	   that	   the	  overexpression	  of	   a	   combination	  of	  Chsts,	   here	  
Chst	  3,	  Chst	  7	  and	  Ust	   led	   to	  a	   significantly	   increased	  number	  of	  neurospheres	   (nsphs)	   in	   the	  
presence	  of	  FGF	  2	  and	  heparin	  compared	  to	  the	  control	  (N1	  =	  114	  ±	  43,	  Chsts	  =	  156	  ±	  46;	  n	  =	  3)	  
(Harrach,	  2010).	   It	  was	  also	   revealed	   that	  a	  growth	   factor	   concentration	  higher	   than	  5	  ng/ml	  
seems	  to	  induce	  a	  rather	  saturated	  situation,	  where	  the	  effect	  of	  the	  modified	  sulfation	  pattern	  
was	  diminished.	  Chst	  3	  and	  Chst	  7	  generate	  the	  CS-­‐C	  unit,	  which	  is	  the	  monosulfated	  basis	  for	  
Ust	  to	  generate	  the	  CS-­‐D	  unit.	  Thus,	  an	  influence	  of	  the	  single	  Ust	  overexpression	  on	  NSC	  self-­‐
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renewal	   was	   probable,	   but	   could	   maybe	   not	   reach	   a	   significant	   level,	   because	   not	   enough	  
required	   CS-­‐C	   was	   present	   to	   enable	   the	   overexpressed	   Ust	   the	   proper	   CS-­‐D	   sulfation.	  
However,	   the	   increased	   CS-­‐D	   detection	   via	   473HD	   antibody	   in	   the	   immunocytochemical	  
stainings	  and	  western	  blot	  analysis	  appear	  inconsistent	  with	  this	  hypothesis.	  When	  sulfation	  is	  
inhibited	  by	   sodium	   chlorate,	   the	  number	  of	   generated	  nsphs	  was	   reduced	   and	  even	   adding	  
defined	  CS-­‐units,	  randomly	  patterned,	  did	  not	  rescue	  the	  nsphs	  formation	  (Akita	  et	  al.,	  2008).	  
So	   an	   impact	   of	   the	   endogenously	   sulfated	   CS-­‐GAGs	   has	   already	   been	   shown,	   although	   a	  
random	  supplementation	  with	  CS-­‐units	  or	  a	   singular	  overexpression	  of	  one	  Chst,	  here	  Ust,	   is	  
not	  sufficient	  to	  clearly	  change	  self-­‐renewal	  capacities.	  
Further	  studies	  reported	  the	  473HD	  epitope	  expression	  on	  RGCs	  and	  its	  implementation	  in	  self-­‐
renewal	  capacity.	  Selectively	  isolated	  473HD+-­‐precursor	  cells	  derived	  from	  E13	  mouse	  cortices	  
exhibited	  a	  threefold	   increased	  generation	  of	  nsphs	   in	  the	  clonal	  density	  assay	  supplemented	  
with	   EGF	   and	   FGF	  2	   in	   comparison	   to	   the	   nonselected	   control	   cells	   (von	   Holst	   et	   al.,	   2006).	  
Additionally,	  after	  interfering	  in	  clonal	  density	  assays	  with	  ChABC	  treatment	  or	  addition	  of	  mAb	  
473HD,	  a	  reduced	  generation	  of	  nsphs	  was	  observed	  (von	  Holst	  et	  al.,	  2006).	  These	  studies	  also	  
indicate	   an	   involvement	  of	   a	   specific	   CS	   sulfation	  pattern	   in	   self-­‐renewal	  property	   regulation	  
during	  cortical	  development.	  
The	  CDA	  analysis	  differs	  from	  proliferation	  analysis	  with	  EdU	  incorporation	  in	  the	  restriction	  of	  
included	  proliferating	  cell	  types.	  The	  CDA	  exclusively	  detects	  nsphs	  forming	  NSCs,	  whereas	  the	  
EdU	   assay	   includes	   all	   cells,	   which	   undergo	   mitosis	   and	   incorporate	   the	   EdU	   during	   DNA	  
replication.	   This	   cell	   pool	   is	   bigger	   and	   includes	  also	  more	   lineage	   restricted	   cell	   types	  as	   for	  
example	   transit	   amplifying	   cells	   or	   neural	   precursor	   cells.	   The	   EdU	   assay	   did	   not	   reveal	   a	  
significant	   difference	   in	   the	   amount	   of	   proliferating	   cells,	   which	   corresponds	   to	   the	   stable	  
numbers	  of	  neural	  precursor	  cells	   (Nestin+)	  obtained	   in	  the	  differentiation	  assay	  as	  well	  as	   to	  
the	   not	   altered	   amount	   of	   self-­‐renewing	   NSCs	   in	   the	   CDA	   assay,	   leaving	   the	   w/o	   condition	  
aside.	  Indicating	  that	  the	  single	  overexpression	  of	  Ust	  only	  offers,	  if	  any,	  a	  very	  small	  impact	  on	  
NSC	  self-­‐renewal	  and	  proliferation	  capacity	  in	  vitro,	  the	  complete	  CS-­‐GAG	  digestion	  with	  ChABC	  
exhibited	   a	   reduced	   number	   of	   BrdU-­‐incorporating	   cells	   in	   the	   nsphs	   culture	   system	  derived	  
from	   cortex	   and	   ganglionic	   eminence	   of	   E13	   mice	   as	   well	   as	   a	   reduced	   amount	   of	   neural	  
progenitor	  cells	  (Nestin+)	  (Sirko	  et	  al.,	  2007).	  The	  increase	  of	  CS-­‐D	  units	  in	  the	  sulfation	  pattern	  
of	   CSPGs	   is	   therefore	   not	   sufficient	   to	   confirm	   the	   general	   implication	   of	   CS-­‐GAGs	   in	   NSC	  
proliferation	  and	  self-­‐renewal	  behaviour.	  
4.3.2	  NSC	  SELF-­‐RENEWAL	  AND	  PROLIFERATION	  IN	  VIVO	  
The	  analysis	  of	  the	  proliferation	  capacity	  in	  vivo	  revealed	  no	  difference	  after	  Ust	  overexpression	  
in	   comparison	   to	   the	   control.	   It	   confirmed	   our	   EdU	   assay	   in	   vitro	   observations	   and	   also	   the	  
constant	   neural	   progenitor	   (Nestin+)	   pool	   in	   the	   differentiation	   assay.	   Therefore,	   it	   can	   be	  
rather	  excluded	  as	  a	   cause	   for	   the	   reduced	  CP	   thickness.	   The	  unchanged	   thickness	  of	   the	  VZ	  
after	   Ust	   overexpression	   was	   expected	   because	   of	   the	   not	   altered	   proliferation	   and	   self-­‐
renewal	   capacities.	   Although,	   the	   small	   but	   significant	   effect	   on	   NSC	   self-­‐renewal	   without	  
supplemented	  GFs	  in	  vitro	  might	  explain	  the	  slightly	  increased	  amount	  of	  Pax6+	  radial	  glia	  cells	  
in	   the	   VZ	   after	   Ust	   overexpression.	   Additionally,	   the	   trend	   towards	   an	   increased	   GF	  
responsiveness	  leads	  to	  the	  conclusion	  that	  Ust	  overexpression	  either	  promotes	  self-­‐renewal	  of	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RGCs	  or	  keeps	  RGCs	  in	  a	  self-­‐renewal	  state	  and	  therefore	  longer	  detectable	  as	  Pax6+	  RGCs.	  This	  
is	   consistent	   with	   data	   that	   showed	   473HD	   expression	   on	   NSCs	   and	   increased	   self-­‐renewal	  
capacity	  of	  473HD+-­‐selected	  NSCs	  (von	  Holst	  et	  al.,	  2006)	  and	  leads	  to	  the	  suggestion,	  that	  Ust	  
overexpression	   increases	   the	   generation	   of	   the	   473HD	   motif,	   therefore	   generating	   a	   bigger	  
Pax6+-­‐cell	  fraction,	  which	  in	  this	  case	  would	  correlate	  with	  the	  abundant	  NSCs,	  the	  Pax6+-­‐RGCs.	  
Either	  generating	  more	  of	  the	  Pax6+-­‐RGCs	  in	  the	  VZ	  would	  be	  an	  explanation	  for	  the	  increased	  
amount	   of	   Pax6+-­‐RGCs	   or	   keeping	   them	   in	   the	   VZ,	  which	  would	   be	   in	   line	  with	   an	   obtained	  
greater	   distance	   of	   BrdU-­‐incoporating	   cells	   to	   the	   ventricular	   surface	   after	   ChABC	   treatment	  
(Sirko	  et	  al.,	  2007),	  but	  still	  needs	  to	  be	  further	  analysed.	  The	  reduced	  amount	  of	  neurons	  and	  
the	   increased	   number	   of	   Pax6+-­‐RGCs	  might	   have	   been	   caused	   by	   a	   decreased	   cell	   cycle	   exit	  
rate.	  The	  experiments	  to	  analyse	  the	  EdU+/Ki67-­‐-­‐cell	  fraction	  was	  unfortunately	  not	  reliable	  due	  
to	   technical	   problems	   and	   is	   therefore	   excluded	   from	   the	   results.	   The	   detected	   amount	   of	  
Ki67+-­‐cells	   was	   at	   a	   very	   low	   level	   and	   not	   comparable	   to	   literature	   values	   at	   this	  
developmental	  stage	  (Hartfuss	  et	  al.,	  2001,	  Woodhead	  et	  al.,	  2006,	  Yu	  et	  al.,	  2009).	  
These	   observations	   fit	   to	   the	   endogenous	   expression	   of	   FGF	  2	   during	   cerebral	   cortex	  
development	   in	   the	   ventricular	   zones	   of	   the	   cortex	   and	   the	   midline	   in	   the	   examined	  
developmental	   time	  window	   between	   E12	   and	   E14	   (Raballo	   et	   al.,	   2000,	   Iwata	   and	   Hevner,	  
2009),	   which	   would	   make	   an	   increased	   responsiveness	   of	   Pax6+	   RGCs	   in	   the	   VZ	   to	   FGF	  2	  
biologically	   reasonable.	   Moreover,	   it	   was	   shown	   that	   the	   removal	   of	   CS-­‐GAGs	   via	  
intracerebroventricular	  ChABC	  injection	  resulted	  in	  a	  decreased	  number	  of	  nsph	  forming	  NSCs	  
in	  the	  presence	  of	  FGF	  2	  (Sirko	  et	  al.,	  2010).	  They	  also	  obtained	  decreased	  proliferation	  rates	  of	  
FGF	  2-­‐sensitive	  NSCs	  after	  ChABC	  treatment	  in	  the	  presence	  of	  FGF	  2.	  Thus,	  an	  alteration	  of	  the	  
proliferation	  capacity	  would	  have	  been	  possible	  after	  Ust	  overexpression	  as	  well,	  although	  the	  
obtained	   results	   show,	   that	   the	   single	  modification	  by	  Ust	  overexpression	   is	  not	   sufficient	   to	  
change	   proliferation	   rates.	   Probably,	   the	   orchestration	   of	   the	   different	   Chsts	   is	   needed	   to	  
generate	  the	  required	  sulfation	  pattern	  code	  to	  enable	  the	  FGF	  2	  signalling	  cascade.	  
Furthermore	   it	  was	  reported	  that	  1	  d	  after	   intracerebroventricular	  ChABC	   injection,	   less	  BrdU	  
was	   incorporated	   into	   cortical	   cells	   at	   E14.5,	   concomitant	   with	   a	   greater	   distance	   to	   the	  
ventricular	   surface	   (Sirko	   et	   al.,	   2007).	   Hence,	   NSC	   proliferation	   and	   also	   the	   localization	   of	  
proliferating	   cells	   within	   the	   VZ	   are	   influenced	   by	   CS-­‐GAGs,	   whereas	   modification	   of	   the	  
sulfation	  pattern	  upon	  Ust	  overexpression	  was	  insufficient.	  
4.4	  IMPLICATIONS	  OF	  THE	  SULFATION	  PATTERN	  ON	  NSC	  BEHAVIOUR	  AND	  POSSIBLE	  MECHANISMS	  
Only	   few	   studies	   deal	   with	   manipulation	   of	   Chst	   expression	   referring	   to	   NSC	   differentiation	  
(Bian	  et	  al.,	  2011),	  mainly	  proliferation	  and	  migration	  are	  examined	  (Liu	  et	  al.,	  2006),	  or	  their	  
involvement	  in	  CNS	  injury	  (Properzi	  et	  al.,	  2005)	  and	  cancer	  (Wade	  et	  al.,	  2013,	  Pantazaka	  and	  
Papadimitriou,	  2014,	  Silver	  and	  Silver,	  2014).	  Especially	  rare	  are	  studies	  examining	  the	  impact	  
of	  Ust	  on	  NSC	  behaviour	  (Ishii	  and	  Maeda,	  2008a,	  Nikolovska	  et	  al.,	  2015).	  
The	   present	   study	   revealed	   an	   implication	   of	   an	   Ust	   modified	   sulfation	   pattern	   on	   NSC	  
differentiation	  and	  self-­‐renewal	  in	  vitro	  and	  in	  vivo.	  It	  is	  the	  first	  time	  that	  Ust	  is	  overexpressed	  
in	   NSC	   in	   vitro	   and	   in	   vivo,	   whereas	   a	   knockdown	   was	   already	   examined	   (Ishii	   and	  Maeda,	  
2008a).	   However,	   the	   knockdown	   study	   reported	   sulfation	   pattern	   involvement	   during	  
neuronal	   migration	   and	   was	   not	   dealing	   with	   differentiation	   during	   cortical	   development.	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Therefore,	   analysis	   referring	   to	   NSC	   differentiation	   processes	   and	  more	   detailed	   analysis	   on	  
NSC	  self-­‐renewal	  upon	  Ust-­‐related	  manipulation	  of	  the	  sulfation	  pattern	  need	  to	  be	  performed.	  
The	  mechanisms	  behind	  the	  influence	  of	  a	  modified	  sulfation	  pattern	  on	  cellular	  behaviour	  are	  
still	  in	  the	  process	  of	  being	  elucidated.	  The	  analyses	  of	  Chst	  11	  and	  Chst	  14	  deficient	  knockout	  
mice	  exhibited	  a	  decreased	  neurogenesis,	  a	  diminished	  proliferation	  of	  NSCs	  concomitant	  with	  
changes	   in	   the	   NSCs	   marker	   expression,	   and	   an	   upregulation	   of	   FGF	  2	   and	   EGF	   receptor	  
expression	   for	   Chst	  14	   (Bian	   et	   al.,	   2011).	   In	   contrast,	   Chst	  11	   deficiency	   did	   not	   have	   the	  
mentioned	  impact	  on	  NSC	  biology	  and	  unfolds	  the	  distinct	  roles	  of	  a	  specific	  sulfation	  pattern	  
on	  NSC	  behaviour,	  here	  CS	  units	  modified	  by	  Chst	  11	  versus	  DS	  units	  sulfated	  by	  Chst	  14.	  These	  
findings	  support	  the	  importance	  of	  a	  specific	  sulfation	  code	  for	  presenting	  GFs	  e.g.	  FGF	  2	  or	  EGF	  
to	  their	  receptors,	  which	  decreased	  FGF	  2-­‐	  and	  EGF-­‐mediated	  proliferation	  of	  NSCs	  in	  vitro	  and	  
proliferation	   rate	   in	   the	  adult	  NSC	  niches,	  dentate	  gyrus	  and	  subventricular	   zone	   (Bian	  et	  al.,	  
2011).	  Moreover,	  Chst	  14	  deficiency	  also	   impaired	  neuronal	  differentiation	   in	  vitro	  and	   in	  the	  
adult	  hippocampus,	  but	  not	  in	  NSCs	  obtained	  from	  the	  adult	  SVZ	  (Bian	  et	  al.,	  2011),	  referring	  to	  
a	   spatially	   and	   temporally	   regulated	   impact	   of	   the	   sulfation	   pattern	   on	   NSC	   behaviour	  
(Nurcombe	  et	  al.,	  1993,	  Ishii	  and	  Maeda,	  2008b).	  The	  involvement	  of	  CSPGs	  in	  the	  regulation	  of	  
proliferation	  and	  differentiation	  had	  been	  described	  for	  FGF	  2-­‐dependent	  signalling	  supporting	  
NSC	  proliferation	  and	  maintaining	  neuron-­‐generating	  properties	   (Ida	  et	  al.,	  2006,	  Sirko	  et	  al.,	  
2010),	   leading	   to	   the	   suggestion	   that	   regulated	   CS	   structural	   changes	   during	   development	  
correspond	   to	   the	   shift	   from	   FGF	  2-­‐dependent	   neurogenesis	   to	   delayed	   EGF-­‐dependent	  
gliogenesis	  (Maeda,	  2010).	  Opposing	  effects	  on	  neurogenesis	  and	  astrocytogenesis	  after	  ChABC	  
treatment	  have	  been	  reported	  as	  well	  (Gu	  et	  al.,	  2009),	  which	  were	  explained	  by	  different	  NSC	  
origin.	  FGF	  2	  ligand	  binding	  to	  cell	  surface	  PG	  GAGs	  and	  its	  thereby	  enabled	  presentation	  to	  FGF	  
receptors	  are	  well	  studied	  for	  heparan	  sulfates	  (Pellegrini	  L,	  2000)	  and	  because	  of	  the	  structural	  
similarities	  of	  HS	   to	  CS	  also	   transferable.	  So	   far,	  HS	  and	  CS	  demonstrate	  controversial	  effects	  
concerning	   FGF	   signalling	   pathways,	   but	   they	   are	   with	   respect	   to	   structure	   and	   sulfation	  
pattern	  variability	  of	  the	  PGs	  (core	  protein	  +	  GAGs)	  explainable	  (Deepa	  et	  al.,	  2004,	  Nikolovska	  
et	   al.,	   2015).	   In	   addition	   to	   the	   immense	   structural	   complexity,	   the	   functionality	   is	   also	  
dependent	  on	  the	  GAG	  bound	  factors,	  which	  can	  cause	  e.g.	  CS	  to	  operate	  as	  an	  attractant	  or	  
repellent	   regulated	   by	   the	   sulfation	   pattern	   (Shipp	   and	   Hsieh-­‐Wilson,	   2007,	   Maeda,	   2015).	  
Anyway,	   the	   sulfation	   pattern	   of	   CSPGs	   exhibits	   an	   effect	   on	   NSC	   differentiation,	  migration,	  
proliferation	  and	  neurite	  outgrowth.	  
The	   research	   focus	   is	   more	   concentrated	   on	   migration,	   plasticity	   and	   regeneration	  
corresponding	   to	   CS	   sulfation	   alterations.	   Analysis	   of	   Ust-­‐mediated	   2-­‐O-­‐sulfation	   revealed	  
FGF	  2-­‐induced	   neuronal	   migration	   through	   ERK1/2	   activation	   (Nikolovska	   et	   al.,	   2015).	  
Moreover,	   it	   was	   reported	   that	   the	   correct	   positioning	   of	   neurons	   during	   developmental	  
migration	   in	   the	   cerebral	   cortex	   is	   regulated	   by	   CS-­‐E	   and	   CS-­‐D	   unit	   appearance	   (Ishii	   and	  
Maeda,	   2008a).	   Especially	   the	   binding	   capacities	   of	   distinct	   CS-­‐units	   have	   been	   analysed.	  
Exemplarily,	   CS-­‐E	   exhibits	   a	   high	   binding	   affinity	   to	   axon	   guidance	  molecules,	   whereas	   CS-­‐A	  
shows	   only	   low	   binding	   capacities	   (Shipp	   and	  Hsieh-­‐Wilson,	   2007).	   A	   high	   binding	   affinity	   to	  
several	  GFs	  (FGF,	  EGF,	  etc.)	  for	  CS-­‐E	  has	  also	  been	  revealed	  (Rogers	  et	  al.,	  2011).	  Furthermore,	  
increased	  binding	   of	   phosphacan,	  which	   exhibits	   an	   especially	   high	   amount	   of	   CS-­‐D	  units,	   to	  
pleiotrophin	  was	  observed	  (Maeda	  et	  al.,	  2003)	  and	   its	   implication	  on	  neurite	  outgrowth	  was	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unfolded	  (Faissner	  et	  al.,	  1994,	  Clement	  et	  al.,	  1998,	  Bao	  et	  al.,	  2005).	  But,	  the	  sulfation	  motif	  
influence	  on	  neurite	   outgrowth	   showed	  opposing	   effects	   depending	  on	   the	  neuronal	   lineage	  
examined	   (Clement	   et	   al.,	   1998,	   Garwood	   et	   al.,	   1999),	   also	   referring	   to	   the	   specialized	  
microenvironment	   influencing	   the	   sulfation	   pattern	   impact	   regulated	   by	   the	   distinct	   ECM	  
composition	  and	  factors	  apparent	  in	  the	  respective	  surroundings.	  
CSPGs	   are	   involved	   in	   numerous	   processes,	   therefore	   CSPG	   implications	   in	   many	   diseases	  
seems	  to	  be	  logical.	  It	  was	  revealed,	  that	  neurons	  with	  aggrecan	  containing	  PNNs	  are	  protected	  
from	  tau-­‐pathology	   in	  Alzheimer's	  disease	   (Burnside	  and	  Bradbury,	  2014).	  CSPG	  expression	   is	  
upregulated	  after	  CNS	  injury	  and	  limits	  regeneration	  (inhibits	  axon	  growth,	  restricts	  plasticity)	  
(Bradbury	  et	  al.,	  2002,	  Silver	  and	  Miller,	  2004,	  Lau	  et	  al.,	  2012,	  Silver	  and	  Silver,	  2014).	  Another	  
example	   of	   CSPG	   involvement	   is	   the	   decreased	   levels	   of	   tenascin	   and	   lecticans	   during	   active	  
periods	   of	  multiple	   sclerosis,	  whereas	   inactive	   lesions	   exhibit	   normalized	   tenascin	   levels,	   but	  
lecticans	   are	   chronically	   upregulated	   (Burnside	   and	   Bradbury,	   2014).	   There	   are	   studies	   that	  
associate	   PGs	   and	   PG-­‐related	   genes	   to	   (mental)	   disorders	   in	   humans	   (Maeda,	   2015),	   for	  
example	  is	  one	  variant	  of	  Ust	  associated	  with	  job-­‐related	  exhaustion	  (Sulkava	  et	  al.,	  2013)	  and	  
phosphacan	  seems	  to	  be	  associated	  with	  schizophrenia	  (Buxbaum	  et	  al.,	  2008,	  Takahashi	  et	  al.,	  
2011).	  
The	   implication	   of	   CSPGs	   by	   changing	   the	   sulfation	   pattern	   and	   thereby	   influencing	   various	  
signalling	   pathways	   appears	   presumable,	   because	   I	   support	  with	   our	   findings	   once	  more	   the	  
influence	  of	  a	  modified	  sulfation	  pattern	  on	  NSC	  behaviour.	  The	  negative	  charge	  along	  the	  GAG	  
chains	   and	   its	   variability	   by	   Chst	   modification	   are	   under	   discussion	   to	   provide	   a	   regulation	  
system	   for	   electrostatic	   interactions	   with	   binding	   factors	   (Ishii	   and	   Maeda,	   2008a).	   Most	  
interesting	   is	   the	   proposition	   of	   a	   HS	   sulfation	   pattern	   code	   hypothesis,	   which	   provides	   a	  
communication	   platform	  within	   the	   extracellular	  matrix	   for	   its	   inherent	   cells	   (Habuchi	   et	   al.,	  
2004,	  Bulow	  and	  Hobert,	  2006).	  Because	  of	  the	  similar	  structure	  of	  chondroitin	  sulfate	  and	  its	  
sulfation	  pattern,	  this	  hypothesis	  would	  be	  transferable	  and	  applicable	   in	  general	   for	  sulfated	  
proteoglycan	  GAG	  chains.	  	  
Figure	  24	  shows	  a	  possible	  mechanism	  how	  modifying	  the	  sulfation	  pattern	   improves	  binding	  
affinity	  for	  signalling	  molecules,	  here	  exemplarily	  depicted	  for	  growth	  factors.	  The	   increase	   in	  
sulfation	   raises	   the	   negative	   charge	   of	   the	  GAGs	   as	  well	   as	   changes	   their	   3D	   conformational	  
state	   and	   thereby	   generating	   for	   example	   more	   binding	   sites	   for	   growth	   factors	   or	   other	  
signalling	  molecules.	  The	  GFs	  can	  be	  stored	  within	  the	  ECM	  by	  secreted	  or	  transmembrane	  PGs	  
and,	   when	   needed,	   sequestered	   by	   their	   GAGs	   into	   the	   ECM.	   Transmembrane	   PGs	   rather	  
present	  the	  signalling	  molecules	  to	  their	  receptors	  on	  the	  cell	  surface	  or	  increase	  the	  activity	  of	  
signalling	  cascades	  as	  it	  was	  already	  shown	  for	  HS	  (Pellegrini	  L,	  2000,	  Schlessinger	  et	  al.,	  2000).	  
Moreover,	   transmembrane	   PGs	   are	   capable	   of	   directly	   transducing	   signals	   through	   cell	  
membranes	   (Alexopoulou	   et	   al.,	   2007)	   and	   additionally	   of	   releasing	   active	   GAG-­‐containing	  
ectodomains	  by	  shedding	  the	  transmembrane	  PG	  (Manon-­‐Jensen	  et	  al.,	  2010).	  So	  far,	  several	  
signalling	  pathways	  have	  been	  shown	  to	  be	   implicated	   in	  CSPG	  and	  CS-­‐GAG	  functionality,	   for	  
example	  the	  Rho/ROCK	  signalling	  pathway,	  ERK1/2	  signalling,	  FAK	  and	  Src	  phosphorylation	  and	  
integrin	   signalling	   (Wu	   et	   al.,	   2005,	   Gu	   et	   al.,	   2009,	   Brown	   et	   al.,	   2012,	   Dyck	   and	   Karimi-­‐
Abdolrezaee,	  2015,	  Nikolovska	  et	  al.,	  2015).	  The	  functionality	  does	  not	  simply	  depend	  on	  the	  
negative	  charge,	  but	  for	  example	  on	  the	  ratio	  of	  4-­‐	  to	  6-­‐sulfated	  CS,	  which	  terminates	  the	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Figure	  24	  Important	  functions	  and	  possible	  mechanisms	  of	  CSPGs	  
There	  are	   three	   forms	  of	  CSPGs:	   secreted,	   transmembrane	  and	  GPI-­‐anchored	  CSPGs.	   The	   shedding	  of	  
transmembrane	   CSPGs	   releases	   an	   active	   CS-­‐GAG-­‐containing	   ectodomain	   into	   the	   ECM.	   There	   are	  
several	  ways	  of	  CSPGs	  or	  PGs	  in	  general	  to	  influence	  signalling	  pathways.	  Here,	  the	  most	  probable	  and	  
important	   interactions	   of	   CSPGs	   with	   a	   modified	   sulfation	   pattern	   referring	   to	   the	   influence	   on	   NSC	  
behaviour	   are	  exemplarily	  depicted	   for	  GF	   signalling.	  CS-­‐GAGs	  exhibit	   growth	   factor	  binding	   sites	   and	  
after	  modifying	  the	  sulfation	  pattern,	  e.g.	  by	  overexpression	  of	  Ust,	  the	  number	  of	  binding	  sites	  present	  
can	  be	  increased.	  With	  more	  GFs	  bound	  to	  the	  GAGs,	  the	  probability	  to	  present	  the	  GFs	  to	  its	  relevant	  
receptor	  is	  higher	  and	  the	  activity	  of	  this	  signalling	  pathway	  is	  increased.	  Another	  function	  of	  CSPGs	  is	  to	  
store	   and	   sequester	   GFs	   in	   the	   matrix.	   Thereby,	   they	   can	   regulate	   the	   relevant	   signalling	   pathways,	  
enable	   the	   spatial	   and	   temporal	   regulation	   of	   the	   release	   and	   establish	  morphogen	   gradients.	   CSPG:	  
chondroitin	  sulphate	  proteoglycan,	  PG:	  proteoglycan,	  CS-­‐GAG:	  chondroitin	  sulphate	  glycosaminoglycan.	  





















critical	  period	  for	  occular	  dominance	  plasticity	  (Miyata	  et	  al.,	  2012),	  supporting	  the	  hypothesis	  
of	  the	  GAG	  sulfation	  pattern	  sequence	  and	  architecture	  importance.	  
Generally,	  the	  sequence,	  the	  conformation	  and	  the	  electrostatic	  potential	  of	  PG-­‐GAGs	  appear	  
more	  important	  than	  the	  simple	  degree	  of	  sulfation	  (Mizumoto	  et	  al.,	  2013).	  There	  is	  evidence,	  
that	   the	  GAG	  sulfation	  pattern	  becomes	  adapted	   to	   its	  needs	  of	   specific	  developmental	   time	  
points	   (e.g.	   neurogenesis,	   gliogenesis)	   by	   the	   spatial	   and	   temporal	   regulation	   of	   PG	   and	   PG-­‐
related	   gene	   expression	   (Nurcombe	   et	   al.,	   1993,	   Akita	   et	   al.,	   2008,	   Ishii	   and	  Maeda,	   2008b,	  
Mizumoto	   et	   al.,	   2013).	   The	   functionality	   of	   PGs	   acts	   in	   a	   context-­‐dependent	   manner	   by	  
structural	  PG	  core	  and	  GAG	  diversity	   (Lindahl,	  2014,	  Maeda,	  2015).	  This	  means	   in	  conclusion,	  
that	   the	   differentially	   regulated	   Chst	   and	   CSPG	   expression	   is	   essential	   for	   the	   mode	   of	  
operation	   and	   because	   of	   their	   involvement	   in	   so	  many	   processes	   it	   is	   complicated	   and	   yet	  
needed	   to	   unravel	   the	   basic	   mechanisms	   underlaying	   the	   complex	   system	   of	   PG	   ECM	  
interaction.	  Finally,	  it	  has	  to	  be	  further	  analysed,	  whether	  there	  is	  a	  sulfation	  code	  existing	  or	  if	  
the	   GAG	   sulfation	   pattern	   functionality	   is	   due	   to	   a	   statistical	   process	   based	   on	   the	  
stoichiometric	  availability	  of	  the	  different	  GAG	  units.	  One	  ECM	  component	  is	  only	  a	  small	  part	  
of	   the	  big	  picture	  and	   its	   specific	   function	   is	   regulated	  by	   its	   temporal	  and	  spatial	  expression	  
within	  its	  ECM	  molecule	  context	  as	  well	  as	  the	  additional	  possible	  combinatorial	  effects,	  which	  
increase	  functional	  diversity	  and	  expand	  the	  possible	   influencing	  pathways.	  To	  throw	  light	  on	  
the	   big	   picture	   these	   correlations	   remain	   to	   be	   better	   understood	   in	   the	   basic	   research	   and	  
maybe	  allow	  some	  day	  to	  improve	  treatment	  potentials	  of	  relevant	  diseases	  or	  developmental	  
disorders.	  
	  
4.5	  FUTURE	  ASPECTS	  
As	   Ust	   shRNA	   experiments	   using	   in	   utero	   electroporation	   revealed	   defects	   in	   neuronal	  
migration	  as	  well	  as	  divergent	  neuron	  morphology	   (Ishii	  and	  Maeda,	  2008a),	  opposite	  effects	  
on	  migration	   and	  an	   increase	   in	  bipolar	   shaped	  neurons	   in	   comparison	   to	  multipolar	   shaped	  
neurons	  in	  the	  control	  situation	  would	  be	  expected	  after	  Ust	  overexpression,	  although	  this	  still	  
needs	  to	  be	  experimentally	  analysed	  and	  validated.	  
In	  utero	  electroporation	  is	  a	  suitable	  way	  to	  analyse	  implications	  of	  a	  modified	  CSPG	  sulfation	  
pattern	   by	   overexpression	   or	   knockdown	   of	   distinct	   Chsts,	   because	   it	   bypasses	   possible	  
compensatory	  mechanisms	  that	  usually	  appear	  with	  chronic	  manipulations	  (Rauch	  et	  al.,	  2005),	  
especially	   with	   a	   number	   of	   7	   Chsts	   available	   to	   modify	   CS-­‐GAGs.	   Additionally,	   to	   prevent	  
functional	  compensation	  an	   inducible	  conditional	  knockout	  mouse	   line	  would	  be	  an	  excellent	  
opportunity	   to	   examine	   sulfation	   pattern	   implication	   on	   e.g.	   NSC	   behaviour	   by	   specifically	  
timed	  or	  restricted	  to	  specific	  cell	  types	  gene	  inactivation/deletion.	  Designing	  the	  Ust	  knockout	  
strategy	   (see	   2.11.3	   Strategy)	   and	   starting	   the	   preparation	   of	   the	   Ust	   conditional	   knockout	  
construct	   enable	   a	   fast	   generation	   of	   the	   transgenic	   mouse	   line	   and	   a	   promising	   analysis	  
strategy	  for	  future	  experiments	  to	  directly	  examine	  the	  role	  of	  a	  missing	  Ust	  CS-­‐GAG	  sulfation	  
on	  differentiation,	  self-­‐renewal,	  proliferation	  and	  migration	  during	  development	  at	  the	  desired	  
time	  point	  and	  addressing	   the	   favoured	  cell	   types.	  This	  would	  also	  allow	  the	  analysis	  of	   later	  
developmental	   time	   points	   as	   for	   example	   gliogenesis	   or	   long-­‐term	   effects,	   which	   were	   not	  
possible	  to	  analyse	  by	  using	  the	  in	  utero	  electroporation	  method.	  It	  would	  be	  interesting	  to	  see,	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   the	   here	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   reported	   impacts	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   and	  





Prof.	  Dr.	  Joachim	  Kirsch	  und	  PD	  Dr.	  Alexander	  von	  Holst	  danke	  ich	  dafür,	  dass	  sie	  mir	  die	  Arbeit	  
in	   Heidelberg	   am	   Institut	   für	   Anatomie	   und	   Zellbiologie	   an	   diesem	   interessanten	   Thema	  
ermöglicht	  haben.	  
Ich	  danke	  auch	  Dr.	  Gonzalo	  Alvarez-­‐Bolado	  und	  Dr.	  Roberta	  Haddad-­‐Tóvolli	  für	  die	  Möglichkeit	  
die	   in	   utero	   Elektroporationsmethode	   zu	   erlernen	   und	   in	   ihren	   Räumlichkeiten	   mit	   ihren	  
Geräten	  anzuwenden.	  
Außerdem	   möchte	   ich	   Prof.	   Dr.	   Thomas	   Kuner	   danken,	   der	   durch	   die	   Mitnutzung	   seines	  
Equipments	  einen	  Großteil	  der	  Auswertung	  ermöglicht	  hat.	  
Dr.	   Francesca	   Ciccolini	   und	   ihrer	   Arbeitsgruppe	   danke	   ich	   für	   unseren	   Austausch	   in	   unseren	  
Seminaren.	  
Die	   Nutzung	   des	   4D	   Electroporators	   zur	   NSC	   Transfektion	   hat	   freundlicherweise	   Dr.	   Ulrike	  
Müller	   ermöglicht,	   neben	  der	   zur	  Verfügungstellung	  des	  Plasmids	   für	  die	  Knockout-­‐Mauslinie	  
und	  die	  beratenden	  Gespräche	  mit	  Dr.	  Jakob	  Tschäpe.	  
Beate	  Quenzer	  danke	  ich	  herzlich	  für	  die	  Anfertigung	  und	  Färbung	  der	  schönen	  Cryoschnitte	  in	  
meiner	  Arbeit.	  
Den	   Mitarbeitern	   des	   Instituts	   möchte	   ich	   für	   die	   herzliche	   Aufnahme	   und	   eine	   schöne	  
gemeinsame	  Zeit	  danken,	  aber	  auch	  für	  die	  technische	  und	  persönliche	  Unterstützung	  während	  
meiner	  Zeit	  in	  Heidelberg.	  
	  
Liebe	   Sabrina,	   lieber	   Richard,	   mein	   besonderer	   Dank	   gilt	   euch,	   unserem	   3-­‐köpfigen	  
Doktoranden-­‐Team,	  ohne	  das	  vieles	  wohl	  anders	  gelaufen	  wäre.	  Ich	  danke	  euch	  so	  sehr	  für	  den	  
starken	  Zusammenhalt,	  die	  gegenseitige	  Unterstützung	   in	   jeglicher	  Form	  und	  besonders	  auch	  
für	   unseren	   offenen,	   ehrlichen	   Umgang	   mit	   viel	   Humor.	   Danke	   auch	   an	   unser	   ehemaliges	  
Labormitglied	  Valentin.	  
	  
Michi,	  du	  bist	  das	  Beste,	  was	  mir	  passiert	  ist.	  Ich	  danke	  dir	  für	  deine	  Unterstützung,	  fürs	  Dasein,	  
für	  deine	  Liebe.	  
	  
Besonderer	   Dank	   gilt	  meiner	   Familie	   für	   eure	   unermüdliche,	   liebevolle	   Unterstützung,	   schon	  
mein	  Leben	  lang.	   Ich	  freue	  mich	  sehr	  über	  die	  herzliche	  Aufnahme	  in	  Michis	  Familie,	   ihr	  zählt	  
für	  mich	  genauso	  dazu,	  also	  danke	  auch	  an	  euch.	  
	  
Ein	   Hoch	   auf	   Freunde	   und	   Familie:	   BBQ	   am	  Neckar,	   Balkon/Terassen-­‐Spaghettieis,	   Atzentag,	  
Sonntagsfrühstück,	   Kochsessions,	   Hängematten,	   Slacklinen,	   KinoMontag,	   Gammeln	   am	   See,	  
Bierchen/Weinchen?!,	   Abspacken,	   Beachen,	   Kaffeepäuschen,	   FestivalFeeling,	   Eispäuschen,	  
Lehrstuhlfrühstück/Filmabend,	   Wandern	   bis	   nach	   Neckarsteinach?!,	   InlinerTouren,	  
Sushisessions,	  Lasertag,	  und	  noch	  so	  vieles	  mehr...	  Danke!	  
	  
Ihr	  seid	  schlicht	  und	  einfach	  die	  Besten	  :)	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AGT GAG TCG TAT TAC AAT TCA CTG GCC GTC GTT TTA CAA CGT CGT GAC TGG GAA AAC
TCA CTC AGC ATA ATG TTA AGT GAC CGG CAG CAA AAT GTT GCA GCA CTG ACC CTT TTG
Comments for pCR®II-TOPO®
3973 nucleotides
LacZα gene:  bases 1-589
M13 Reverse priming site: bases 205-221
Sp6 promoter:  bases 239-256
Multiple Cloning Site:  bases 269-383
T7 promoter:  bases 406-425
M13 (-20) Forward priming site: bases 433-448
f1 origin:  bases 590-1027
Kanamycin resistance ORF:  bases 1361-2155
Ampicillin resistance ORF:  bases 2173-3033
















M13 Reverse Primer Sp6 Promoter
T7 Promoter M13 (-20) Forward Primer
Nsi I Hind III Kpn I Sac I Spe IBamH  I
BstX I Not I Xho I Nsi I Xba I Apa I
BstX I EcoR I EcoR I EcoR V
lacZα ATG
CAG GAA ACA GCT ATG ACC ATG ATT ACG CCA AGC TAT TTA GGT GAC ACT ATA GAA
GTC CTT TGT CGA TAC TGG TAC TAA TGC GGT TCG ATA AAT CCA CTG TGA TAT CTT
TAC TCA AGC TAT GCA TCA AGC TTG GTA CCG AGC TCG GAT CCA CTA GTA ACG GCC
ATG AGT TCG ATA CGT AGT TCG AAC CAT GGC TCG AGC CTA GGT GAT CAT TGC CGG
CCA TCA CAC TGG CGG CCG CTC GAG CAT GCA TCT AGA GGG CCC AAT TCG CCC TAT
GGT AGT GTG ACC GCC GGC GAG CTC GTA CGT AGA TCT CCC GGG TTA AGC GGG ATA
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pXL201- 3 X FLAG
7293 bp
